{"id": "298_597_1_412", "text": "WASP suppresses the growth defect of Saccharomyces cerevisiae las17Delta strain in the presence of WIP.", "text_with_entity_marker": "[E1]WASP[/E1] suppresses the growth defect of Saccharomyces cerevisiae las17Delta strain in the presence of [E2]WIP[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "WASP", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "WIP", "entity_2_idx": [[99, 102]], "entity_2_idx_in_text_with_entity_marker": [112, 115], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "298_598_1_413", "text": "Wiskott-Aldrich syndrome is caused by alterations in the Wiskott-Aldrich syndrome protein (WASP) and several of these mutations affect WASP's interaction with WIP (WASP-interacting protein), suggesting that loss of interaction between WASP and WIP is causal to the disease", "text_with_entity_marker": "Wiskott-Aldrich syndrome is caused by alterations in the Wiskott-Aldrich syndrome protein ([E1]WASP[/E1]) and several of these mutations affect WASP's interaction with [E2]WIP[/E2] (WASP-interacting protein), suggesting that loss of interaction between WASP and WIP is causal to the disease", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "WASP", "entity_1_idx": [[91, 95]], "entity_1_idx_in_text_with_entity_marker": [95, 99], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "WIP", "entity_2_idx": [[159, 162]], "entity_2_idx_in_text_with_entity_marker": [172, 175], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "83_168_10_111", "text": "Biochemical studies show that IAA1/AXR5 interacts with TIR1 in an auxin-dependent manner", "text_with_entity_marker": "Biochemical studies show that [E1]IAA1/AXR5[/E1] interacts with [E2]TIR1[/E2] in an auxin-dependent manner", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IAA1/AXR5", "entity_1_idx": [[30, 39]], "entity_1_idx_in_text_with_entity_marker": [34, 43], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "TIR1", "entity_2_idx": [[55, 59]], "entity_2_idx_in_text_with_entity_marker": [68, 72], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "115_231_1_155", "text": "Complex formation between Mad1p, Bub1p and Bub3p is crucial for spindle checkpoint function.", "text_with_entity_marker": "Complex formation between [E1]Mad1p[/E1], [E2]Bub1p[/E2] and Bub3p is crucial for spindle checkpoint function.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Mad1p", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Bub1p", "entity_2_idx": [[33, 38]], "entity_2_idx_in_text_with_entity_marker": [46, 51], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "115_231_1_156", "text": "Complex formation between Mad1p, Bub1p and Bub3p is crucial for spindle checkpoint function.", "text_with_entity_marker": "Complex formation between [E1]Mad1p[/E1], Bub1p and [E2]Bub3p[/E2] is crucial for spindle checkpoint function.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Mad1p", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Bub3p", "entity_2_idx": [[43, 48]], "entity_2_idx_in_text_with_entity_marker": [56, 61], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "115_232_9_157", "text": "Mutation of this motif abolishes checkpoint function, indicating that formation of the Mad1p-Bub1p-Bub3p complex is a crucial step in the spindle checkpoint mechanism.", "text_with_entity_marker": "Mutation of this motif abolishes checkpoint function, indicating that formation of the [E1]Mad1p[/E1]-[E2]Bub1p[/E2]-Bub3p complex is a crucial step in the spindle checkpoint mechanism.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Mad1p", "entity_1_idx": [[87, 92]], "entity_1_idx_in_text_with_entity_marker": [91, 96], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Bub1p", "entity_2_idx": [[93, 98]], "entity_2_idx_in_text_with_entity_marker": [106, 111], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "115_232_9_158", "text": "Mutation of this motif abolishes checkpoint function, indicating that formation of the Mad1p-Bub1p-Bub3p complex is a crucial step in the spindle checkpoint mechanism.", "text_with_entity_marker": "Mutation of this motif abolishes checkpoint function, indicating that formation of the [E1]Mad1p[/E1]-Bub1p-[E2]Bub3p[/E2] complex is a crucial step in the spindle checkpoint mechanism.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Mad1p", "entity_1_idx": [[87, 92]], "entity_1_idx_in_text_with_entity_marker": [91, 96], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Bub3p", "entity_2_idx": [[99, 104]], "entity_2_idx_in_text_with_entity_marker": [112, 117], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "188_377_1_245", "text": "Dab1 stabilizes its interaction with Cin85 by suppressing Cin85 phosphorylation at serine 587.", "text_with_entity_marker": "[E1]Dab1[/E1] stabilizes its interaction with [E2]Cin85[/E2] by suppressing Cin85 phosphorylation at serine 587.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Dab1", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Cin85", "entity_2_idx": [[37, 42]], "entity_2_idx_in_text_with_entity_marker": [50, 55], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "188_378_3_246", "text": "Here using mass spectrometry, biochemical and mutational analyses we show that Dab1 suppresses Cin85 phosphorylation at Ser587", "text_with_entity_marker": "Here using mass spectrometry, biochemical and mutational analyses we show that [E1]Dab1[/E1] suppresses [E2]Cin85[/E2] phosphorylation at Ser587", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Dab1", "entity_1_idx": [[79, 83]], "entity_1_idx_in_text_with_entity_marker": [83, 87], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Cin85", "entity_2_idx": [[95, 100]], "entity_2_idx_in_text_with_entity_marker": [108, 113], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "336_674_10_447", "text": "Direct interaction between Kae1p and Bud32p in yeast is required both for the transcription and the telomere homeostasis function of EKC/KEOPS.", "text_with_entity_marker": "Direct interaction between [E1]Kae1p[/E1] and [E2]Bud32p[/E2] in yeast is required both for the transcription and the telomere homeostasis function of EKC/KEOPS.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Kae1p", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Bud32p", "entity_2_idx": [[37, 43]], "entity_2_idx_in_text_with_entity_marker": [50, 56], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "138_278_2_193", "text": "We describe here the isolation and characterization of a Golgi protein, GOPC, as a frizzled interacting protein", "text_with_entity_marker": "We describe here the isolation and characterization of a Golgi protein, [E1]GOPC[/E1], as a [E2]frizzled[/E2] interacting protein", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "GOPC", "entity_1_idx": [[72, 76]], "entity_1_idx_in_text_with_entity_marker": [76, 80], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "frizzled", "entity_2_idx": [[83, 91]], "entity_2_idx_in_text_with_entity_marker": [96, 104], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "138_278_11_194", "text": "Taken together, these results indicate that GOPC may play a role in the vesicle transport of frizzled from the Golgi apparatus to the plasma membrane.", "text_with_entity_marker": "Taken together, these results indicate that [E1]GOPC[/E1] may play a role in the vesicle transport of [E2]frizzled[/E2] from the Golgi apparatus to the plasma membrane.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "GOPC", "entity_1_idx": [[44, 48]], "entity_1_idx_in_text_with_entity_marker": [48, 52], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "frizzled", "entity_2_idx": [[93, 101]], "entity_2_idx_in_text_with_entity_marker": [106, 114], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "43_87_1_68", "text": "Association of Bovine Papillomavirus Type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif.", "text_with_entity_marker": "Association of Bovine [E1]Papillomavirus Type 1 E6 oncoprotein[/E1] with the focal adhesion protein [E2]paxillin[/E2] through a conserved protein interaction motif.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Papillomavirus Type 1 E6 oncoprotein", "entity_1_idx": [[22, 58]], "entity_1_idx_in_text_with_entity_marker": [26, 62], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "paxillin", "entity_2_idx": [[91, 99]], "entity_2_idx_in_text_with_entity_marker": [104, 112], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "206_414_6_270", "text": "Functional assays showed reduced binding of this TRAF3IP2 variant to TRAF6, suggesting altered modulation of immunoregulatory signals through altered TRAF interactions as a new and shared pathway for PsA and PsV.", "text_with_entity_marker": "Functional assays showed reduced binding of this [E1]TRAF3IP2[/E1] variant to [E2]TRAF6[/E2], suggesting altered modulation of immunoregulatory signals through altered TRAF interactions as a new and shared pathway for PsA and PsV.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TRAF3IP2", "entity_1_idx": [[49, 57]], "entity_1_idx_in_text_with_entity_marker": [53, 61], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "TRAF6", "entity_2_idx": [[69, 74]], "entity_2_idx_in_text_with_entity_marker": [82, 87], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "258_518_4_344", "text": "In contrast, a surface specific to TAB2 and TAB3 binds the proximal ubiquitin", "text_with_entity_marker": "In contrast, a surface specific to [E1]TAB2[/E1] and TAB3 binds the proximal [E2]ubiquitin[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TAB2", "entity_1_idx": [[35, 39]], "entity_1_idx_in_text_with_entity_marker": [39, 43], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "ubiquitin", "entity_2_idx": [[68, 77]], "entity_2_idx_in_text_with_entity_marker": [81, 90], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "258_518_4_345", "text": "In contrast, a surface specific to TAB2 and TAB3 binds the proximal ubiquitin", "text_with_entity_marker": "In contrast, a surface specific to TAB2 and [E1]TAB3[/E1] binds the proximal [E2]ubiquitin[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TAB3", "entity_1_idx": [[44, 48]], "entity_1_idx_in_text_with_entity_marker": [48, 52], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "ubiquitin", "entity_2_idx": [[68, 77]], "entity_2_idx_in_text_with_entity_marker": [81, 90], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "167_336_8_216", "text": "Our data therefore strongly support the idea that the Cdc28 CDK regulates cytokinesis partly by directly phosphorylating the actomyosin ring component Iqg1.", "text_with_entity_marker": "Our data therefore strongly support the idea that the [E1]Cdc28 CDK[/E1] regulates cytokinesis partly by directly phosphorylating the actomyosin ring component [E2]Iqg1[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Cdc28 CDK", "entity_1_idx": [[54, 63]], "entity_1_idx_in_text_with_entity_marker": [58, 67], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Iqg1", "entity_2_idx": [[151, 155]], "entity_2_idx_in_text_with_entity_marker": [164, 168], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "312_625_1_423", "text": "Telomeric protein Pin2/TRF1 as an important ATM target in response to double strand DNA breaks.", "text_with_entity_marker": "Telomeric protein Pin2/TRF1 as an important [E1]ATM[/E1][E2]Pin2/TRF1[/E2] as an important ATM target in response to double strand DNA breaks.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ATM", "entity_1_idx": [[44, 47]], "entity_1_idx_in_text_with_entity_marker": [48, 51], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Pin2/TRF1", "entity_2_idx": [[18, 27]], "entity_2_idx_in_text_with_entity_marker": [60, 69], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "312_626_14_424", "text": "These results demonstrate for the first time that ATM interacts with and phosphorylates Pin2/TRF1 and suggest that Pin2/TRF1 may be involved in the cellular response to double strand DNA breaks.", "text_with_entity_marker": "These results demonstrate for the first time that [E1]ATM[/E1] interacts with and phosphorylates [E2]Pin2/TRF1[/E2] and suggest that Pin2/TRF1 may be involved in the cellular response to double strand DNA breaks.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ATM", "entity_1_idx": [[50, 53]], "entity_1_idx_in_text_with_entity_marker": [54, 57], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Pin2/TRF1", "entity_2_idx": [[88, 97]], "entity_2_idx_in_text_with_entity_marker": [101, 110], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "102_206_2_128", "text": "Binding of the talin phosphotyrosine-binding (PTB) domain to integrin beta subunit cytoplasmic domains (tails) causes activation, whereas numerous other PTB-domain-containing proteins bind integrins without activating them", "text_with_entity_marker": "Binding of the [E1]talin[/E1] phosphotyrosine-binding (PTB) domain to [E2]integrin[/E2] beta subunit cytoplasmic domains (tails) causes activation, whereas numerous other PTB-domain-containing proteins bind integrins without activating them", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[15, 20]], "entity_1_idx_in_text_with_entity_marker": [19, 24], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "integrin", "entity_2_idx": [[61, 69]], "entity_2_idx_in_text_with_entity_marker": [74, 82], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "61_123_1_84", "text": "NDR1 interaction with RIN4 mediates the differential activation of multiple disease resistance pathways in Arabidopsis.", "text_with_entity_marker": "[E1]NDR1[/E1] interaction with [E2]RIN4[/E2] mediates the differential activation of multiple disease resistance pathways in Arabidopsis.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "NDR1", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "RIN4", "entity_2_idx": [[22, 26]], "entity_2_idx_in_text_with_entity_marker": [35, 39], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "61_124_9_85", "text": "We demonstrate that like RPS2 and RPM1, NDR1 also associates with RIN4 in planta", "text_with_entity_marker": "We demonstrate that like RPS2 and RPM1, [E1]NDR1[/E1] also associates with [E2]RIN4[/E2] in planta", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "NDR1", "entity_1_idx": [[40, 44]], "entity_1_idx_in_text_with_entity_marker": [44, 48], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "RIN4", "entity_2_idx": [[66, 70]], "entity_2_idx_in_text_with_entity_marker": [79, 83], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "61_124_9_86", "text": "We demonstrate that like RPS2 and RPM1, NDR1 also associates with RIN4 in planta", "text_with_entity_marker": "We demonstrate that like [E1]RPS2[/E1] and RPM1, NDR1 also associates with [E2]RIN4[/E2] in planta", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RPS2", "entity_1_idx": [[25, 29]], "entity_1_idx_in_text_with_entity_marker": [29, 33], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "RIN4", "entity_2_idx": [[66, 70]], "entity_2_idx_in_text_with_entity_marker": [79, 83], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "61_124_9_87", "text": "We demonstrate that like RPS2 and RPM1, NDR1 also associates with RIN4 in planta", "text_with_entity_marker": "We demonstrate that like RPS2 and [E1]RPM1[/E1], NDR1 also associates with [E2]RIN4[/E2] in planta", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RPM1", "entity_1_idx": [[34, 38]], "entity_1_idx_in_text_with_entity_marker": [38, 42], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "RIN4", "entity_2_idx": [[66, 70]], "entity_2_idx_in_text_with_entity_marker": [79, 83], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "289_579_1_397", "text": "Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1.", "text_with_entity_marker": "Ebola virus protein [E1]VP35[/E1] impairs the function of interferon regulatory factor-activating kinases [E2]IKKepsilon[/E2] and TBK-1.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "VP35", "entity_1_idx": [[20, 24]], "entity_1_idx_in_text_with_entity_marker": [24, 28], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "IKKepsilon", "entity_2_idx": [[97, 107]], "entity_2_idx_in_text_with_entity_marker": [110, 120], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "289_579_1_398", "text": "Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1.", "text_with_entity_marker": "Ebola virus protein [E1]VP35[/E1] impairs the function of interferon regulatory factor-activating kinases IKKepsilon and [E2]TBK-1[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "VP35", "entity_1_idx": [[20, 24]], "entity_1_idx_in_text_with_entity_marker": [24, 28], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "TBK-1", "entity_2_idx": [[112, 117]], "entity_2_idx_in_text_with_entity_marker": [125, 130], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "289_580_10_399", "text": "These data suggest that VP35 exerts its IFN-antagonist function, at least in part, by blocking necessary interactions between the kinases IKKepsilon and TBK-1 and their normal interaction partners, including their substrates, IRF-3 and IRF-7.", "text_with_entity_marker": "These data suggest that [E1]VP35[/E1] exerts its IFN-antagonist function, at least in part, by blocking necessary interactions between the kinases IKKepsilon and TBK-1 and their normal interaction partners, including their substrates, [E2]IRF-3[/E2] and IRF-7.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "VP35", "entity_1_idx": [[24, 28]], "entity_1_idx_in_text_with_entity_marker": [28, 32], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "IRF-3", "entity_2_idx": [[226, 231]], "entity_2_idx_in_text_with_entity_marker": [239, 244], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "289_580_10_400", "text": "These data suggest that VP35 exerts its IFN-antagonist function, at least in part, by blocking necessary interactions between the kinases IKKepsilon and TBK-1 and their normal interaction partners, including their substrates, IRF-3 and IRF-7.", "text_with_entity_marker": "These data suggest that [E1]VP35[/E1] exerts its IFN-antagonist function, at least in part, by blocking necessary interactions between the kinases IKKepsilon and TBK-1 and their normal interaction partners, including their substrates, IRF-3 and [E2]IRF-7[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "VP35", "entity_1_idx": [[24, 28]], "entity_1_idx_in_text_with_entity_marker": [28, 32], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "IRF-7", "entity_2_idx": [[236, 241]], "entity_2_idx_in_text_with_entity_marker": [249, 254], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "216_433_1_283", "text": "c-Abl phosphorylates a-synuclein and regulates its degradation: implication for a-synuclein clearance and contribution to the pathogenesis of Parkinson's disease.", "text_with_entity_marker": "[E1]c-Abl[/E1] phosphorylates [E2]a-synuclein[/E2] and regulates its degradation: implication for a-synuclein clearance and contribution to the pathogenesis of Parkinson's disease.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "c-Abl", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "a-synuclein", "entity_2_idx": [[21, 32]], "entity_2_idx_in_text_with_entity_marker": [34, 45], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "216_434_2_284", "text": "c-Abl has been shown to regulate the degradation of two proteins implicated in the pathogenesis of PD, parkin and a-synuclein (a-syn)", "text_with_entity_marker": "[E1]c-Abl[/E1] has been shown to regulate the degradation of two proteins implicated in the pathogenesis of PD, [E2]parkin[/E2] and a-synuclein (a-syn)", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "c-Abl", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "parkin", "entity_2_idx": [[103, 109]], "entity_2_idx_in_text_with_entity_marker": [116, 122], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "131_263_1_179", "text": "A single amino acid change in the transmembrane domain of the VirB8 protein affects dimerization, interaction with VirB10 and Brucella suis virulence.", "text_with_entity_marker": "A single amino acid change in the transmembrane domain of the [E1]VirB8[/E1] protein affects dimerization, interaction with [E2]VirB10[/E2] and Brucella suis virulence.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "VirB8", "entity_1_idx": [[62, 67]], "entity_1_idx_in_text_with_entity_marker": [66, 71], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "VirB10", "entity_2_idx": [[115, 121]], "entity_2_idx_in_text_with_entity_marker": [128, 134], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "293_587_1_405", "text": "SUMOylation of Blimp-1 is critical for plasma cell differentiation.", "text_with_entity_marker": "[E1]SUMO[/E1]ylation of [E2]Blimp-1[/E2] is critical for plasma cell differentiation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SUMO", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Blimp-1", "entity_2_idx": [[15, 22]], "entity_2_idx_in_text_with_entity_marker": [28, 35], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "293_588_4_406", "text": "Thus, the SUMO pathway critically regulates Blimp-1 function during plasma cell differentiation.", "text_with_entity_marker": "Thus, the [E1]SUMO[/E1] pathway critically regulates [E2]Blimp-1[/E2] function during plasma cell differentiation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SUMO", "entity_1_idx": [[10, 14]], "entity_1_idx_in_text_with_entity_marker": [14, 18], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Blimp-1", "entity_2_idx": [[44, 51]], "entity_2_idx_in_text_with_entity_marker": [57, 64], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "285_571_1_393", "text": "GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by ArfGAP1.", "text_with_entity_marker": "GTPase activity and neuronal toxicity of Parkinson's disease-associated LRRK2 is regulated by [E1]ArfGAP1[/E1][E2]LRRK2[/E2] is regulated by ArfGAP1.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ArfGAP1", "entity_1_idx": [[94, 101]], "entity_1_idx_in_text_with_entity_marker": [98, 105], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "LRRK2", "entity_2_idx": [[72, 77]], "entity_2_idx_in_text_with_entity_marker": [114, 119], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "285_572_6_394", "text": "Here, we identify a novel functional interaction between LRRK2 and ADP-ribosylation factor GTPase-activating protein 1 (ArfGAP1)", "text_with_entity_marker": "Here, we identify a novel functional interaction between [E1]LRRK2[/E1] and [E2]ADP-ribosylation factor GTPase-activating protein 1 (ArfGAP1)[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "LRRK2", "entity_1_idx": [[57, 62]], "entity_1_idx_in_text_with_entity_marker": [61, 66], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "ADP-ribosylation factor GTPase-activating protein 1 (ArfGAP1)", "entity_2_idx": [[67, 128]], "entity_2_idx_in_text_with_entity_marker": [80, 141], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "226_454_2_295", "text": "In Escherichia coli, cytoplasmic membrane proteins ExbB and ExbD promote conformational changes in TonB, which transmits this energy to the transporters", "text_with_entity_marker": "In Escherichia coli, cytoplasmic membrane proteins [E1]ExbB[/E1] and ExbD promote conformational changes in [E2]TonB[/E2], which transmits this energy to the transporters", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "ExbB", "entity_1_idx": [[51, 55]], "entity_1_idx_in_text_with_entity_marker": [55, 59], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "TonB", "entity_2_idx": [[99, 103]], "entity_2_idx_in_text_with_entity_marker": [112, 116], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "226_454_2_296", "text": "In Escherichia coli, cytoplasmic membrane proteins ExbB and ExbD promote conformational changes in TonB, which transmits this energy to the transporters", "text_with_entity_marker": "In Escherichia coli, cytoplasmic membrane proteins ExbB and [E1]ExbD[/E1] promote conformational changes in [E2]TonB[/E2], which transmits this energy to the transporters", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "ExbD", "entity_1_idx": [[60, 64]], "entity_1_idx_in_text_with_entity_marker": [64, 68], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "TonB", "entity_2_idx": [[99, 103]], "entity_2_idx_in_text_with_entity_marker": [112, 116], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "2_5_1_4", "text": "A direct interaction between the Utp6 half-a-tetratricopeptide repeat domain and a specific peptide in Utp21 is essential for efficient pre-rRNA processing.", "text_with_entity_marker": "A direct interaction between the [E1]Utp6[/E1] half-a-tetratricopeptide repeat domain and a specific peptide in [E2]Utp21[/E2] is essential for efficient pre-rRNA processing.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Utp6", "entity_1_idx": [[33, 37]], "entity_1_idx_in_text_with_entity_marker": [37, 41], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Utp21", "entity_2_idx": [[103, 108]], "entity_2_idx_in_text_with_entity_marker": [116, 121], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "2_6_3_5", "text": "We present a comprehensive map of the interactions within the UtpB subcomplex and further show that the N-terminal domain of Utp6 interacts with Utp18 while the HAT domain interacts with Utp21", "text_with_entity_marker": "We present a comprehensive map of the interactions within the UtpB subcomplex and further show that the N-terminal domain of [E1]Utp6[/E1] interacts with [E2]Utp18[/E2] while the HAT domain interacts with Utp21", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Utp6", "entity_1_idx": [[125, 129]], "entity_1_idx_in_text_with_entity_marker": [129, 133], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Utp18", "entity_2_idx": [[145, 150]], "entity_2_idx_in_text_with_entity_marker": [158, 163], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "2_6_3_6", "text": "We present a comprehensive map of the interactions within the UtpB subcomplex and further show that the N-terminal domain of Utp6 interacts with Utp18 while the HAT domain interacts with Utp21", "text_with_entity_marker": "We present a comprehensive map of the interactions within the UtpB subcomplex and further show that the N-terminal domain of [E1]Utp6[/E1] interacts with Utp18 while the HAT domain interacts with [E2]Utp21[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Utp6", "entity_1_idx": [[125, 129]], "entity_1_idx_in_text_with_entity_marker": [129, 133], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Utp21", "entity_2_idx": [[187, 192]], "entity_2_idx_in_text_with_entity_marker": [200, 205], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "299_599_1_414", "text": "AIF promotes chromatinolysis and caspase-independent programmed necrosis by interacting with histone H2AX.", "text_with_entity_marker": "[E1]AIF[/E1] promotes chromatinolysis and caspase-independent programmed necrosis by interacting with histone [E2]H2AX[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "AIF", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "H2AX", "entity_2_idx": [[101, 105]], "entity_2_idx_in_text_with_entity_marker": [114, 118], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "299_600_4_415", "text": "We show here that, through its C-terminal proline-rich binding domain (PBD, residues 543-559), AIF associates in the nucleus with histone H2AX", "text_with_entity_marker": "We show here that, through its C-terminal proline-rich binding domain (PBD, residues 543-559), [E1]AIF[/E1] associates in the nucleus with histone [E2]H2AX[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "AIF", "entity_1_idx": [[95, 98]], "entity_1_idx_in_text_with_entity_marker": [99, 102], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "H2AX", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "147_295_1_203", "text": "MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation.", "text_with_entity_marker": "[E1]MED25[/E1] is distinct from TRAP220/MED1 in cooperating with [E2]CBP[/E2] for retinoid receptor activation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MED25", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[56, 59]], "entity_2_idx_in_text_with_entity_marker": [69, 72], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "147_296_9_204", "text": "Our data suggest that MED25, in cooperation with CBP and Mediators through its distinct domains, imposes a selective advantage on RAR/RXR activation.", "text_with_entity_marker": "Our data suggest that [E1]MED25[/E1], in cooperation with [E2]CBP[/E2] and Mediators through its distinct domains, imposes a selective advantage on RAR/RXR activation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MED25", "entity_1_idx": [[22, 27]], "entity_1_idx_in_text_with_entity_marker": [26, 31], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[49, 52]], "entity_2_idx_in_text_with_entity_marker": [62, 65], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "329_659_1_445", "text": "Mycobacterium tuberculosis WhiB3 interacts with RpoV to affect host survival but is dispensable for in vivo growth.", "text_with_entity_marker": "Mycobacterium tuberculosis [E1]WhiB3[/E1] interacts with [E2]RpoV[/E2] to affect host survival but is dispensable for in vivo growth.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "WhiB3", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "RpoV", "entity_2_idx": [[48, 52]], "entity_2_idx_in_text_with_entity_marker": [61, 65], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "181_364_3_233", "text": "Here, we identified both catalytic gamma-isoforms of protein phosphatase 1C (PP1gamma1 and PP1gamma2) as binding partners of the group I metabotropic glutamate receptors type 1a, 5a, and 5b in yeast cells and pull-down assays, using recombinant and native protein preparations", "text_with_entity_marker": "Here, we identified both [E1]catalytic gamma-isoforms of protein phosphatase 1C (PP1gamma1 and PP1gamma2)[/E1] as binding partners of the group I metabotropic [E2]glutamate receptors type 1a[/E2], 5a, and 5b in yeast cells and pull-down assays, using recombinant and native protein preparations", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "catalytic gamma-isoforms of protein phosphatase 1C (PP1gamma1 and PP1gamma2)", "entity_1_idx": [[25, 101]], "entity_1_idx_in_text_with_entity_marker": [29, 105], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "glutamate receptors type 1a", "entity_2_idx": [[150, 177]], "entity_2_idx_in_text_with_entity_marker": [163, 190], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "181_364_3_234", "text": "Here, we identified both catalytic gamma-isoforms of protein phosphatase 1C (PP1gamma1 and PP1gamma2) as binding partners of the group I metabotropic glutamate receptors type 1a, 5a, and 5b in yeast cells and pull-down assays, using recombinant and native protein preparations", "text_with_entity_marker": "Here, we identified both [E1]catalytic gamma-isoforms of protein phosphatase 1C (PP1gamma1 and PP1gamma2)[/E1] as binding partners of the group I metabotropic glutamate receptors type 1a, [E2]5a[/E2], and 5b in yeast cells and pull-down assays, using recombinant and native protein preparations", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "catalytic gamma-isoforms of protein phosphatase 1C (PP1gamma1 and PP1gamma2)", "entity_1_idx": [[25, 101]], "entity_1_idx_in_text_with_entity_marker": [29, 105], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "5a", "entity_2_idx": [[179, 181]], "entity_2_idx_in_text_with_entity_marker": [192, 194], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "181_364_3_235", "text": "Here, we identified both catalytic gamma-isoforms of protein phosphatase 1C (PP1gamma1 and PP1gamma2) as binding partners of the group I metabotropic glutamate receptors type 1a, 5a, and 5b in yeast cells and pull-down assays, using recombinant and native protein preparations", "text_with_entity_marker": "Here, we identified both [E1]catalytic gamma-isoforms of protein phosphatase 1C (PP1gamma1 and PP1gamma2)[/E1] as binding partners of the group I metabotropic glutamate receptors type 1a, 5a, [E2]and 5b[/E2] in yeast cells and pull-down assays, using recombinant and native protein preparations", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "catalytic gamma-isoforms of protein phosphatase 1C (PP1gamma1 and PP1gamma2)", "entity_1_idx": [[25, 101]], "entity_1_idx_in_text_with_entity_marker": [29, 105], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "and 5b", "entity_2_idx": [[183, 189]], "entity_2_idx_in_text_with_entity_marker": [196, 202], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "317_635_1_430", "text": "Phospholipase Cgamma/diacylglycerol-dependent activation of beta2-chimaerin restricts EGF-induced Rac signaling.", "text_with_entity_marker": "[E1]Phospholipase Cgamma[/E1]/diacylglycerol-dependent activation of [E2]beta2-chimaerin[/E2] restricts EGF-induced Rac signaling.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Phospholipase Cgamma", "entity_1_idx": [[0, 20]], "entity_1_idx_in_text_with_entity_marker": [4, 24], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "beta2-chimaerin", "entity_2_idx": [[60, 75]], "entity_2_idx_in_text_with_entity_marker": [73, 88], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d136.s1154_AIMed.d136.s1154.p19", "text": "Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the IL-2 receptor.", "text_with_entity_marker": "Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that [E1]IL-15[/E1] uses components of the [E2]IL-2 receptor[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "IL-15", "entity_1_idx": [[163, 168]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-2 receptor", "entity_2_idx": [[192, 205]], "entity_2_idx_in_text_with_entity_marker": [205, 218], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d164.s1378_AIMed.d164.s1378.p0", "text": "The splicing factor U2AF (U2 snRNP auxiliary factor) is a heterodimer with subunits of 65 and 35 kD (U2AF65 and U2AF35).", "text_with_entity_marker": "The splicing factor U2AF (U2 snRNP auxiliary factor) is a heterodimer with subunits of 65 and 35 kD ([E1]U2AF65[/E1] and [E2]U2AF35[/E2]).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "U2AF65", "entity_1_idx": [[101, 107]], "entity_1_idx_in_text_with_entity_marker": [105, 111], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "U2AF35", "entity_2_idx": [[112, 118]], "entity_2_idx_in_text_with_entity_marker": [125, 131], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d156.s1320_AIMed.d156.s1320.p0", "text": "IRAK: a kinase associated with the interleukin-1 receptor.", "text_with_entity_marker": "[E1]IRAK[/E1]: a kinase associated with the [E2]interleukin-1 receptor[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IRAK", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "interleukin-1 receptor", "entity_2_idx": [[35, 57]], "entity_2_idx_in_text_with_entity_marker": [48, 70], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d156.s1321_AIMed.d156.s1321.p1", "text": "The pleiotropic biological activities of interleukin-1 (IL-1) are mediated by its type I receptor (IL-1RI).", "text_with_entity_marker": "The pleiotropic biological activities of [E1]interleukin-1[/E1] (IL-1) are mediated by its type I receptor ([E2]IL-1RI[/E2]).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "interleukin-1", "entity_1_idx": [[41, 54]], "entity_1_idx_in_text_with_entity_marker": [45, 58], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-1RI", "entity_2_idx": [[99, 105]], "entity_2_idx_in_text_with_entity_marker": [112, 118], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d156.s1321_AIMed.d156.s1321.p2", "text": "The pleiotropic biological activities of interleukin-1 (IL-1) are mediated by its type I receptor (IL-1RI).", "text_with_entity_marker": "The pleiotropic biological activities of interleukin-1 ([E1]IL-1[/E1]) are mediated by its type I receptor ([E2]IL-1RI[/E2]).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-1", "entity_1_idx": [[56, 60]], "entity_1_idx_in_text_with_entity_marker": [60, 64], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-1RI", "entity_2_idx": [[99, 105]], "entity_2_idx_in_text_with_entity_marker": [112, 118], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d156.s1324_AIMed.d156.s1324.p5", "text": "When human embryonic kidney cells (cell line 293) over-expressing IL-1RI or HeLa cells were exposed to IL-1, IRAK rapidly associated with the IL-1RI complex and was phosphorylated.", "text_with_entity_marker": "When human embryonic kidney cells (cell line 293) over-expressing IL-1RI or HeLa cells were exposed to IL-1, [E1]IRAK[/E1] rapidly associated with the [E2]IL-1RI[/E2] complex and was phosphorylated.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IRAK", "entity_1_idx": [[109, 113]], "entity_1_idx_in_text_with_entity_marker": [113, 117], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-1RI", "entity_2_idx": [[142, 148]], "entity_2_idx_in_text_with_entity_marker": [155, 161], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d178.s1508_AIMed.d178.s1508.p0", "text": "In vitro and in nonproliferating cells, p27 associates with and inhibits cyclin/cycin-dependent kinase (CDK) holoenzymes containing either CDK4, CDK6, or CDK2.", "text_with_entity_marker": "In vitro and in nonproliferating cells, [E1]p27[/E1] associates with and inhibits cyclin/cycin-dependent kinase (CDK) holoenzymes containing either [E2]CDK4[/E2], CDK6, or CDK2.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[40, 43]], "entity_1_idx_in_text_with_entity_marker": [44, 47], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CDK4", "entity_2_idx": [[139, 143]], "entity_2_idx_in_text_with_entity_marker": [152, 156], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d178.s1508_AIMed.d178.s1508.p1", "text": "In vitro and in nonproliferating cells, p27 associates with and inhibits cyclin/cycin-dependent kinase (CDK) holoenzymes containing either CDK4, CDK6, or CDK2.", "text_with_entity_marker": "In vitro and in nonproliferating cells, [E1]p27[/E1] associates with and inhibits cyclin/cycin-dependent kinase (CDK) holoenzymes containing either CDK4, [E2]CDK6[/E2], or CDK2.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[40, 43]], "entity_1_idx_in_text_with_entity_marker": [44, 47], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CDK6", "entity_2_idx": [[145, 149]], "entity_2_idx_in_text_with_entity_marker": [158, 162], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d178.s1508_AIMed.d178.s1508.p2", "text": "In vitro and in nonproliferating cells, p27 associates with and inhibits cyclin/cycin-dependent kinase (CDK) holoenzymes containing either CDK4, CDK6, or CDK2.", "text_with_entity_marker": "In vitro and in nonproliferating cells, [E1]p27[/E1] associates with and inhibits cyclin/cycin-dependent kinase (CDK) holoenzymes containing either CDK4, CDK6, or [E2]CDK2[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[40, 43]], "entity_1_idx_in_text_with_entity_marker": [44, 47], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CDK2", "entity_2_idx": [[154, 158]], "entity_2_idx_in_text_with_entity_marker": [167, 171], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d178.s1511_AIMed.d178.s1511.p0", "text": "In addition, p27 associates with three different CDKs: CDK2, CDK4, and CDK6.", "text_with_entity_marker": "In addition, [E1]p27[/E1] associates with three different CDKs: [E2]CDK2[/E2], CDK4, and CDK6.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[13, 16]], "entity_1_idx_in_text_with_entity_marker": [17, 20], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CDK2", "entity_2_idx": [[55, 59]], "entity_2_idx_in_text_with_entity_marker": [68, 72], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d178.s1511_AIMed.d178.s1511.p1", "text": "In addition, p27 associates with three different CDKs: CDK2, CDK4, and CDK6.", "text_with_entity_marker": "In addition, [E1]p27[/E1] associates with three different CDKs: CDK2, [E2]CDK4[/E2], and CDK6.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[13, 16]], "entity_1_idx_in_text_with_entity_marker": [17, 20], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CDK4", "entity_2_idx": [[61, 65]], "entity_2_idx_in_text_with_entity_marker": [74, 78], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d178.s1511_AIMed.d178.s1511.p2", "text": "In addition, p27 associates with three different CDKs: CDK2, CDK4, and CDK6.", "text_with_entity_marker": "In addition, [E1]p27[/E1] associates with three different CDKs: CDK2, CDK4, and [E2]CDK6[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[13, 16]], "entity_1_idx_in_text_with_entity_marker": [17, 20], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CDK6", "entity_2_idx": [[71, 75]], "entity_2_idx_in_text_with_entity_marker": [84, 88], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d178.s1513_AIMed.d178.s1513.p1", "text": "The amount of CDK4 and CDK6 associated with p27 does not change in a cell cycle-dependent fashion; in contrast, the amount of CDK2 associated with p27 is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.", "text_with_entity_marker": "The amount of [E1]CDK4[/E1] and CDK6 associated with [E2]p27[/E2] does not change in a cell cycle-dependent fashion; in contrast, the amount of CDK2 associated with p27 is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CDK4", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p27", "entity_2_idx": [[44, 47]], "entity_2_idx_in_text_with_entity_marker": [57, 60], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d178.s1513_AIMed.d178.s1513.p4", "text": "The amount of CDK4 and CDK6 associated with p27 does not change in a cell cycle-dependent fashion; in contrast, the amount of CDK2 associated with p27 is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.", "text_with_entity_marker": "The amount of CDK4 and [E1]CDK6[/E1] associated with [E2]p27[/E2] does not change in a cell cycle-dependent fashion; in contrast, the amount of CDK2 associated with p27 is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CDK6", "entity_1_idx": [[23, 27]], "entity_1_idx_in_text_with_entity_marker": [27, 31], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p27", "entity_2_idx": [[44, 47]], "entity_2_idx_in_text_with_entity_marker": [57, 60], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d178.s1513_AIMed.d178.s1513.p9", "text": "The amount of CDK4 and CDK6 associated with p27 does not change in a cell cycle-dependent fashion; in contrast, the amount of CDK2 associated with p27 is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.", "text_with_entity_marker": "The amount of CDK4 and CDK6 associated with p27 does not change in a cell cycle-dependent fashion; in contrast, the amount of [E1]CDK2[/E1] associated with [E2]p27[/E2] is lowest in early G1 cells and increases to a maximum in mid-G1 phase, reaching a steady-state level in late G1-phase cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CDK2", "entity_1_idx": [[126, 130]], "entity_1_idx_in_text_with_entity_marker": [130, 134], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p27", "entity_2_idx": [[147, 150]], "entity_2_idx_in_text_with_entity_marker": [160, 163], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d178.s1517_AIMed.d178.s1517.p0", "text": "In contrast, p27 complexes containing CDK2 are incapable of phosphorylating histone H1.", "text_with_entity_marker": "In contrast, [E1]p27[/E1] complexes containing [E2]CDK2[/E2] are incapable of phosphorylating histone H1.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[13, 16]], "entity_1_idx_in_text_with_entity_marker": [17, 20], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CDK2", "entity_2_idx": [[38, 42]], "entity_2_idx_in_text_with_entity_marker": [51, 55], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d92.s785_AIMed.d92.s785.p1", "text": "Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.", "text_with_entity_marker": "[E1]Nerve growth factor[/E1] binds independently to two transmembrane receptors, the [E2]p75 neurotrophin receptor[/E2] and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Nerve growth factor", "entity_1_idx": [[0, 19]], "entity_1_idx_in_text_with_entity_marker": [4, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p75 neurotrophin receptor", "entity_2_idx": [[76, 101]], "entity_2_idx_in_text_with_entity_marker": [89, 114], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d92.s785_AIMed.d92.s785.p4", "text": "Nerve growth factor binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the p140trk (trkA) tyrosine kinase receptor, which are both co-expressed in the majority of neuronal cells that respond to NGF.", "text_with_entity_marker": "[E1]Nerve growth factor[/E1] binds independently to two transmembrane receptors, the p75 neurotrophin receptor and the [E2]p140trk (trkA) tyrosine kinase receptor[/E2], which are both co-expressed in the majority of neuronal cells that respond to NGF.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Nerve growth factor", "entity_1_idx": [[0, 19]], "entity_1_idx_in_text_with_entity_marker": [4, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p140trk (trkA) tyrosine kinase receptor", "entity_2_idx": [[110, 149]], "entity_2_idx_in_text_with_entity_marker": [123, 162], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d125.s1062_AIMed.d125.s1062.p1", "text": "Interactions of the Bcl-2 protein with itself and other members of the Bcl-2 family, including Bcl-X-L, Bcl-X-S, Mcl-1, and Bax, were explored with a yeast two-hybrid system.", "text_with_entity_marker": "Interactions of the [E1]Bcl-2[/E1] protein with itself and other members of the Bcl-2 family, including [E2]Bcl-X-L[/E2], Bcl-X-S, Mcl-1, and Bax, were explored with a yeast two-hybrid system.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Bcl-2", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Bcl-X-L", "entity_2_idx": [[95, 102]], "entity_2_idx_in_text_with_entity_marker": [108, 115], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d125.s1062_AIMed.d125.s1062.p2", "text": "Interactions of the Bcl-2 protein with itself and other members of the Bcl-2 family, including Bcl-X-L, Bcl-X-S, Mcl-1, and Bax, were explored with a yeast two-hybrid system.", "text_with_entity_marker": "Interactions of the [E1]Bcl-2[/E1] protein with itself and other members of the Bcl-2 family, including Bcl-X-L, [E2]Bcl-X-S[/E2], Mcl-1, and Bax, were explored with a yeast two-hybrid system.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Bcl-2", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Bcl-X-S", "entity_2_idx": [[104, 111]], "entity_2_idx_in_text_with_entity_marker": [117, 124], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d125.s1062_AIMed.d125.s1062.p3", "text": "Interactions of the Bcl-2 protein with itself and other members of the Bcl-2 family, including Bcl-X-L, Bcl-X-S, Mcl-1, and Bax, were explored with a yeast two-hybrid system.", "text_with_entity_marker": "Interactions of the [E1]Bcl-2[/E1] protein with itself and other members of the Bcl-2 family, including Bcl-X-L, Bcl-X-S, [E2]Mcl-1[/E2], and Bax, were explored with a yeast two-hybrid system.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Bcl-2", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Mcl-1", "entity_2_idx": [[113, 118]], "entity_2_idx_in_text_with_entity_marker": [126, 131], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d125.s1062_AIMed.d125.s1062.p4", "text": "Interactions of the Bcl-2 protein with itself and other members of the Bcl-2 family, including Bcl-X-L, Bcl-X-S, Mcl-1, and Bax, were explored with a yeast two-hybrid system.", "text_with_entity_marker": "Interactions of the [E1]Bcl-2[/E1] protein with itself and other members of the Bcl-2 family, including Bcl-X-L, Bcl-X-S, Mcl-1, and [E2]Bax[/E2], were explored with a yeast two-hybrid system.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Bcl-2", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Bax", "entity_2_idx": [[124, 127]], "entity_2_idx_in_text_with_entity_marker": [137, 140], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d125.s1066_AIMed.d125.s1066.p0", "text": "Bcl-2 also interacted with Bcl-X-L and Mcl-1 and with the dominant inhibitors Bax and Bcl-X-S.", "text_with_entity_marker": "[E1]Bcl-2[/E1] also interacted with [E2]Bcl-X-L[/E2] and Mcl-1 and with the dominant inhibitors Bax and Bcl-X-S.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Bcl-2", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Bcl-X-L", "entity_2_idx": [[27, 34]], "entity_2_idx_in_text_with_entity_marker": [40, 47], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d125.s1066_AIMed.d125.s1066.p1", "text": "Bcl-2 also interacted with Bcl-X-L and Mcl-1 and with the dominant inhibitors Bax and Bcl-X-S.", "text_with_entity_marker": "[E1]Bcl-2[/E1] also interacted with Bcl-X-L and [E2]Mcl-1[/E2] and with the dominant inhibitors Bax and Bcl-X-S.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Bcl-2", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Mcl-1", "entity_2_idx": [[39, 44]], "entity_2_idx_in_text_with_entity_marker": [52, 57], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d125.s1066_AIMed.d125.s1066.p2", "text": "Bcl-2 also interacted with Bcl-X-L and Mcl-1 and with the dominant inhibitors Bax and Bcl-X-S.", "text_with_entity_marker": "[E1]Bcl-2[/E1] also interacted with Bcl-X-L and Mcl-1 and with the dominant inhibitors [E2]Bax[/E2] and Bcl-X-S.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Bcl-2", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Bax", "entity_2_idx": [[78, 81]], "entity_2_idx_in_text_with_entity_marker": [91, 94], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d125.s1066_AIMed.d125.s1066.p3", "text": "Bcl-2 also interacted with Bcl-X-L and Mcl-1 and with the dominant inhibitors Bax and Bcl-X-S.", "text_with_entity_marker": "[E1]Bcl-2[/E1] also interacted with Bcl-X-L and Mcl-1 and with the dominant inhibitors Bax and [E2]Bcl-X-S[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Bcl-2", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Bcl-X-S", "entity_2_idx": [[86, 93]], "entity_2_idx_in_text_with_entity_marker": [99, 106], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d98.s832_AIMed.d98.s832.p0", "text": "Raf-1, which is known to bind 14-3-3 proteins, has recently been shown to associate with cdc25A and to stimulate its phosphatase activity.", "text_with_entity_marker": "[E1]Raf-1[/E1], which is known to bind 14-3-3 proteins, has recently been shown to associate with [E2]cdc25A[/E2] and to stimulate its phosphatase activity.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Raf-1", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "cdc25A", "entity_2_idx": [[89, 95]], "entity_2_idx_in_text_with_entity_marker": [102, 108], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d98.s834_AIMed.d98.s834.p0", "text": "Instead, 14-3-3 may facilitate the association of cdc25 with Raf-1 in vivo, participating in the linkage between mitogenic signaling and the cell cycle machinery.", "text_with_entity_marker": "Instead, 14-3-3 may facilitate the association of [E1]cdc25[/E1] with [E2]Raf-1[/E2] in vivo, participating in the linkage between mitogenic signaling and the cell cycle machinery.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cdc25", "entity_1_idx": [[50, 55]], "entity_1_idx_in_text_with_entity_marker": [54, 59], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[61, 66]], "entity_2_idx_in_text_with_entity_marker": [74, 79], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d214.s1858_AIMed.d214.s1858.p2", "text": "The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)/SH3 domain-containing adapters such as Grb2, Crk, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.", "text_with_entity_marker": "The molecular adapter [E1]c-Cbl[/E1] is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)/SH3 domain-containing adapters such as [E2]Grb2[/E2], Crk, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "c-Cbl", "entity_1_idx": [[22, 27]], "entity_1_idx_in_text_with_entity_marker": [26, 31], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Grb2", "entity_2_idx": [[188, 192]], "entity_2_idx_in_text_with_entity_marker": [201, 205], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d214.s1858_AIMed.d214.s1858.p3", "text": "The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)/SH3 domain-containing adapters such as Grb2, Crk, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.", "text_with_entity_marker": "The molecular adapter [E1]c-Cbl[/E1] is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)/SH3 domain-containing adapters such as Grb2, [E2]Crk[/E2], and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "c-Cbl", "entity_1_idx": [[22, 27]], "entity_1_idx_in_text_with_entity_marker": [26, 31], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Crk", "entity_2_idx": [[194, 197]], "entity_2_idx_in_text_with_entity_marker": [207, 210], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d214.s1858_AIMed.d214.s1858.p4", "text": "The molecular adapter c-Cbl is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)/SH3 domain-containing adapters such as Grb2, Crk, and Crk-L, which interact with guanine nucleotide exchange factors specific for the Ras family.", "text_with_entity_marker": "The molecular adapter [E1]c-Cbl[/E1] is rapidly tyrosine phosphorylated following stimulation through the TCR and associates with Src homology domain-2 (SH2)/SH3 domain-containing adapters such as Grb2, Crk, and [E2]Crk-L[/E2], which interact with guanine nucleotide exchange factors specific for the Ras family.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "c-Cbl", "entity_1_idx": [[22, 27]], "entity_1_idx_in_text_with_entity_marker": [26, 31], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Crk-L", "entity_2_idx": [[203, 208]], "entity_2_idx_in_text_with_entity_marker": [216, 221], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d214.s1862_AIMed.d214.s1862.p0", "text": "Vav/c-Cbl interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor CTLA-4, in which c-Cbl is hyperphosphorylated on tyrosine residues.", "text_with_entity_marker": "[E1]Vav[/E1]/[E2]c-Cbl[/E2] interactions are also detectable in freshly isolated T cells from gene-targeted mice that lack the T cell-specific inhibitory receptor CTLA-4, in which c-Cbl is hyperphosphorylated on tyrosine residues.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Vav", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-Cbl", "entity_2_idx": [[4, 9]], "entity_2_idx_in_text_with_entity_marker": [17, 22], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d214.s1863_AIMed.d214.s1863.p0", "text": "The interaction between Vav and c-Cbl is directly mediated via the SH2 domain of Vav and is dependent on tyrosine phosphorylation of c-Cbl.", "text_with_entity_marker": "The interaction between [E1]Vav[/E1] and [E2]c-Cbl[/E2] is directly mediated via the SH2 domain of Vav and is dependent on tyrosine phosphorylation of c-Cbl.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Vav", "entity_1_idx": [[24, 27]], "entity_1_idx_in_text_with_entity_marker": [28, 31], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-Cbl", "entity_2_idx": [[32, 37]], "entity_2_idx_in_text_with_entity_marker": [45, 50], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d191.s1631_AIMed.d191.s1631.p0", "text": "RANTES interacts with CCR5 and SDF-1 with CXCR4 receptors.", "text_with_entity_marker": "[E1]RANTES[/E1] interacts with [E2]CCR5[/E2] and SDF-1 with CXCR4 receptors.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "RANTES", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCR5", "entity_2_idx": [[22, 26]], "entity_2_idx_in_text_with_entity_marker": [35, 39], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d191.s1631_AIMed.d191.s1631.p5", "text": "RANTES interacts with CCR5 and SDF-1 with CXCR4 receptors.", "text_with_entity_marker": "RANTES interacts with CCR5 and [E1]SDF-1[/E1] with [E2]CXCR4[/E2] receptors.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "SDF-1", "entity_1_idx": [[31, 36]], "entity_1_idx_in_text_with_entity_marker": [35, 40], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CXCR4", "entity_2_idx": [[42, 47]], "entity_2_idx_in_text_with_entity_marker": [55, 60], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d159.s1340_AIMed.d159.s1340.p0", "text": "The carboxy-terminal region of dystrophin has previously been shown to interact directly with alpha1 syntrophin, a cytoplasmic component of the dystrophin-glycoprotein complex, by in vitro biochemical studies such as overlay assay or immunoprecipitation.", "text_with_entity_marker": "The carboxy-terminal region of [E1]dystrophin[/E1] has previously been shown to interact directly with [E2]alpha1 syntrophin[/E2], a cytoplasmic component of the dystrophin-glycoprotein complex, by in vitro biochemical studies such as overlay assay or immunoprecipitation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "dystrophin", "entity_1_idx": [[31, 41]], "entity_1_idx_in_text_with_entity_marker": [35, 45], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "alpha1 syntrophin", "entity_2_idx": [[94, 111]], "entity_2_idx_in_text_with_entity_marker": [107, 124], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d211.s1833_AIMed.d211.s1833.p0", "text": "Recombinant neuregulin-2beta induces the tyrosine-phosphorylation of ErbB2, ErbB3 and ErbB4 in cell lines expressing all of these ErbB-family receptors.", "text_with_entity_marker": "Recombinant [E1]neuregulin-2beta[/E1] induces the tyrosine-phosphorylation of [E2]ErbB2[/E2], ErbB3 and ErbB4 in cell lines expressing all of these ErbB-family receptors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "neuregulin-2beta", "entity_1_idx": [[12, 28]], "entity_1_idx_in_text_with_entity_marker": [16, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ErbB2", "entity_2_idx": [[69, 74]], "entity_2_idx_in_text_with_entity_marker": [82, 87], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d211.s1833_AIMed.d211.s1833.p1", "text": "Recombinant neuregulin-2beta induces the tyrosine-phosphorylation of ErbB2, ErbB3 and ErbB4 in cell lines expressing all of these ErbB-family receptors.", "text_with_entity_marker": "Recombinant [E1]neuregulin-2beta[/E1] induces the tyrosine-phosphorylation of ErbB2, [E2]ErbB3[/E2] and ErbB4 in cell lines expressing all of these ErbB-family receptors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "neuregulin-2beta", "entity_1_idx": [[12, 28]], "entity_1_idx_in_text_with_entity_marker": [16, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ErbB3", "entity_2_idx": [[76, 81]], "entity_2_idx_in_text_with_entity_marker": [89, 94], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d211.s1833_AIMed.d211.s1833.p2", "text": "Recombinant neuregulin-2beta induces the tyrosine-phosphorylation of ErbB2, ErbB3 and ErbB4 in cell lines expressing all of these ErbB-family receptors.", "text_with_entity_marker": "Recombinant [E1]neuregulin-2beta[/E1] induces the tyrosine-phosphorylation of ErbB2, ErbB3 and [E2]ErbB4[/E2] in cell lines expressing all of these ErbB-family receptors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "neuregulin-2beta", "entity_1_idx": [[12, 28]], "entity_1_idx_in_text_with_entity_marker": [16, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ErbB4", "entity_2_idx": [[86, 91]], "entity_2_idx_in_text_with_entity_marker": [99, 104], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d211.s1834_AIMed.d211.s1834.p0", "text": "However, in cell lines with defined combinations of ErbBs, neuregulin-2beta only activates those with ErbB3 and/or ErbB4, suggesting that signalling by neuregulin-2 is mediated by ErbB3 and/or ErbB4 receptors.", "text_with_entity_marker": "However, in cell lines with defined combinations of ErbBs, [E1]neuregulin-2beta[/E1] only activates those with [E2]ErbB3[/E2] and/or ErbB4, suggesting that signalling by neuregulin-2 is mediated by ErbB3 and/or ErbB4 receptors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "neuregulin-2beta", "entity_1_idx": [[59, 75]], "entity_1_idx_in_text_with_entity_marker": [63, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ErbB3", "entity_2_idx": [[102, 107]], "entity_2_idx_in_text_with_entity_marker": [115, 120], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d211.s1834_AIMed.d211.s1834.p1", "text": "However, in cell lines with defined combinations of ErbBs, neuregulin-2beta only activates those with ErbB3 and/or ErbB4, suggesting that signalling by neuregulin-2 is mediated by ErbB3 and/or ErbB4 receptors.", "text_with_entity_marker": "However, in cell lines with defined combinations of ErbBs, [E1]neuregulin-2beta[/E1] only activates those with ErbB3 and/or [E2]ErbB4[/E2], suggesting that signalling by neuregulin-2 is mediated by ErbB3 and/or ErbB4 receptors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "neuregulin-2beta", "entity_1_idx": [[59, 75]], "entity_1_idx_in_text_with_entity_marker": [63, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ErbB4", "entity_2_idx": [[115, 120]], "entity_2_idx_in_text_with_entity_marker": [128, 133], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p1", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like [E1]beta 1-syntrophin[/E1], both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of [E2]dystrophin[/E2], utrophin/dystrophin related protein, and the Torpedo 87K protein.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta 1-syntrophin", "entity_1_idx": [[97, 114]], "entity_1_idx_in_text_with_entity_marker": [101, 118], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "dystrophin", "entity_2_idx": [[217, 227]], "entity_2_idx_in_text_with_entity_marker": [230, 240], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p2", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like [E1]beta 1-syntrophin[/E1], both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, [E2]utrophin[/E2]/dystrophin related protein, and the Torpedo 87K protein.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta 1-syntrophin", "entity_1_idx": [[97, 114]], "entity_1_idx_in_text_with_entity_marker": [101, 118], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "utrophin", "entity_2_idx": [[229, 237]], "entity_2_idx_in_text_with_entity_marker": [242, 250], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p4", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like [E1]beta 1-syntrophin[/E1], both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/[E2]dystrophin related protein[/E2], and the Torpedo 87K protein.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta 1-syntrophin", "entity_1_idx": [[97, 114]], "entity_1_idx_in_text_with_entity_marker": [101, 118], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "dystrophin related protein", "entity_2_idx": [[238, 264]], "entity_2_idx_in_text_with_entity_marker": [251, 277], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p5", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like [E1]beta 1-syntrophin[/E1], both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the [E2]Torpedo 87K protein[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta 1-syntrophin", "entity_1_idx": [[97, 114]], "entity_1_idx_in_text_with_entity_marker": [101, 118], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Torpedo 87K protein", "entity_2_idx": [[274, 293]], "entity_2_idx_in_text_with_entity_marker": [287, 306], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p6", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and [E1]alpha 1-syntrophin[/E1] interact with peptides encoding the syntrophin-binding region of [E2]dystrophin[/E2], utrophin/dystrophin related protein, and the Torpedo 87K protein.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha 1-syntrophin", "entity_1_idx": [[133, 151]], "entity_1_idx_in_text_with_entity_marker": [137, 155], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "dystrophin", "entity_2_idx": [[217, 227]], "entity_2_idx_in_text_with_entity_marker": [230, 240], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p7", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and [E1]alpha 1-syntrophin[/E1] interact with peptides encoding the syntrophin-binding region of dystrophin, [E2]utrophin[/E2]/dystrophin related protein, and the Torpedo 87K protein.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha 1-syntrophin", "entity_1_idx": [[133, 151]], "entity_1_idx_in_text_with_entity_marker": [137, 155], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "utrophin", "entity_2_idx": [[229, 237]], "entity_2_idx_in_text_with_entity_marker": [242, 250], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p9", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and [E1]alpha 1-syntrophin[/E1] interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/[E2]dystrophin related protein[/E2], and the Torpedo 87K protein.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha 1-syntrophin", "entity_1_idx": [[133, 151]], "entity_1_idx_in_text_with_entity_marker": [137, 155], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "dystrophin related protein", "entity_2_idx": [[238, 264]], "entity_2_idx_in_text_with_entity_marker": [251, 277], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d154.s1314_AIMed.d154.s1314.p10", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and [E1]alpha 1-syntrophin[/E1] interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the [E2]Torpedo 87K protein[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha 1-syntrophin", "entity_1_idx": [[133, 151]], "entity_1_idx_in_text_with_entity_marker": [137, 155], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Torpedo 87K protein", "entity_2_idx": [[274, 293]], "entity_2_idx_in_text_with_entity_marker": [287, 306], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d139.s1173_AIMed.d139.s1173.p0", "text": "The self-association site appears to be formed by interactions between helices 1 and 2 of beta spectrin repeat 17 of one dimer with helix 3 of alpha spectrin repeat 1 of the other dimer to form two combined alpha-beta triple-helical segments.", "text_with_entity_marker": "The self-association site appears to be formed by interactions between helices 1 and 2 of [E1]beta spectrin[/E1] repeat 17 of one dimer with helix 3 of [E2]alpha spectrin[/E2] repeat 1 of the other dimer to form two combined alpha-beta triple-helical segments.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta spectrin", "entity_1_idx": [[90, 103]], "entity_1_idx_in_text_with_entity_marker": [94, 107], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "alpha spectrin", "entity_2_idx": [[143, 157]], "entity_2_idx_in_text_with_entity_marker": [156, 170], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d99.s841_AIMed.d99.s841.p0", "text": "CSA protein interacts with CSB protein and with p44 protein, a subunit of the human RNA polymerase II transcription factor IIH.", "text_with_entity_marker": "[E1]CSA[/E1] protein interacts with [E2]CSB[/E2] protein and with p44 protein, a subunit of the human RNA polymerase II transcription factor IIH.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CSA", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CSB", "entity_2_idx": [[27, 30]], "entity_2_idx_in_text_with_entity_marker": [40, 43], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d99.s841_AIMed.d99.s841.p1", "text": "CSA protein interacts with CSB protein and with p44 protein, a subunit of the human RNA polymerase II transcription factor IIH.", "text_with_entity_marker": "[E1]CSA[/E1] protein interacts with CSB protein and with [E2]p44[/E2] protein, a subunit of the human RNA polymerase II transcription factor IIH.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CSA", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p44", "entity_2_idx": [[48, 51]], "entity_2_idx_in_text_with_entity_marker": [61, 64], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d47.s411_AIMed.d47.s411.p0", "text": "Crystal structure of the BMP-2-BRIA ectodomain complex.", "text_with_entity_marker": "Crystal structure of the [E1]BMP-2[/E1]-[E2]BRIA[/E2] ectodomain complex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "BMP-2", "entity_1_idx": [[25, 30]], "entity_1_idx_in_text_with_entity_marker": [29, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "BRIA", "entity_2_idx": [[31, 35]], "entity_2_idx_in_text_with_entity_marker": [44, 48], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1900_AIMed.d219.s1900.p0", "text": "Although Raf-1 is a critical effector of Ras signaling and transformation, the mechanism by which Ras promotes Raf-1 activation is complex and remains poorly understood.", "text_with_entity_marker": "Although [E1]Raf-1[/E1] is a critical effector of [E2]Ras[/E2] signaling and transformation, the mechanism by which Ras promotes Raf-1 activation is complex and remains poorly understood.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Raf-1", "entity_1_idx": [[9, 14]], "entity_1_idx_in_text_with_entity_marker": [13, 18], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Ras", "entity_2_idx": [[41, 44]], "entity_2_idx_in_text_with_entity_marker": [54, 57], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1900_AIMed.d219.s1900.p1", "text": "Although Raf-1 is a critical effector of Ras signaling and transformation, the mechanism by which Ras promotes Raf-1 activation is complex and remains poorly understood.", "text_with_entity_marker": "Although [E1]Raf-1[/E1] is a critical effector of Ras signaling and transformation, the mechanism by which [E2]Ras[/E2] promotes Raf-1 activation is complex and remains poorly understood.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Raf-1", "entity_1_idx": [[9, 14]], "entity_1_idx_in_text_with_entity_marker": [13, 18], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Ras", "entity_2_idx": [[98, 101]], "entity_2_idx_in_text_with_entity_marker": [111, 114], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1900_AIMed.d219.s1900.p2", "text": "Although Raf-1 is a critical effector of Ras signaling and transformation, the mechanism by which Ras promotes Raf-1 activation is complex and remains poorly understood.", "text_with_entity_marker": "Although [E1]Raf-1[/E1] is a critical effector of Ras signaling and transformation, the mechanism by which Ras promotes [E2]Raf-1[/E2] activation is complex and remains poorly understood.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Raf-1", "entity_1_idx": [[9, 14]], "entity_1_idx_in_text_with_entity_marker": [13, 18], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1900_AIMed.d219.s1900.p3", "text": "Although Raf-1 is a critical effector of Ras signaling and transformation, the mechanism by which Ras promotes Raf-1 activation is complex and remains poorly understood.", "text_with_entity_marker": "Although Raf-1 is a critical effector of [E1]Ras[/E1] signaling and transformation, the mechanism by which [E2]Ras[/E2] promotes Raf-1 activation is complex and remains poorly understood.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Ras", "entity_1_idx": [[41, 44]], "entity_1_idx_in_text_with_entity_marker": [45, 48], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Ras", "entity_2_idx": [[98, 101]], "entity_2_idx_in_text_with_entity_marker": [111, 114], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1900_AIMed.d219.s1900.p4", "text": "Although Raf-1 is a critical effector of Ras signaling and transformation, the mechanism by which Ras promotes Raf-1 activation is complex and remains poorly understood.", "text_with_entity_marker": "Although Raf-1 is a critical effector of [E1]Ras[/E1] signaling and transformation, the mechanism by which Ras promotes [E2]Raf-1[/E2] activation is complex and remains poorly understood.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Ras", "entity_1_idx": [[41, 44]], "entity_1_idx_in_text_with_entity_marker": [45, 48], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1900_AIMed.d219.s1900.p5", "text": "Although Raf-1 is a critical effector of Ras signaling and transformation, the mechanism by which Ras promotes Raf-1 activation is complex and remains poorly understood.", "text_with_entity_marker": "Although Raf-1 is a critical effector of Ras signaling and transformation, the mechanism by which [E1]Ras[/E1] promotes [E2]Raf-1[/E2] activation is complex and remains poorly understood.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Ras", "entity_1_idx": [[98, 101]], "entity_1_idx_in_text_with_entity_marker": [102, 105], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1902_AIMed.d219.s1902.p0", "text": "The Raf-CRD is located in the NH2-terminal negative regulatory domain of Raf-1 and is highly homologous to cysteine-rich domains found in protein kinase C family members.", "text_with_entity_marker": "The [E1]Raf-CRD[/E1] is located in the NH2-terminal negative regulatory domain of [E2]Raf-1[/E2] and is highly homologous to cysteine-rich domains found in protein kinase C family members.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Raf-CRD", "entity_1_idx": [[4, 11]], "entity_1_idx_in_text_with_entity_marker": [8, 15], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[73, 78]], "entity_2_idx_in_text_with_entity_marker": [86, 91], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d219.s1904_AIMed.d219.s1904.p0", "text": "However, whether 14-3-3 proteins interact directly with the Raf-CRD and how this interaction may mediate Raf-1 function has not been determined.", "text_with_entity_marker": "However, whether 14-3-3 proteins interact directly with the [E1]Raf-CRD[/E1] and how this interaction may mediate [E2]Raf-1[/E2] function has not been determined.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Raf-CRD", "entity_1_idx": [[60, 67]], "entity_1_idx_in_text_with_entity_marker": [64, 71], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d106.s894_AIMed.d106.s894.p0", "text": "The Ras and Raf1 proto-oncogenes transduce extracellular signals that promote cell growth.", "text_with_entity_marker": "The [E1]Ras[/E1] and [E2]Raf1[/E2] proto-oncogenes transduce extracellular signals that promote cell growth.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Ras", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf1", "entity_2_idx": [[12, 16]], "entity_2_idx_in_text_with_entity_marker": [25, 29], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d152.s1293_AIMed.d152.s1293.p0", "text": "TRADD is a TNFR1-associated signal transducer that is involved in activating both pathways.", "text_with_entity_marker": "[E1]TRADD[/E1] is a [E2]TNFR1[/E2]-associated signal transducer that is involved in activating both pathways.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRADD", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNFR1", "entity_2_idx": [[11, 16]], "entity_2_idx_in_text_with_entity_marker": [24, 29], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d152.s1296_AIMed.d152.s1296.p0", "text": "Conversely, a FADD mutant lacking its N-terminal 79 amino acids is a dominant-negative inhibitor of TNF-induced apoptosis, but does not inhibit NF-kappa B activation.", "text_with_entity_marker": "Conversely, a [E1]FADD[/E1] mutant lacking its N-terminal 79 amino acids is a dominant-negative inhibitor of TNF-induced apoptosis, but does not inhibit [E2]NF-kappa B[/E2] activation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FADD", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "NF-kappa B", "entity_2_idx": [[144, 154]], "entity_2_idx_in_text_with_entity_marker": [157, 167], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d152.s1297_AIMed.d152.s1297.p0", "text": "Thus, these two TNFR1-TRADD signaling cascades appear to bifurcate at TRADD.", "text_with_entity_marker": "Thus, these two [E1]TNFR1[/E1]-[E2]TRADD[/E2] signaling cascades appear to bifurcate at TRADD.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNFR1", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[22, 27]], "entity_2_idx_in_text_with_entity_marker": [35, 40], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d152.s1297_AIMed.d152.s1297.p1", "text": "Thus, these two TNFR1-TRADD signaling cascades appear to bifurcate at TRADD.", "text_with_entity_marker": "Thus, these two [E1]TNFR1[/E1]-TRADD signaling cascades appear to bifurcate at [E2]TRADD[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNFR1", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[70, 75]], "entity_2_idx_in_text_with_entity_marker": [83, 88], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d152.s1297_AIMed.d152.s1297.p2", "text": "Thus, these two TNFR1-TRADD signaling cascades appear to bifurcate at TRADD.", "text_with_entity_marker": "Thus, these two TNFR1-[E1]TRADD[/E1] signaling cascades appear to bifurcate at [E2]TRADD[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRADD", "entity_1_idx": [[22, 27]], "entity_1_idx_in_text_with_entity_marker": [26, 31], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[70, 75]], "entity_2_idx_in_text_with_entity_marker": [83, 88], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d98.s833_AIMed.d98.s833.p0", "text": "14-3-3 protein, however, has no effect on the cdc25A-kinase activity of Raf-1.", "text_with_entity_marker": "14-3-3 protein, however, has no effect on the [E1]cdc25A[/E1]-kinase activity of [E2]Raf-1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "cdc25A", "entity_1_idx": [[46, 52]], "entity_1_idx_in_text_with_entity_marker": [50, 56], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[72, 77]], "entity_2_idx_in_text_with_entity_marker": [85, 90], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1205_AIMed.d143.s1205.p0", "text": "IL-11 is a novel cytokine with a variety of biofunctions which overlap with those of IL-6.", "text_with_entity_marker": "[E1]IL-11[/E1] is a novel cytokine with a variety of biofunctions which overlap with those of [E2]IL-6[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-11", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-6", "entity_2_idx": [[85, 89]], "entity_2_idx_in_text_with_entity_marker": [98, 102], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1207_AIMed.d143.s1207.p0", "text": "The similarities in biofunctions and differences in ligand binding proteins between IL-11 and IL-6 prompted us to investigate whether IL-11 shares common signal transduction mechanisms with IL-6.", "text_with_entity_marker": "The similarities in biofunctions and differences in ligand binding proteins between [E1]IL-11[/E1] and [E2]IL-6[/E2] prompted us to investigate whether IL-11 shares common signal transduction mechanisms with IL-6.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-11", "entity_1_idx": [[84, 89]], "entity_1_idx_in_text_with_entity_marker": [88, 93], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-6", "entity_2_idx": [[94, 98]], "entity_2_idx_in_text_with_entity_marker": [107, 111], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1207_AIMed.d143.s1207.p1", "text": "The similarities in biofunctions and differences in ligand binding proteins between IL-11 and IL-6 prompted us to investigate whether IL-11 shares common signal transduction mechanisms with IL-6.", "text_with_entity_marker": "The similarities in biofunctions and differences in ligand binding proteins between [E1]IL-11[/E1] and IL-6 prompted us to investigate whether [E2]IL-11[/E2] shares common signal transduction mechanisms with IL-6.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-11", "entity_1_idx": [[84, 89]], "entity_1_idx_in_text_with_entity_marker": [88, 93], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-11", "entity_2_idx": [[134, 139]], "entity_2_idx_in_text_with_entity_marker": [147, 152], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1207_AIMed.d143.s1207.p2", "text": "The similarities in biofunctions and differences in ligand binding proteins between IL-11 and IL-6 prompted us to investigate whether IL-11 shares common signal transduction mechanisms with IL-6.", "text_with_entity_marker": "The similarities in biofunctions and differences in ligand binding proteins between [E1]IL-11[/E1] and IL-6 prompted us to investigate whether IL-11 shares common signal transduction mechanisms with [E2]IL-6[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-11", "entity_1_idx": [[84, 89]], "entity_1_idx_in_text_with_entity_marker": [88, 93], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-6", "entity_2_idx": [[190, 194]], "entity_2_idx_in_text_with_entity_marker": [203, 207], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1207_AIMed.d143.s1207.p3", "text": "The similarities in biofunctions and differences in ligand binding proteins between IL-11 and IL-6 prompted us to investigate whether IL-11 shares common signal transduction mechanisms with IL-6.", "text_with_entity_marker": "The similarities in biofunctions and differences in ligand binding proteins between IL-11 and [E1]IL-6[/E1] prompted us to investigate whether [E2]IL-11[/E2] shares common signal transduction mechanisms with IL-6.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-6", "entity_1_idx": [[94, 98]], "entity_1_idx_in_text_with_entity_marker": [98, 102], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-11", "entity_2_idx": [[134, 139]], "entity_2_idx_in_text_with_entity_marker": [147, 152], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1207_AIMed.d143.s1207.p4", "text": "The similarities in biofunctions and differences in ligand binding proteins between IL-11 and IL-6 prompted us to investigate whether IL-11 shares common signal transduction mechanisms with IL-6.", "text_with_entity_marker": "The similarities in biofunctions and differences in ligand binding proteins between IL-11 and [E1]IL-6[/E1] prompted us to investigate whether IL-11 shares common signal transduction mechanisms with [E2]IL-6[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-6", "entity_1_idx": [[94, 98]], "entity_1_idx_in_text_with_entity_marker": [98, 102], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-6", "entity_2_idx": [[190, 194]], "entity_2_idx_in_text_with_entity_marker": [203, 207], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1207_AIMed.d143.s1207.p5", "text": "The similarities in biofunctions and differences in ligand binding proteins between IL-11 and IL-6 prompted us to investigate whether IL-11 shares common signal transduction mechanisms with IL-6.", "text_with_entity_marker": "The similarities in biofunctions and differences in ligand binding proteins between IL-11 and IL-6 prompted us to investigate whether [E1]IL-11[/E1] shares common signal transduction mechanisms with [E2]IL-6[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-11", "entity_1_idx": [[134, 139]], "entity_1_idx_in_text_with_entity_marker": [138, 143], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-6", "entity_2_idx": [[190, 194]], "entity_2_idx_in_text_with_entity_marker": [203, 207], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1208_AIMed.d143.s1208.p0", "text": "We have examined early signals triggered by IL-11 or IL-6 in a multifactor-dependent human erythroleukemic cell line, TF-1.", "text_with_entity_marker": "We have examined early signals triggered by [E1]IL-11[/E1] or [E2]IL-6[/E2] in a multifactor-dependent human erythroleukemic cell line, TF-1.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-11", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-6", "entity_2_idx": [[53, 57]], "entity_2_idx_in_text_with_entity_marker": [66, 70], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1210_AIMed.d143.s1210.p0", "text": "These findings imply that IL-11 and IL-6 share similar early signaling events with the possibility of using the same signal transducer, gp130.", "text_with_entity_marker": "These findings imply that [E1]IL-11[/E1] and [E2]IL-6[/E2] share similar early signaling events with the possibility of using the same signal transducer, gp130.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-11", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-6", "entity_2_idx": [[36, 40]], "entity_2_idx_in_text_with_entity_marker": [49, 53], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1210_AIMed.d143.s1210.p1", "text": "These findings imply that IL-11 and IL-6 share similar early signaling events with the possibility of using the same signal transducer, gp130.", "text_with_entity_marker": "These findings imply that [E1]IL-11[/E1] and IL-6 share similar early signaling events with the possibility of using the same signal transducer, [E2]gp130[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-11", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gp130", "entity_2_idx": [[136, 141]], "entity_2_idx_in_text_with_entity_marker": [149, 154], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1210_AIMed.d143.s1210.p2", "text": "These findings imply that IL-11 and IL-6 share similar early signaling events with the possibility of using the same signal transducer, gp130.", "text_with_entity_marker": "These findings imply that IL-11 and [E1]IL-6[/E1] share similar early signaling events with the possibility of using the same signal transducer, [E2]gp130[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-6", "entity_1_idx": [[36, 40]], "entity_1_idx_in_text_with_entity_marker": [40, 44], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gp130", "entity_2_idx": [[136, 141]], "entity_2_idx_in_text_with_entity_marker": [149, 154], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1211_AIMed.d143.s1211.p0", "text": "We next tested whether IL-11 induced signaling can be inhibited by anti-gp130 antibodies which blocked IL-6-mediated functions.", "text_with_entity_marker": "We next tested whether [E1]IL-11[/E1] induced signaling can be inhibited by anti-[E2]gp130[/E2] antibodies which blocked IL-6-mediated functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-11", "entity_1_idx": [[23, 28]], "entity_1_idx_in_text_with_entity_marker": [27, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gp130", "entity_2_idx": [[72, 77]], "entity_2_idx_in_text_with_entity_marker": [85, 90], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1211_AIMed.d143.s1211.p1", "text": "We next tested whether IL-11 induced signaling can be inhibited by anti-gp130 antibodies which blocked IL-6-mediated functions.", "text_with_entity_marker": "We next tested whether [E1]IL-11[/E1] induced signaling can be inhibited by anti-gp130 antibodies which blocked [E2]IL-6[/E2]-mediated functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-11", "entity_1_idx": [[23, 28]], "entity_1_idx_in_text_with_entity_marker": [27, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-6", "entity_2_idx": [[103, 107]], "entity_2_idx_in_text_with_entity_marker": [116, 120], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1211_AIMed.d143.s1211.p2", "text": "We next tested whether IL-11 induced signaling can be inhibited by anti-gp130 antibodies which blocked IL-6-mediated functions.", "text_with_entity_marker": "We next tested whether IL-11 induced signaling can be inhibited by anti-[E1]gp130[/E1] antibodies which blocked [E2]IL-6[/E2]-mediated functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gp130", "entity_1_idx": [[72, 77]], "entity_1_idx_in_text_with_entity_marker": [76, 81], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-6", "entity_2_idx": [[103, 107]], "entity_2_idx_in_text_with_entity_marker": [116, 120], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1212_AIMed.d143.s1212.p0", "text": "It was observed that anti-gp130 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by IL-11 or IL-6 in TF-1 cells.", "text_with_entity_marker": "It was observed that anti-[E1]gp130[/E1] antibodies abolished cell proliferation, protein tyrosine phosphorylation, and [E2]junB[/E2] gene expression elicited by IL-11 or IL-6 in TF-1 cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gp130", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "junB", "entity_2_idx": [[111, 115]], "entity_2_idx_in_text_with_entity_marker": [124, 128], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1212_AIMed.d143.s1212.p1", "text": "It was observed that anti-gp130 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by IL-11 or IL-6 in TF-1 cells.", "text_with_entity_marker": "It was observed that anti-[E1]gp130[/E1] antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by [E2]IL-11[/E2] or IL-6 in TF-1 cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gp130", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-11", "entity_2_idx": [[144, 149]], "entity_2_idx_in_text_with_entity_marker": [157, 162], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1212_AIMed.d143.s1212.p2", "text": "It was observed that anti-gp130 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by IL-11 or IL-6 in TF-1 cells.", "text_with_entity_marker": "It was observed that anti-[E1]gp130[/E1] antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by IL-11 or [E2]IL-6[/E2] in TF-1 cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gp130", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-6", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1212_AIMed.d143.s1212.p3", "text": "It was observed that anti-gp130 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by IL-11 or IL-6 in TF-1 cells.", "text_with_entity_marker": "It was observed that anti-gp130 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and [E1]junB[/E1] gene expression elicited by [E2]IL-11[/E2] or IL-6 in TF-1 cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "junB", "entity_1_idx": [[111, 115]], "entity_1_idx_in_text_with_entity_marker": [115, 119], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-11", "entity_2_idx": [[144, 149]], "entity_2_idx_in_text_with_entity_marker": [157, 162], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1212_AIMed.d143.s1212.p4", "text": "It was observed that anti-gp130 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by IL-11 or IL-6 in TF-1 cells.", "text_with_entity_marker": "It was observed that anti-gp130 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and [E1]junB[/E1] gene expression elicited by IL-11 or [E2]IL-6[/E2] in TF-1 cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "junB", "entity_1_idx": [[111, 115]], "entity_1_idx_in_text_with_entity_marker": [115, 119], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-6", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1212_AIMed.d143.s1212.p5", "text": "It was observed that anti-gp130 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by IL-11 or IL-6 in TF-1 cells.", "text_with_entity_marker": "It was observed that anti-gp130 antibodies abolished cell proliferation, protein tyrosine phosphorylation, and junB gene expression elicited by [E1]IL-11[/E1] or [E2]IL-6[/E2] in TF-1 cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-11", "entity_1_idx": [[144, 149]], "entity_1_idx_in_text_with_entity_marker": [148, 153], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-6", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1214_AIMed.d143.s1214.p0", "text": "Finally, anti-IL-6R antibody inhibited the ability of IL-6, but not IL-11, to transduce early signals in TF-1 cells.", "text_with_entity_marker": "Finally, anti-[E1]IL-6R[/E1] antibody inhibited the ability of [E2]IL-6[/E2], but not IL-11, to transduce early signals in TF-1 cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-6R", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-6", "entity_2_idx": [[54, 58]], "entity_2_idx_in_text_with_entity_marker": [67, 71], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1214_AIMed.d143.s1214.p1", "text": "Finally, anti-IL-6R antibody inhibited the ability of IL-6, but not IL-11, to transduce early signals in TF-1 cells.", "text_with_entity_marker": "Finally, anti-[E1]IL-6R[/E1] antibody inhibited the ability of IL-6, but not [E2]IL-11[/E2], to transduce early signals in TF-1 cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-6R", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-11", "entity_2_idx": [[68, 73]], "entity_2_idx_in_text_with_entity_marker": [81, 86], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1214_AIMed.d143.s1214.p2", "text": "Finally, anti-IL-6R antibody inhibited the ability of IL-6, but not IL-11, to transduce early signals in TF-1 cells.", "text_with_entity_marker": "Finally, anti-IL-6R antibody inhibited the ability of [E1]IL-6[/E1], but not [E2]IL-11[/E2], to transduce early signals in TF-1 cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-6", "entity_1_idx": [[54, 58]], "entity_1_idx_in_text_with_entity_marker": [58, 62], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-11", "entity_2_idx": [[68, 73]], "entity_2_idx_in_text_with_entity_marker": [81, 86], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d55.s482_AIMed.d55.s482.p0", "text": "Liver-expressed chemokine (LEC)/CCL16 is a human CC chemokine selectively expressed in the liver.", "text_with_entity_marker": "[E1]Liver-expressed chemokine[/E1] ([E2]LEC[/E2])/CCL16 is a human CC chemokine selectively expressed in the liver.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Liver-expressed chemokine", "entity_1_idx": [[0, 25]], "entity_1_idx_in_text_with_entity_marker": [4, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "LEC", "entity_2_idx": [[27, 30]], "entity_2_idx_in_text_with_entity_marker": [40, 43], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d55.s482_AIMed.d55.s482.p1", "text": "Liver-expressed chemokine (LEC)/CCL16 is a human CC chemokine selectively expressed in the liver.", "text_with_entity_marker": "[E1]Liver-expressed chemokine[/E1] (LEC)/[E2]CCL16[/E2] is a human CC chemokine selectively expressed in the liver.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Liver-expressed chemokine", "entity_1_idx": [[0, 25]], "entity_1_idx_in_text_with_entity_marker": [4, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCL16", "entity_2_idx": [[32, 37]], "entity_2_idx_in_text_with_entity_marker": [45, 50], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d55.s482_AIMed.d55.s482.p2", "text": "Liver-expressed chemokine (LEC)/CCL16 is a human CC chemokine selectively expressed in the liver.", "text_with_entity_marker": "Liver-expressed chemokine ([E1]LEC[/E1])/[E2]CCL16[/E2] is a human CC chemokine selectively expressed in the liver.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "LEC", "entity_1_idx": [[27, 30]], "entity_1_idx_in_text_with_entity_marker": [31, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCL16", "entity_2_idx": [[32, 37]], "entity_2_idx_in_text_with_entity_marker": [45, 50], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d217.s1881_AIMed.d217.s1881.p0", "text": "When human soluble FasL (sFasL, containing the extracellular portion) was expressed in human embryo kidney 293 cells, the three N-linked glycans of each FasL monomer were found to be essential for efficient secretion.", "text_with_entity_marker": "When human soluble [E1]FasL[/E1] (sFasL, containing the extracellular portion) was expressed in human embryo kidney 293 cells, the three N-linked glycans of each [E2]FasL[/E2] monomer were found to be essential for efficient secretion.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FasL", "entity_1_idx": [[19, 23]], "entity_1_idx_in_text_with_entity_marker": [23, 27], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FasL", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d217.s1885_AIMed.d217.s1885.p0", "text": "Mutants P206R, P206D, and P206F displayed reduced cytotoxicity toward Fas-positive cells with a concomitant decrease in the binding affinity for the recombinant Fas-immunoglobulin Fc fusion proteins.", "text_with_entity_marker": "Mutants P206R, P206D, and P206F displayed reduced cytotoxicity toward [E1]Fas[/E1]-positive cells with a concomitant decrease in the binding affinity for the recombinant [E2]Fas[/E2]-immunoglobulin Fc fusion proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas", "entity_1_idx": [[70, 73]], "entity_1_idx_in_text_with_entity_marker": [74, 77], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Fas", "entity_2_idx": [[161, 164]], "entity_2_idx_in_text_with_entity_marker": [174, 177], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d29.s243_AIMed.d29.s243.p0", "text": "We have probed an epitope sequence (His18-Pro19-Lys20-Phe21) in interleukin-8 (IL-8) by site-directed mutagenesis.", "text_with_entity_marker": "We have probed an epitope sequence (His18-Pro19-Lys20-Phe21) in [E1]interleukin-8[/E1] ([E2]IL-8[/E2]) by site-directed mutagenesis.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interleukin-8", "entity_1_idx": [[64, 77]], "entity_1_idx_in_text_with_entity_marker": [68, 81], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-8", "entity_2_idx": [[79, 83]], "entity_2_idx_in_text_with_entity_marker": [92, 96], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d29.s245_AIMed.d29.s245.p0", "text": "These Ala mutants triggered neutrophil degranulation and induced calcium responses mediated by CXCR1 and CXCR2.", "text_with_entity_marker": "These Ala mutants triggered neutrophil degranulation and induced calcium responses mediated by [E1]CXCR1[/E1] and [E2]CXCR2[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CXCR1", "entity_1_idx": [[95, 100]], "entity_1_idx_in_text_with_entity_marker": [99, 104], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CXCR2", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d36.s302_AIMed.d36.s302.p0", "text": "In a previous work, we predicted and demonstrated that the 29-42-residue fragment of beta-amyloid peptide (Abeta peptide) has in vitro capacities close to those of the tilted fragment of viral fusion proteins.", "text_with_entity_marker": "In a previous work, we predicted and demonstrated that the 29-42-residue fragment of [E1]beta-amyloid peptide[/E1] ([E2]Abeta peptide[/E2]) has in vitro capacities close to those of the tilted fragment of viral fusion proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-amyloid peptide", "entity_1_idx": [[85, 105]], "entity_1_idx_in_text_with_entity_marker": [89, 109], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Abeta peptide", "entity_2_idx": [[107, 120]], "entity_2_idx_in_text_with_entity_marker": [120, 133], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d36.s304_AIMed.d36.s304.p0", "text": "Therefore, we suggested that this fragment is implicated in the neurotoxicity of Abeta and in the protective effects of apolipoprotein E in Alzheimer's disease.", "text_with_entity_marker": "Therefore, we suggested that this fragment is implicated in the neurotoxicity of [E1]Abeta[/E1] and in the protective effects of [E2]apolipoprotein E[/E2] in Alzheimer's disease.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Abeta", "entity_1_idx": [[81, 86]], "entity_1_idx_in_text_with_entity_marker": [85, 90], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "apolipoprotein E", "entity_2_idx": [[120, 136]], "entity_2_idx_in_text_with_entity_marker": [133, 149], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d88.s750_AIMed.d88.s750.p0", "text": "Transfection of G alpha i2 and nucleobindin in COS cells increased G alpha i2 expression relative to cells transfected with G alpha i2 and mock vector.", "text_with_entity_marker": "Transfection of [E1]G alpha i2[/E1] and [E2]nucleobindin[/E2] in COS cells increased G alpha i2 expression relative to cells transfected with G alpha i2 and mock vector.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "G alpha i2", "entity_1_idx": [[16, 26]], "entity_1_idx_in_text_with_entity_marker": [20, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "nucleobindin", "entity_2_idx": [[31, 43]], "entity_2_idx_in_text_with_entity_marker": [44, 56], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d88.s750_AIMed.d88.s750.p1", "text": "Transfection of G alpha i2 and nucleobindin in COS cells increased G alpha i2 expression relative to cells transfected with G alpha i2 and mock vector.", "text_with_entity_marker": "Transfection of [E1]G alpha i2[/E1] and nucleobindin in COS cells increased [E2]G alpha i2[/E2] expression relative to cells transfected with G alpha i2 and mock vector.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "G alpha i2", "entity_1_idx": [[16, 26]], "entity_1_idx_in_text_with_entity_marker": [20, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "G alpha i2", "entity_2_idx": [[67, 77]], "entity_2_idx_in_text_with_entity_marker": [80, 90], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d88.s750_AIMed.d88.s750.p2", "text": "Transfection of G alpha i2 and nucleobindin in COS cells increased G alpha i2 expression relative to cells transfected with G alpha i2 and mock vector.", "text_with_entity_marker": "Transfection of [E1]G alpha i2[/E1] and nucleobindin in COS cells increased G alpha i2 expression relative to cells transfected with [E2]G alpha i2[/E2] and mock vector.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "G alpha i2", "entity_1_idx": [[16, 26]], "entity_1_idx_in_text_with_entity_marker": [20, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "G alpha i2", "entity_2_idx": [[124, 134]], "entity_2_idx_in_text_with_entity_marker": [137, 147], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d88.s750_AIMed.d88.s750.p3", "text": "Transfection of G alpha i2 and nucleobindin in COS cells increased G alpha i2 expression relative to cells transfected with G alpha i2 and mock vector.", "text_with_entity_marker": "Transfection of G alpha i2 and [E1]nucleobindin[/E1] in COS cells increased [E2]G alpha i2[/E2] expression relative to cells transfected with G alpha i2 and mock vector.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleobindin", "entity_1_idx": [[31, 43]], "entity_1_idx_in_text_with_entity_marker": [35, 47], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "G alpha i2", "entity_2_idx": [[67, 77]], "entity_2_idx_in_text_with_entity_marker": [80, 90], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d88.s750_AIMed.d88.s750.p4", "text": "Transfection of G alpha i2 and nucleobindin in COS cells increased G alpha i2 expression relative to cells transfected with G alpha i2 and mock vector.", "text_with_entity_marker": "Transfection of G alpha i2 and [E1]nucleobindin[/E1] in COS cells increased G alpha i2 expression relative to cells transfected with [E2]G alpha i2[/E2] and mock vector.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleobindin", "entity_1_idx": [[31, 43]], "entity_1_idx_in_text_with_entity_marker": [35, 47], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "G alpha i2", "entity_2_idx": [[124, 134]], "entity_2_idx_in_text_with_entity_marker": [137, 147], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d88.s750_AIMed.d88.s750.p5", "text": "Transfection of G alpha i2 and nucleobindin in COS cells increased G alpha i2 expression relative to cells transfected with G alpha i2 and mock vector.", "text_with_entity_marker": "Transfection of G alpha i2 and nucleobindin in COS cells increased [E1]G alpha i2[/E1] expression relative to cells transfected with [E2]G alpha i2[/E2] and mock vector.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "G alpha i2", "entity_1_idx": [[67, 77]], "entity_1_idx_in_text_with_entity_marker": [71, 81], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "G alpha i2", "entity_2_idx": [[124, 134]], "entity_2_idx_in_text_with_entity_marker": [137, 147], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d94.s797_AIMed.d94.s797.p0", "text": "We have isolated a human cDNA encoding the first eosinophil-selective chemokine receptor, designated CC chemokine receptor 3 (CC CKR3).", "text_with_entity_marker": "We have isolated a human cDNA encoding the first eosinophil-selective chemokine receptor, designated [E1]CC chemokine receptor 3[/E1] ([E2]CC CKR3[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CC chemokine receptor 3", "entity_1_idx": [[101, 124]], "entity_1_idx_in_text_with_entity_marker": [105, 128], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CC CKR3", "entity_2_idx": [[126, 133]], "entity_2_idx_in_text_with_entity_marker": [139, 146], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d94.s798_AIMed.d94.s798.p0", "text": "CC CKR3 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor CC CKR1 (also known as the MIP-1 alpha/RANTES receptor).", "text_with_entity_marker": "[E1]CC CKR3[/E1] is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor [E2]CC CKR1[/E2] (also known as the MIP-1 alpha/RANTES receptor).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CC CKR3", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CC CKR1", "entity_2_idx": [[159, 166]], "entity_2_idx_in_text_with_entity_marker": [172, 179], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d94.s798_AIMed.d94.s798.p1", "text": "CC CKR3 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor CC CKR1 (also known as the MIP-1 alpha/RANTES receptor).", "text_with_entity_marker": "[E1]CC CKR3[/E1] is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor CC CKR1 (also known as the [E2]MIP-1 alpha[/E2]/RANTES receptor).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CC CKR3", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "MIP-1 alpha", "entity_2_idx": [[186, 197]], "entity_2_idx_in_text_with_entity_marker": [199, 210], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d94.s798_AIMed.d94.s798.p2", "text": "CC CKR3 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor CC CKR1 (also known as the MIP-1 alpha/RANTES receptor).", "text_with_entity_marker": "[E1]CC CKR3[/E1] is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor CC CKR1 (also known as the MIP-1 alpha/[E2]RANTES[/E2] receptor).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CC CKR3", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RANTES", "entity_2_idx": [[198, 204]], "entity_2_idx_in_text_with_entity_marker": [211, 217], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d94.s798_AIMed.d94.s798.p3", "text": "CC CKR3 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor CC CKR1 (also known as the MIP-1 alpha/RANTES receptor).", "text_with_entity_marker": "CC CKR3 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor [E1]CC CKR1[/E1] (also known as the [E2]MIP-1 alpha[/E2]/RANTES receptor).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CC CKR1", "entity_1_idx": [[159, 166]], "entity_1_idx_in_text_with_entity_marker": [163, 170], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "MIP-1 alpha", "entity_2_idx": [[186, 197]], "entity_2_idx_in_text_with_entity_marker": [199, 210], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d94.s798_AIMed.d94.s798.p4", "text": "CC CKR3 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor CC CKR1 (also known as the MIP-1 alpha/RANTES receptor).", "text_with_entity_marker": "CC CKR3 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor [E1]CC CKR1[/E1] (also known as the MIP-1 alpha/[E2]RANTES[/E2] receptor).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CC CKR1", "entity_1_idx": [[159, 166]], "entity_1_idx_in_text_with_entity_marker": [163, 170], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RANTES", "entity_2_idx": [[198, 204]], "entity_2_idx_in_text_with_entity_marker": [211, 217], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d94.s798_AIMed.d94.s798.p5", "text": "CC CKR3 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor CC CKR1 (also known as the MIP-1 alpha/RANTES receptor).", "text_with_entity_marker": "CC CKR3 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor CC CKR1 (also known as the [E1]MIP-1 alpha[/E1]/[E2]RANTES[/E2] receptor).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MIP-1 alpha", "entity_1_idx": [[186, 197]], "entity_1_idx_in_text_with_entity_marker": [190, 201], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RANTES", "entity_2_idx": [[198, 204]], "entity_2_idx_in_text_with_entity_marker": [211, 217], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s30_AIMed.d3.s30.p0", "text": "Temporally following this growth arrest, the cells develop a senescence morphology and express senescence-associated beta-galactosidase (SA-beta-gal).", "text_with_entity_marker": "Temporally following this growth arrest, the cells develop a senescence morphology and express [E1]senescence-associated [E2]beta-galactosidase[/E1-E2] (SA-beta-gal).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "senescence-associated [E2]beta-galactosidase", "entity_1_idx": [[95, 135]], "entity_1_idx_in_text_with_entity_marker": [99, 143], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "beta-galactosidase", "entity_2_idx": [[117, 135]], "entity_2_idx_in_text_with_entity_marker": [125, 143], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s30_AIMed.d3.s30.p1", "text": "Temporally following this growth arrest, the cells develop a senescence morphology and express senescence-associated beta-galactosidase (SA-beta-gal).", "text_with_entity_marker": "Temporally following this growth arrest, the cells develop a senescence morphology and express senescence-associated [E1]beta-galactosidase[/E1] ([E2]SA-beta-gal[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-galactosidase", "entity_1_idx": [[117, 135]], "entity_1_idx_in_text_with_entity_marker": [121, 139], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SA-beta-gal", "entity_2_idx": [[137, 148]], "entity_2_idx_in_text_with_entity_marker": [150, 161], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s30_AIMed.d3.s30.p2", "text": "Temporally following this growth arrest, the cells develop a senescence morphology and express senescence-associated beta-galactosidase (SA-beta-gal).", "text_with_entity_marker": "Temporally following this growth arrest, the cells develop a senescence morphology and express [E1]senescence-associated beta-galactosidase[/E1] ([E2]SA-beta-gal[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "senescence-associated beta-galactosidase", "entity_1_idx": [[95, 135]], "entity_1_idx_in_text_with_entity_marker": [99, 139], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SA-beta-gal", "entity_2_idx": [[137, 148]], "entity_2_idx_in_text_with_entity_marker": [150, 161], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s31_AIMed.d3.s31.p0", "text": "Levels of p16(INK4a) and p57(KIP2) rise in HUCs during progressive passages, whereas only p16 increases in HPEC cultures.", "text_with_entity_marker": "Levels of [E1]p16[/E1]([E2]INK4a[/E2]) and p57(KIP2) rise in HUCs during progressive passages, whereas only p16 increases in HPEC cultures.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p16", "entity_1_idx": [[10, 13]], "entity_1_idx_in_text_with_entity_marker": [14, 17], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "INK4a", "entity_2_idx": [[14, 19]], "entity_2_idx_in_text_with_entity_marker": [27, 32], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s31_AIMed.d3.s31.p1", "text": "Levels of p16(INK4a) and p57(KIP2) rise in HUCs during progressive passages, whereas only p16 increases in HPEC cultures.", "text_with_entity_marker": "Levels of [E1]p16[/E1](INK4a) and [E2]p57[/E2](KIP2) rise in HUCs during progressive passages, whereas only p16 increases in HPEC cultures.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p16", "entity_1_idx": [[10, 13]], "entity_1_idx_in_text_with_entity_marker": [14, 17], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p57", "entity_2_idx": [[25, 28]], "entity_2_idx_in_text_with_entity_marker": [38, 41], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s31_AIMed.d3.s31.p2", "text": "Levels of p16(INK4a) and p57(KIP2) rise in HUCs during progressive passages, whereas only p16 increases in HPEC cultures.", "text_with_entity_marker": "Levels of [E1]p16[/E1](INK4a) and p57([E2]KIP2[/E2]) rise in HUCs during progressive passages, whereas only p16 increases in HPEC cultures.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p16", "entity_1_idx": [[10, 13]], "entity_1_idx_in_text_with_entity_marker": [14, 17], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "KIP2", "entity_2_idx": [[29, 33]], "entity_2_idx_in_text_with_entity_marker": [42, 46], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s31_AIMed.d3.s31.p3", "text": "Levels of p16(INK4a) and p57(KIP2) rise in HUCs during progressive passages, whereas only p16 increases in HPEC cultures.", "text_with_entity_marker": "Levels of [E1]p16[/E1](INK4a) and p57(KIP2) rise in HUCs during progressive passages, whereas only [E2]p16[/E2] increases in HPEC cultures.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p16", "entity_1_idx": [[10, 13]], "entity_1_idx_in_text_with_entity_marker": [14, 17], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p16", "entity_2_idx": [[90, 93]], "entity_2_idx_in_text_with_entity_marker": [103, 106], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s31_AIMed.d3.s31.p4", "text": "Levels of p16(INK4a) and p57(KIP2) rise in HUCs during progressive passages, whereas only p16 increases in HPEC cultures.", "text_with_entity_marker": "Levels of p16([E1]INK4a[/E1]) and [E2]p57[/E2](KIP2) rise in HUCs during progressive passages, whereas only p16 increases in HPEC cultures.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "INK4a", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p57", "entity_2_idx": [[25, 28]], "entity_2_idx_in_text_with_entity_marker": [38, 41], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s31_AIMed.d3.s31.p5", "text": "Levels of p16(INK4a) and p57(KIP2) rise in HUCs during progressive passages, whereas only p16 increases in HPEC cultures.", "text_with_entity_marker": "Levels of p16([E1]INK4a[/E1]) and p57([E2]KIP2[/E2]) rise in HUCs during progressive passages, whereas only p16 increases in HPEC cultures.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "INK4a", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "KIP2", "entity_2_idx": [[29, 33]], "entity_2_idx_in_text_with_entity_marker": [42, 46], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s31_AIMed.d3.s31.p6", "text": "Levels of p16(INK4a) and p57(KIP2) rise in HUCs during progressive passages, whereas only p16 increases in HPEC cultures.", "text_with_entity_marker": "Levels of p16([E1]INK4a[/E1]) and p57(KIP2) rise in HUCs during progressive passages, whereas only [E2]p16[/E2] increases in HPEC cultures.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "INK4a", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p16", "entity_2_idx": [[90, 93]], "entity_2_idx_in_text_with_entity_marker": [103, 106], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s31_AIMed.d3.s31.p7", "text": "Levels of p16(INK4a) and p57(KIP2) rise in HUCs during progressive passages, whereas only p16 increases in HPEC cultures.", "text_with_entity_marker": "Levels of p16(INK4a) and [E1]p57[/E1]([E2]KIP2[/E2]) rise in HUCs during progressive passages, whereas only p16 increases in HPEC cultures.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p57", "entity_1_idx": [[25, 28]], "entity_1_idx_in_text_with_entity_marker": [29, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "KIP2", "entity_2_idx": [[29, 33]], "entity_2_idx_in_text_with_entity_marker": [42, 46], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s31_AIMed.d3.s31.p8", "text": "Levels of p16(INK4a) and p57(KIP2) rise in HUCs during progressive passages, whereas only p16 increases in HPEC cultures.", "text_with_entity_marker": "Levels of p16(INK4a) and [E1]p57[/E1](KIP2) rise in HUCs during progressive passages, whereas only [E2]p16[/E2] increases in HPEC cultures.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p57", "entity_1_idx": [[25, 28]], "entity_1_idx_in_text_with_entity_marker": [29, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p16", "entity_2_idx": [[90, 93]], "entity_2_idx_in_text_with_entity_marker": [103, 106], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s31_AIMed.d3.s31.p9", "text": "Levels of p16(INK4a) and p57(KIP2) rise in HUCs during progressive passages, whereas only p16 increases in HPEC cultures.", "text_with_entity_marker": "Levels of p16(INK4a) and p57([E1]KIP2[/E1]) rise in HUCs during progressive passages, whereas only [E2]p16[/E2] increases in HPEC cultures.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "KIP2", "entity_1_idx": [[29, 33]], "entity_1_idx_in_text_with_entity_marker": [33, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p16", "entity_2_idx": [[90, 93]], "entity_2_idx_in_text_with_entity_marker": [103, 106], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s32_AIMed.d3.s32.p0", "text": "The induced expression of p57, similar to p16, produces a senescent-like phenotype.", "text_with_entity_marker": "The induced expression of [E1]p57[/E1], similar to [E2]p16[/E2], produces a senescent-like phenotype.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p57", "entity_1_idx": [[26, 29]], "entity_1_idx_in_text_with_entity_marker": [30, 33], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p16", "entity_2_idx": [[42, 45]], "entity_2_idx_in_text_with_entity_marker": [55, 58], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s33_AIMed.d3.s33.p0", "text": "pRB, cyclin D, p19(INK4d) and p27(KIP1) decrease in both cell types.", "text_with_entity_marker": "[E1]pRB[/E1], [E2]cyclin D[/E2], p19(INK4d) and p27(KIP1) decrease in both cell types.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "pRB", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "cyclin D", "entity_2_idx": [[5, 13]], "entity_2_idx_in_text_with_entity_marker": [18, 26], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s33_AIMed.d3.s33.p1", "text": "pRB, cyclin D, p19(INK4d) and p27(KIP1) decrease in both cell types.", "text_with_entity_marker": "[E1]pRB[/E1], cyclin D, [E2]p19[/E2](INK4d) and p27(KIP1) decrease in both cell types.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "pRB", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p19", "entity_2_idx": [[15, 18]], "entity_2_idx_in_text_with_entity_marker": [28, 31], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s33_AIMed.d3.s33.p2", "text": "pRB, cyclin D, p19(INK4d) and p27(KIP1) decrease in both cell types.", "text_with_entity_marker": "[E1]pRB[/E1], cyclin D, p19([E2]INK4d[/E2]) and p27(KIP1) decrease in both cell types.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "pRB", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "INK4d", "entity_2_idx": [[19, 24]], "entity_2_idx_in_text_with_entity_marker": [32, 37], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s33_AIMed.d3.s33.p3", "text": "pRB, cyclin D, p19(INK4d) and p27(KIP1) decrease in both cell types.", "text_with_entity_marker": "[E1]pRB[/E1], cyclin D, p19(INK4d) and [E2]p27[/E2](KIP1) decrease in both cell types.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "pRB", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p27", "entity_2_idx": [[30, 33]], "entity_2_idx_in_text_with_entity_marker": [43, 46], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s33_AIMed.d3.s33.p4", "text": "pRB, cyclin D, p19(INK4d) and p27(KIP1) decrease in both cell types.", "text_with_entity_marker": "[E1]pRB[/E1], cyclin D, p19(INK4d) and p27([E2]KIP1[/E2]) decrease in both cell types.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "pRB", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "KIP1", "entity_2_idx": [[34, 38]], "entity_2_idx_in_text_with_entity_marker": [47, 51], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s33_AIMed.d3.s33.p5", "text": "pRB, cyclin D, p19(INK4d) and p27(KIP1) decrease in both cell types.", "text_with_entity_marker": "pRB, [E1]cyclin D[/E1], [E2]p19[/E2](INK4d) and p27(KIP1) decrease in both cell types.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "cyclin D", "entity_1_idx": [[5, 13]], "entity_1_idx_in_text_with_entity_marker": [9, 17], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p19", "entity_2_idx": [[15, 18]], "entity_2_idx_in_text_with_entity_marker": [28, 31], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s33_AIMed.d3.s33.p6", "text": "pRB, cyclin D, p19(INK4d) and p27(KIP1) decrease in both cell types.", "text_with_entity_marker": "pRB, [E1]cyclin D[/E1], p19([E2]INK4d[/E2]) and p27(KIP1) decrease in both cell types.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "cyclin D", "entity_1_idx": [[5, 13]], "entity_1_idx_in_text_with_entity_marker": [9, 17], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "INK4d", "entity_2_idx": [[19, 24]], "entity_2_idx_in_text_with_entity_marker": [32, 37], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s33_AIMed.d3.s33.p7", "text": "pRB, cyclin D, p19(INK4d) and p27(KIP1) decrease in both cell types.", "text_with_entity_marker": "pRB, [E1]cyclin D[/E1], p19(INK4d) and [E2]p27[/E2](KIP1) decrease in both cell types.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "cyclin D", "entity_1_idx": [[5, 13]], "entity_1_idx_in_text_with_entity_marker": [9, 17], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p27", "entity_2_idx": [[30, 33]], "entity_2_idx_in_text_with_entity_marker": [43, 46], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s33_AIMed.d3.s33.p8", "text": "pRB, cyclin D, p19(INK4d) and p27(KIP1) decrease in both cell types.", "text_with_entity_marker": "pRB, [E1]cyclin D[/E1], p19(INK4d) and p27([E2]KIP1[/E2]) decrease in both cell types.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "cyclin D", "entity_1_idx": [[5, 13]], "entity_1_idx_in_text_with_entity_marker": [9, 17], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "KIP1", "entity_2_idx": [[34, 38]], "entity_2_idx_in_text_with_entity_marker": [47, 51], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s33_AIMed.d3.s33.p9", "text": "pRB, cyclin D, p19(INK4d) and p27(KIP1) decrease in both cell types.", "text_with_entity_marker": "pRB, cyclin D, [E1]p19[/E1]([E2]INK4d[/E2]) and p27(KIP1) decrease in both cell types.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p19", "entity_1_idx": [[15, 18]], "entity_1_idx_in_text_with_entity_marker": [19, 22], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "INK4d", "entity_2_idx": [[19, 24]], "entity_2_idx_in_text_with_entity_marker": [32, 37], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s33_AIMed.d3.s33.p10", "text": "pRB, cyclin D, p19(INK4d) and p27(KIP1) decrease in both cell types.", "text_with_entity_marker": "pRB, cyclin D, [E1]p19[/E1](INK4d) and [E2]p27[/E2](KIP1) decrease in both cell types.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p19", "entity_1_idx": [[15, 18]], "entity_1_idx_in_text_with_entity_marker": [19, 22], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p27", "entity_2_idx": [[30, 33]], "entity_2_idx_in_text_with_entity_marker": [43, 46], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s33_AIMed.d3.s33.p11", "text": "pRB, cyclin D, p19(INK4d) and p27(KIP1) decrease in both cell types.", "text_with_entity_marker": "pRB, cyclin D, [E1]p19[/E1](INK4d) and p27([E2]KIP1[/E2]) decrease in both cell types.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p19", "entity_1_idx": [[15, 18]], "entity_1_idx_in_text_with_entity_marker": [19, 22], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "KIP1", "entity_2_idx": [[34, 38]], "entity_2_idx_in_text_with_entity_marker": [47, 51], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s33_AIMed.d3.s33.p12", "text": "pRB, cyclin D, p19(INK4d) and p27(KIP1) decrease in both cell types.", "text_with_entity_marker": "pRB, cyclin D, p19([E1]INK4d[/E1]) and [E2]p27[/E2](KIP1) decrease in both cell types.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "INK4d", "entity_1_idx": [[19, 24]], "entity_1_idx_in_text_with_entity_marker": [23, 28], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p27", "entity_2_idx": [[30, 33]], "entity_2_idx_in_text_with_entity_marker": [43, 46], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s33_AIMed.d3.s33.p13", "text": "pRB, cyclin D, p19(INK4d) and p27(KIP1) decrease in both cell types.", "text_with_entity_marker": "pRB, cyclin D, p19([E1]INK4d[/E1]) and p27([E2]KIP1[/E2]) decrease in both cell types.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "INK4d", "entity_1_idx": [[19, 24]], "entity_1_idx_in_text_with_entity_marker": [23, 28], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "KIP1", "entity_2_idx": [[34, 38]], "entity_2_idx_in_text_with_entity_marker": [47, 51], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s33_AIMed.d3.s33.p14", "text": "pRB, cyclin D, p19(INK4d) and p27(KIP1) decrease in both cell types.", "text_with_entity_marker": "pRB, cyclin D, p19(INK4d) and [E1]p27[/E1]([E2]KIP1[/E2]) decrease in both cell types.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p27", "entity_1_idx": [[30, 33]], "entity_1_idx_in_text_with_entity_marker": [34, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "KIP1", "entity_2_idx": [[34, 38]], "entity_2_idx_in_text_with_entity_marker": [47, 51], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s34_AIMed.d3.s34.p0", "text": "We find that p53, p21(CIP1) and p15(INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.", "text_with_entity_marker": "We find that [E1]p53[/E1], [E2]p21[/E2](CIP1) and p15(INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[13, 16]], "entity_1_idx_in_text_with_entity_marker": [17, 20], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[18, 21]], "entity_2_idx_in_text_with_entity_marker": [31, 34], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s34_AIMed.d3.s34.p1", "text": "We find that p53, p21(CIP1) and p15(INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.", "text_with_entity_marker": "We find that [E1]p53[/E1], p21([E2]CIP1[/E2]) and p15(INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[13, 16]], "entity_1_idx_in_text_with_entity_marker": [17, 20], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CIP1", "entity_2_idx": [[22, 26]], "entity_2_idx_in_text_with_entity_marker": [35, 39], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s34_AIMed.d3.s34.p2", "text": "We find that p53, p21(CIP1) and p15(INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.", "text_with_entity_marker": "We find that [E1]p53[/E1], p21(CIP1) and [E2]p15[/E2](INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[13, 16]], "entity_1_idx_in_text_with_entity_marker": [17, 20], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p15", "entity_2_idx": [[32, 35]], "entity_2_idx_in_text_with_entity_marker": [45, 48], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s34_AIMed.d3.s34.p3", "text": "We find that p53, p21(CIP1) and p15(INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.", "text_with_entity_marker": "We find that [E1]p53[/E1], p21(CIP1) and p15([E2]INK4b[/E2]) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[13, 16]], "entity_1_idx_in_text_with_entity_marker": [17, 20], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "INK4b", "entity_2_idx": [[36, 41]], "entity_2_idx_in_text_with_entity_marker": [49, 54], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s34_AIMed.d3.s34.p4", "text": "We find that p53, p21(CIP1) and p15(INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.", "text_with_entity_marker": "We find that p53, [E1]p21[/E1]([E2]CIP1[/E2]) and p15(INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p21", "entity_1_idx": [[18, 21]], "entity_1_idx_in_text_with_entity_marker": [22, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CIP1", "entity_2_idx": [[22, 26]], "entity_2_idx_in_text_with_entity_marker": [35, 39], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s34_AIMed.d3.s34.p5", "text": "We find that p53, p21(CIP1) and p15(INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.", "text_with_entity_marker": "We find that p53, [E1]p21[/E1](CIP1) and [E2]p15[/E2](INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p21", "entity_1_idx": [[18, 21]], "entity_1_idx_in_text_with_entity_marker": [22, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p15", "entity_2_idx": [[32, 35]], "entity_2_idx_in_text_with_entity_marker": [45, 48], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s34_AIMed.d3.s34.p6", "text": "We find that p53, p21(CIP1) and p15(INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.", "text_with_entity_marker": "We find that p53, [E1]p21[/E1](CIP1) and p15([E2]INK4b[/E2]) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p21", "entity_1_idx": [[18, 21]], "entity_1_idx_in_text_with_entity_marker": [22, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "INK4b", "entity_2_idx": [[36, 41]], "entity_2_idx_in_text_with_entity_marker": [49, 54], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s34_AIMed.d3.s34.p7", "text": "We find that p53, p21(CIP1) and p15(INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.", "text_with_entity_marker": "We find that p53, p21([E1]CIP1[/E1]) and [E2]p15[/E2](INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CIP1", "entity_1_idx": [[22, 26]], "entity_1_idx_in_text_with_entity_marker": [26, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p15", "entity_2_idx": [[32, 35]], "entity_2_idx_in_text_with_entity_marker": [45, 48], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s34_AIMed.d3.s34.p8", "text": "We find that p53, p21(CIP1) and p15(INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.", "text_with_entity_marker": "We find that p53, p21([E1]CIP1[/E1]) and p15([E2]INK4b[/E2]) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CIP1", "entity_1_idx": [[22, 26]], "entity_1_idx_in_text_with_entity_marker": [26, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "INK4b", "entity_2_idx": [[36, 41]], "entity_2_idx_in_text_with_entity_marker": [49, 54], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s34_AIMed.d3.s34.p9", "text": "We find that p53, p21(CIP1) and p15(INK4b) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.", "text_with_entity_marker": "We find that p53, p21(CIP1) and [E1]p15[/E1]([E2]INK4b[/E2]) are transiently elevated in HPECs and HUCs at the pre-senescent growth arrest, then return to low proliferating levels at terminal senescence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p15", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "INK4b", "entity_2_idx": [[36, 41]], "entity_2_idx_in_text_with_entity_marker": [49, 54], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p0", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of [E1]p53[/E1], [E2]p21[/E2](CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[12, 15]], "entity_1_idx_in_text_with_entity_marker": [16, 19], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[17, 20]], "entity_2_idx_in_text_with_entity_marker": [30, 33], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p1", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of [E1]p53[/E1], p21([E2]CIP1[/E2]), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[12, 15]], "entity_1_idx_in_text_with_entity_marker": [16, 19], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CIP1", "entity_2_idx": [[21, 25]], "entity_2_idx_in_text_with_entity_marker": [34, 38], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p2", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of [E1]p53[/E1], p21(CIP1), [E2]p15[/E2](INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[12, 15]], "entity_1_idx_in_text_with_entity_marker": [16, 19], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p15", "entity_2_idx": [[28, 31]], "entity_2_idx_in_text_with_entity_marker": [41, 44], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p3", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of [E1]p53[/E1], p21(CIP1), p15([E2]INK4b[/E2]), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[12, 15]], "entity_1_idx_in_text_with_entity_marker": [16, 19], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "INK4b", "entity_2_idx": [[32, 37]], "entity_2_idx_in_text_with_entity_marker": [45, 50], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p4", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of [E1]p53[/E1], p21(CIP1), p15(INK4b), [E2]p16[/E2](INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[12, 15]], "entity_1_idx_in_text_with_entity_marker": [16, 19], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p16", "entity_2_idx": [[40, 43]], "entity_2_idx_in_text_with_entity_marker": [53, 56], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p5", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of [E1]p53[/E1], p21(CIP1), p15(INK4b), p16([E2]INK4a[/E2]), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[12, 15]], "entity_1_idx_in_text_with_entity_marker": [16, 19], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "INK4a", "entity_2_idx": [[44, 49]], "entity_2_idx_in_text_with_entity_marker": [57, 62], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p6", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of [E1]p53[/E1], p21(CIP1), p15(INK4b), p16(INK4a), and [E2]p57[/E2](KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[12, 15]], "entity_1_idx_in_text_with_entity_marker": [16, 19], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p57", "entity_2_idx": [[56, 59]], "entity_2_idx_in_text_with_entity_marker": [69, 72], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p7", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of [E1]p53[/E1], p21(CIP1), p15(INK4b), p16(INK4a), and p57([E2]KIP2[/E2]) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[12, 15]], "entity_1_idx_in_text_with_entity_marker": [16, 19], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "KIP2", "entity_2_idx": [[60, 64]], "entity_2_idx_in_text_with_entity_marker": [73, 77], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p8", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, [E1]p21[/E1]([E2]CIP1[/E2]), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p21", "entity_1_idx": [[17, 20]], "entity_1_idx_in_text_with_entity_marker": [21, 24], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CIP1", "entity_2_idx": [[21, 25]], "entity_2_idx_in_text_with_entity_marker": [34, 38], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p9", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, [E1]p21[/E1](CIP1), [E2]p15[/E2](INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p21", "entity_1_idx": [[17, 20]], "entity_1_idx_in_text_with_entity_marker": [21, 24], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p15", "entity_2_idx": [[28, 31]], "entity_2_idx_in_text_with_entity_marker": [41, 44], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p10", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, [E1]p21[/E1](CIP1), p15([E2]INK4b[/E2]), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p21", "entity_1_idx": [[17, 20]], "entity_1_idx_in_text_with_entity_marker": [21, 24], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "INK4b", "entity_2_idx": [[32, 37]], "entity_2_idx_in_text_with_entity_marker": [45, 50], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p11", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, [E1]p21[/E1](CIP1), p15(INK4b), [E2]p16[/E2](INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p21", "entity_1_idx": [[17, 20]], "entity_1_idx_in_text_with_entity_marker": [21, 24], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p16", "entity_2_idx": [[40, 43]], "entity_2_idx_in_text_with_entity_marker": [53, 56], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p12", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, [E1]p21[/E1](CIP1), p15(INK4b), p16([E2]INK4a[/E2]), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p21", "entity_1_idx": [[17, 20]], "entity_1_idx_in_text_with_entity_marker": [21, 24], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "INK4a", "entity_2_idx": [[44, 49]], "entity_2_idx_in_text_with_entity_marker": [57, 62], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p13", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, [E1]p21[/E1](CIP1), p15(INK4b), p16(INK4a), and [E2]p57[/E2](KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p21", "entity_1_idx": [[17, 20]], "entity_1_idx_in_text_with_entity_marker": [21, 24], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p57", "entity_2_idx": [[56, 59]], "entity_2_idx_in_text_with_entity_marker": [69, 72], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p14", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, [E1]p21[/E1](CIP1), p15(INK4b), p16(INK4a), and p57([E2]KIP2[/E2]) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p21", "entity_1_idx": [[17, 20]], "entity_1_idx_in_text_with_entity_marker": [21, 24], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "KIP2", "entity_2_idx": [[60, 64]], "entity_2_idx_in_text_with_entity_marker": [73, 77], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p15", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, p21([E1]CIP1[/E1]), [E2]p15[/E2](INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CIP1", "entity_1_idx": [[21, 25]], "entity_1_idx_in_text_with_entity_marker": [25, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p15", "entity_2_idx": [[28, 31]], "entity_2_idx_in_text_with_entity_marker": [41, 44], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p16", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, p21([E1]CIP1[/E1]), p15([E2]INK4b[/E2]), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CIP1", "entity_1_idx": [[21, 25]], "entity_1_idx_in_text_with_entity_marker": [25, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "INK4b", "entity_2_idx": [[32, 37]], "entity_2_idx_in_text_with_entity_marker": [45, 50], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p17", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, p21([E1]CIP1[/E1]), p15(INK4b), [E2]p16[/E2](INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CIP1", "entity_1_idx": [[21, 25]], "entity_1_idx_in_text_with_entity_marker": [25, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p16", "entity_2_idx": [[40, 43]], "entity_2_idx_in_text_with_entity_marker": [53, 56], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p18", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, p21([E1]CIP1[/E1]), p15(INK4b), p16([E2]INK4a[/E2]), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CIP1", "entity_1_idx": [[21, 25]], "entity_1_idx_in_text_with_entity_marker": [25, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "INK4a", "entity_2_idx": [[44, 49]], "entity_2_idx_in_text_with_entity_marker": [57, 62], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p19", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, p21([E1]CIP1[/E1]), p15(INK4b), p16(INK4a), and [E2]p57[/E2](KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CIP1", "entity_1_idx": [[21, 25]], "entity_1_idx_in_text_with_entity_marker": [25, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p57", "entity_2_idx": [[56, 59]], "entity_2_idx_in_text_with_entity_marker": [69, 72], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p20", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, p21([E1]CIP1[/E1]), p15(INK4b), p16(INK4a), and p57([E2]KIP2[/E2]) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CIP1", "entity_1_idx": [[21, 25]], "entity_1_idx_in_text_with_entity_marker": [25, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "KIP2", "entity_2_idx": [[60, 64]], "entity_2_idx_in_text_with_entity_marker": [73, 77], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p21", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, p21(CIP1), [E1]p15[/E1]([E2]INK4b[/E2]), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p15", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "INK4b", "entity_2_idx": [[32, 37]], "entity_2_idx_in_text_with_entity_marker": [45, 50], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p22", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, p21(CIP1), [E1]p15[/E1](INK4b), [E2]p16[/E2](INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p15", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p16", "entity_2_idx": [[40, 43]], "entity_2_idx_in_text_with_entity_marker": [53, 56], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p23", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, p21(CIP1), [E1]p15[/E1](INK4b), p16([E2]INK4a[/E2]), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p15", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "INK4a", "entity_2_idx": [[44, 49]], "entity_2_idx_in_text_with_entity_marker": [57, 62], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p24", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, p21(CIP1), [E1]p15[/E1](INK4b), p16(INK4a), and [E2]p57[/E2](KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p15", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p57", "entity_2_idx": [[56, 59]], "entity_2_idx_in_text_with_entity_marker": [69, 72], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p25", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, p21(CIP1), [E1]p15[/E1](INK4b), p16(INK4a), and p57([E2]KIP2[/E2]) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p15", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "KIP2", "entity_2_idx": [[60, 64]], "entity_2_idx_in_text_with_entity_marker": [73, 77], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p26", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, p21(CIP1), p15([E1]INK4b[/E1]), [E2]p16[/E2](INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "INK4b", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p16", "entity_2_idx": [[40, 43]], "entity_2_idx_in_text_with_entity_marker": [53, 56], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p27", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, p21(CIP1), p15([E1]INK4b[/E1]), p16([E2]INK4a[/E2]), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "INK4b", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "INK4a", "entity_2_idx": [[44, 49]], "entity_2_idx_in_text_with_entity_marker": [57, 62], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p28", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, p21(CIP1), p15([E1]INK4b[/E1]), p16(INK4a), and [E2]p57[/E2](KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "INK4b", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p57", "entity_2_idx": [[56, 59]], "entity_2_idx_in_text_with_entity_marker": [69, 72], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p29", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, p21(CIP1), p15([E1]INK4b[/E1]), p16(INK4a), and p57([E2]KIP2[/E2]) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "INK4b", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "KIP2", "entity_2_idx": [[60, 64]], "entity_2_idx_in_text_with_entity_marker": [73, 77], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p30", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, p21(CIP1), p15(INK4b), [E1]p16[/E1]([E2]INK4a[/E2]), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p16", "entity_1_idx": [[40, 43]], "entity_1_idx_in_text_with_entity_marker": [44, 47], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "INK4a", "entity_2_idx": [[44, 49]], "entity_2_idx_in_text_with_entity_marker": [57, 62], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p31", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, p21(CIP1), p15(INK4b), [E1]p16[/E1](INK4a), and [E2]p57[/E2](KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p16", "entity_1_idx": [[40, 43]], "entity_1_idx_in_text_with_entity_marker": [44, 47], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p57", "entity_2_idx": [[56, 59]], "entity_2_idx_in_text_with_entity_marker": [69, 72], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p32", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, p21(CIP1), p15(INK4b), [E1]p16[/E1](INK4a), and p57([E2]KIP2[/E2]) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p16", "entity_1_idx": [[40, 43]], "entity_1_idx_in_text_with_entity_marker": [44, 47], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "KIP2", "entity_2_idx": [[60, 64]], "entity_2_idx_in_text_with_entity_marker": [73, 77], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p33", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, p21(CIP1), p15(INK4b), p16([E1]INK4a[/E1]), and [E2]p57[/E2](KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "INK4a", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p57", "entity_2_idx": [[56, 59]], "entity_2_idx_in_text_with_entity_marker": [69, 72], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p34", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, p21(CIP1), p15(INK4b), p16([E1]INK4a[/E1]), and p57([E2]KIP2[/E2]) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "INK4a", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "KIP2", "entity_2_idx": [[60, 64]], "entity_2_idx_in_text_with_entity_marker": [73, 77], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d3.s35_AIMed.d3.s35.p35", "text": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and p57(KIP2) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "text_with_entity_marker": "Analysis of p53, p21(CIP1), p15(INK4b), p16(INK4a), and [E1]p57[/E1]([E2]KIP2[/E2]) reveals altered expression in immortalized, non-tumorigenic HPV16 E6 and E7 prostate lines and in tumorigenic prostate cancer cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p57", "entity_1_idx": [[56, 59]], "entity_1_idx_in_text_with_entity_marker": [60, 63], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "KIP2", "entity_2_idx": [[60, 64]], "entity_2_idx_in_text_with_entity_marker": [73, 77], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d9.s73_AIMed.d9.s73.p0", "text": "We investigated the mechanism of calcium-stimulated gastrin release from gastrinoma cells in vitro with a particular focus on the calcium-sensing receptor (CaR).", "text_with_entity_marker": "We investigated the mechanism of calcium-stimulated [E1]gastrin[/E1] release from gastrinoma cells in vitro with a particular focus on the [E2]calcium-sensing receptor[/E2] (CaR).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gastrin", "entity_1_idx": [[52, 59]], "entity_1_idx_in_text_with_entity_marker": [56, 63], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "calcium-sensing receptor", "entity_2_idx": [[130, 154]], "entity_2_idx_in_text_with_entity_marker": [143, 167], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d9.s73_AIMed.d9.s73.p1", "text": "We investigated the mechanism of calcium-stimulated gastrin release from gastrinoma cells in vitro with a particular focus on the calcium-sensing receptor (CaR).", "text_with_entity_marker": "We investigated the mechanism of calcium-stimulated [E1]gastrin[/E1] release from gastrinoma cells in vitro with a particular focus on the calcium-sensing receptor ([E2]CaR[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gastrin", "entity_1_idx": [[52, 59]], "entity_1_idx_in_text_with_entity_marker": [56, 63], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CaR", "entity_2_idx": [[156, 159]], "entity_2_idx_in_text_with_entity_marker": [169, 172], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d9.s73_AIMed.d9.s73.p2", "text": "We investigated the mechanism of calcium-stimulated gastrin release from gastrinoma cells in vitro with a particular focus on the calcium-sensing receptor (CaR).", "text_with_entity_marker": "We investigated the mechanism of calcium-stimulated gastrin release from gastrinoma cells in vitro with a particular focus on the [E1]calcium-sensing receptor[/E1] ([E2]CaR[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "calcium-sensing receptor", "entity_1_idx": [[130, 154]], "entity_1_idx_in_text_with_entity_marker": [134, 158], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CaR", "entity_2_idx": [[156, 159]], "entity_2_idx_in_text_with_entity_marker": [169, 172], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d9.s80_AIMed.d9.s80.p0", "text": "Our results demonstrated that CaR was expressed in human gastrinoma cells and could be involved in the mechanism of calcium-evoked gastrin release.", "text_with_entity_marker": "Our results demonstrated that [E1]CaR[/E1] was expressed in human gastrinoma cells and could be involved in the mechanism of calcium-evoked [E2]gastrin[/E2] release.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CaR", "entity_1_idx": [[30, 33]], "entity_1_idx_in_text_with_entity_marker": [34, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gastrin", "entity_2_idx": [[131, 138]], "entity_2_idx_in_text_with_entity_marker": [144, 151], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d102.s860_AIMed.d102.s860.p0", "text": "RB, the protein product of the retinoblastoma tumor-suppressor gene, regulates the activity of specific transcription factors.", "text_with_entity_marker": "[E1]RB[/E1], the protein product of the [E2]retinoblastoma[/E2] tumor-suppressor gene, regulates the activity of specific transcription factors.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RB", "entity_1_idx": [[0, 2]], "entity_1_idx_in_text_with_entity_marker": [4, 6], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "retinoblastoma", "entity_2_idx": [[31, 45]], "entity_2_idx_in_text_with_entity_marker": [44, 58], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d102.s863_AIMed.d102.s863.p0", "text": "These cells contain a temperature-sensitive mutation in the TATA-binding protein-associated factor TAFII250, first identified as the cell cycle regulatory protein CCG1.", "text_with_entity_marker": "These cells contain a temperature-sensitive mutation in the [E1-E2]TATA-binding protein[/E1]-associated factor[/E2] TAFII250, first identified as the cell cycle regulatory protein CCG1.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TATA-binding protein", "entity_1_idx": [[60, 80]], "entity_1_idx_in_text_with_entity_marker": [67, 87], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TATA-binding protein[/E1]-associated factor", "entity_2_idx": [[60, 98]], "entity_2_idx_in_text_with_entity_marker": [67, 110], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d102.s863_AIMed.d102.s863.p1", "text": "These cells contain a temperature-sensitive mutation in the TATA-binding protein-associated factor TAFII250, first identified as the cell cycle regulatory protein CCG1.", "text_with_entity_marker": "These cells contain a temperature-sensitive mutation in the [E1]TATA-binding protein[/E1]-associated factor [E2]TAFII250[/E2], first identified as the cell cycle regulatory protein CCG1.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TATA-binding protein", "entity_1_idx": [[60, 80]], "entity_1_idx_in_text_with_entity_marker": [64, 84], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII250", "entity_2_idx": [[99, 107]], "entity_2_idx_in_text_with_entity_marker": [112, 120], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d102.s863_AIMed.d102.s863.p2", "text": "These cells contain a temperature-sensitive mutation in the TATA-binding protein-associated factor TAFII250, first identified as the cell cycle regulatory protein CCG1.", "text_with_entity_marker": "These cells contain a temperature-sensitive mutation in the [E1]TATA-binding protein[/E1]-associated factor TAFII250, first identified as the cell cycle regulatory protein [E2]CCG1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TATA-binding protein", "entity_1_idx": [[60, 80]], "entity_1_idx_in_text_with_entity_marker": [64, 84], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCG1", "entity_2_idx": [[163, 167]], "entity_2_idx_in_text_with_entity_marker": [176, 180], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d102.s863_AIMed.d102.s863.p3", "text": "These cells contain a temperature-sensitive mutation in the TATA-binding protein-associated factor TAFII250, first identified as the cell cycle regulatory protein CCG1.", "text_with_entity_marker": "These cells contain a temperature-sensitive mutation in the [E1]TATA-binding protein-associated factor[/E1] [E2]TAFII250[/E2], first identified as the cell cycle regulatory protein CCG1.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TATA-binding protein-associated factor", "entity_1_idx": [[60, 98]], "entity_1_idx_in_text_with_entity_marker": [64, 102], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII250", "entity_2_idx": [[99, 107]], "entity_2_idx_in_text_with_entity_marker": [112, 120], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d102.s863_AIMed.d102.s863.p4", "text": "These cells contain a temperature-sensitive mutation in the TATA-binding protein-associated factor TAFII250, first identified as the cell cycle regulatory protein CCG1.", "text_with_entity_marker": "These cells contain a temperature-sensitive mutation in the [E1]TATA-binding protein-associated factor[/E1] TAFII250, first identified as the cell cycle regulatory protein [E2]CCG1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TATA-binding protein-associated factor", "entity_1_idx": [[60, 98]], "entity_1_idx_in_text_with_entity_marker": [64, 102], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCG1", "entity_2_idx": [[163, 167]], "entity_2_idx_in_text_with_entity_marker": [176, 180], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d102.s863_AIMed.d102.s863.p5", "text": "These cells contain a temperature-sensitive mutation in the TATA-binding protein-associated factor TAFII250, first identified as the cell cycle regulatory protein CCG1.", "text_with_entity_marker": "These cells contain a temperature-sensitive mutation in the TATA-binding protein-associated factor [E1]TAFII250[/E1], first identified as the cell cycle regulatory protein [E2]CCG1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TAFII250", "entity_1_idx": [[99, 107]], "entity_1_idx_in_text_with_entity_marker": [103, 111], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCG1", "entity_2_idx": [[163, 167]], "entity_2_idx_in_text_with_entity_marker": [176, 180], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d120.s1016_AIMed.d120.s1016.p0", "text": "However, the function of HSP27 and the identity of proteins that interact with HSP27 remain unknown.", "text_with_entity_marker": "However, the function of [E1]HSP27[/E1] and the identity of proteins that interact with [E2]HSP27[/E2] remain unknown.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "HSP27", "entity_1_idx": [[25, 30]], "entity_1_idx_in_text_with_entity_marker": [29, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "HSP27", "entity_2_idx": [[79, 84]], "entity_2_idx_in_text_with_entity_marker": [92, 97], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d120.s1017_AIMed.d120.s1017.p0", "text": "To identify specific HSP27-protein interactions, a recombinant fusion protein affinity reagent was constructed and used to identify proteins associating with HSP27 from human platelet lysates and erythroleukemia cells.", "text_with_entity_marker": "To identify specific [E1]HSP27[/E1]-protein interactions, a recombinant fusion protein affinity reagent was constructed and used to identify proteins associating with [E2]HSP27[/E2] from human platelet lysates and erythroleukemia cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "HSP27", "entity_1_idx": [[21, 26]], "entity_1_idx_in_text_with_entity_marker": [25, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "HSP27", "entity_2_idx": [[158, 163]], "entity_2_idx_in_text_with_entity_marker": [171, 176], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d129.s1104_AIMed.d129.s1104.p0", "text": "Antibodies to p23 detect similar levels of p23 in all tissues tested and cross-react with a protein of the same size in mice, rabbits, guinea pigs, humans, and Saccharomyces cerevisiae, indicating that p23 is a conserved protein of broad tissue distribution.", "text_with_entity_marker": "Antibodies to [E1]p23[/E1] detect similar levels of [E2]p23[/E2] in all tissues tested and cross-react with a protein of the same size in mice, rabbits, guinea pigs, humans, and Saccharomyces cerevisiae, indicating that p23 is a conserved protein of broad tissue distribution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p23", "entity_1_idx": [[14, 17]], "entity_1_idx_in_text_with_entity_marker": [18, 21], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p23", "entity_2_idx": [[43, 46]], "entity_2_idx_in_text_with_entity_marker": [56, 59], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d129.s1104_AIMed.d129.s1104.p1", "text": "Antibodies to p23 detect similar levels of p23 in all tissues tested and cross-react with a protein of the same size in mice, rabbits, guinea pigs, humans, and Saccharomyces cerevisiae, indicating that p23 is a conserved protein of broad tissue distribution.", "text_with_entity_marker": "Antibodies to [E1]p23[/E1] detect similar levels of p23 in all tissues tested and cross-react with a protein of the same size in mice, rabbits, guinea pigs, humans, and Saccharomyces cerevisiae, indicating that [E2]p23[/E2] is a conserved protein of broad tissue distribution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p23", "entity_1_idx": [[14, 17]], "entity_1_idx_in_text_with_entity_marker": [18, 21], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p23", "entity_2_idx": [[202, 205]], "entity_2_idx_in_text_with_entity_marker": [215, 218], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d129.s1104_AIMed.d129.s1104.p2", "text": "Antibodies to p23 detect similar levels of p23 in all tissues tested and cross-react with a protein of the same size in mice, rabbits, guinea pigs, humans, and Saccharomyces cerevisiae, indicating that p23 is a conserved protein of broad tissue distribution.", "text_with_entity_marker": "Antibodies to p23 detect similar levels of [E1]p23[/E1] in all tissues tested and cross-react with a protein of the same size in mice, rabbits, guinea pigs, humans, and Saccharomyces cerevisiae, indicating that [E2]p23[/E2] is a conserved protein of broad tissue distribution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p23", "entity_1_idx": [[43, 46]], "entity_1_idx_in_text_with_entity_marker": [47, 50], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p23", "entity_2_idx": [[202, 205]], "entity_2_idx_in_text_with_entity_marker": [215, 218], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d129.s1110_AIMed.d129.s1110.p0", "text": "Bacterially overexpressed human p23 was used to raise several monoclonal antibodies to p23.", "text_with_entity_marker": "Bacterially overexpressed human [E1]p23[/E1] was used to raise several monoclonal antibodies to [E2]p23[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p23", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p23", "entity_2_idx": [[87, 90]], "entity_2_idx_in_text_with_entity_marker": [100, 103], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d112.s950_AIMed.d112.s950.p0", "text": "Crosslinking of cell surface IgM led to rapid activation of both tyrosine and serine/threonine protein kinase activities that resulted in phosphorylation in vitro of proteins coprecipitating with Syk--in particular, a serine/threonine phosphorylated protein 120 kDa in size (pp120).", "text_with_entity_marker": "Crosslinking of cell surface IgM led to rapid activation of both tyrosine and serine/threonine protein kinase activities that resulted in phosphorylation in vitro of proteins coprecipitating with [E1]Syk[/E1]--in particular, a serine/threonine phosphorylated protein 120 kDa in size ([E2]pp120[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Syk", "entity_1_idx": [[196, 199]], "entity_1_idx_in_text_with_entity_marker": [200, 203], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "pp120", "entity_2_idx": [[275, 280]], "entity_2_idx_in_text_with_entity_marker": [288, 293], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d112.s951_AIMed.d112.s951.p0", "text": "Several phosphoproteins, including one of 72 kDa and one of 120 kDa, coprecipitated with phospholipase C-gamma 1 (PLC gamma 1).", "text_with_entity_marker": "Several phosphoproteins, including one of 72 kDa and one of 120 kDa, coprecipitated with [E1]phospholipase C-gamma 1[/E1] ([E2]PLC gamma 1[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phospholipase C-gamma 1", "entity_1_idx": [[89, 112]], "entity_1_idx_in_text_with_entity_marker": [93, 116], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PLC gamma 1", "entity_2_idx": [[114, 125]], "entity_2_idx_in_text_with_entity_marker": [127, 138], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d142.s1200_AIMed.d142.s1200.p0", "text": "To study the mechanism underlying the apparent functional cooperation between YY1 and Sp1, we explored the possibility of protein-protein interactions between these two transcription factors.", "text_with_entity_marker": "To study the mechanism underlying the apparent functional cooperation between [E1]YY1[/E1] and [E2]Sp1[/E2], we explored the possibility of protein-protein interactions between these two transcription factors.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "YY1", "entity_1_idx": [[78, 81]], "entity_1_idx_in_text_with_entity_marker": [82, 85], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Sp1", "entity_2_idx": [[86, 89]], "entity_2_idx_in_text_with_entity_marker": [99, 102], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d247.s0_BioInfer.d247.s0.p0", "text": "Here, we prepared a profilin mutant (H119E) defective in actin binding, but retaining the ability to bind to other proteins.", "text_with_entity_marker": "Here, we prepared a [E1]profilin[/E1] mutant (H119E) defective in [E2]actin[/E2] binding, but retaining the ability to bind to other proteins.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[20, 28], [37, 42]], "entity_1_idx_in_text_with_entity_marker": [24, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[57, 62]], "entity_2_idx_in_text_with_entity_marker": [70, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d247.s1_BioInfer.d247.s1.p0", "text": "The essential role of profilin in the assembly of actin for microspike formation.", "text_with_entity_marker": "The essential role of [E1]profilin[/E1] in the assembly of [E2]actin[/E2] for microspike formation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[22, 30]], "entity_1_idx_in_text_with_entity_marker": [26, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[50, 55]], "entity_2_idx_in_text_with_entity_marker": [63, 68], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d247.s2_BioInfer.d247.s2.p0", "text": "These findings provide the first evidence that profilin is a key molecule linking a signaling network to rapid actin polymerization in microspike formation.", "text_with_entity_marker": "These findings provide the first evidence that [E1]profilin[/E1] is a key molecule linking a signaling network to rapid [E2]actin[/E2] polymerization in microspike formation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[47, 55]], "entity_1_idx_in_text_with_entity_marker": [51, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d247.s3_BioInfer.d247.s3.p0", "text": "This mutant profilin I suppresses actin polymerization in microspike formation induced by N-WASP, the essential factor in microspike formation.", "text_with_entity_marker": "This mutant [E1]profilin I[/E1] suppresses actin polymerization in microspike formation induced by [E2]N-WASP[/E2], the essential factor in microspike formation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "profilin I", "entity_1_idx": [[12, 22]], "entity_1_idx_in_text_with_entity_marker": [16, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N-WASP", "entity_2_idx": [[90, 96]], "entity_2_idx_in_text_with_entity_marker": [103, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d247.s3_BioInfer.d247.s3.p1", "text": "This mutant profilin I suppresses actin polymerization in microspike formation induced by N-WASP, the essential factor in microspike formation.", "text_with_entity_marker": "This mutant [E1]profilin I[/E1] suppresses [E2]actin[/E2] polymerization in microspike formation induced by N-WASP, the essential factor in microspike formation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin I", "entity_1_idx": [[12, 22]], "entity_1_idx_in_text_with_entity_marker": [16, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[34, 39]], "entity_2_idx_in_text_with_entity_marker": [47, 52], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d247.s3_BioInfer.d247.s3.p2", "text": "This mutant profilin I suppresses actin polymerization in microspike formation induced by N-WASP, the essential factor in microspike formation.", "text_with_entity_marker": "This mutant profilin I suppresses [E1]actin[/E1] polymerization in microspike formation induced by [E2]N-WASP[/E2], the essential factor in microspike formation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[34, 39]], "entity_1_idx_in_text_with_entity_marker": [38, 43], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N-WASP", "entity_2_idx": [[90, 96]], "entity_2_idx_in_text_with_entity_marker": [103, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d787.s0_BioInfer.d787.s0.p6", "text": "Using ITP (a substrate for myosin II ATPase) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "text_with_entity_marker": "Using ITP (a substrate for [E1]myosin II[/E1] [E2]ATPase[/E2]) and/or ATP gamma S (a substrate for myosin II heavy-chain kinase [MHCK]), we demonstrated that phosphorylation of myosin heavy chains occurred at the foci within the actin network, a result that suggests that MHCK was localized at the foci.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "myosin II", "entity_1_idx": [[27, 36]], "entity_1_idx_in_text_with_entity_marker": [31, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ATPase", "entity_2_idx": [[37, 43]], "entity_2_idx_in_text_with_entity_marker": [50, 56], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d130.s0_BioInfer.d130.s0.p0", "text": "CD26 is a T cell activation antigen known to bind adenosine deaminase and have dipeptidyl peptidase IV activity.", "text_with_entity_marker": "[E1]CD26[/E1] is a T cell activation antigen known to bind [E2]adenosine deaminase[/E2] and have dipeptidyl peptidase IV activity.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CD26", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "adenosine deaminase", "entity_2_idx": [[50, 69]], "entity_2_idx_in_text_with_entity_marker": [63, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d130.s0_BioInfer.d130.s0.p1", "text": "CD26 is a T cell activation antigen known to bind adenosine deaminase and have dipeptidyl peptidase IV activity.", "text_with_entity_marker": "[E1]CD26[/E1] is a T cell activation antigen known to bind adenosine deaminase and have [E2]dipeptidyl peptidase IV[/E2] activity.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CD26", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "dipeptidyl peptidase IV", "entity_2_idx": [[79, 102]], "entity_2_idx_in_text_with_entity_marker": [92, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d550.s0_BioInfer.d550.s0.p2", "text": "Stable transfection of mutant plakoglobin molecules showed that deletion of the N-cadherin binding domain, but not the alpha-catenin binding domain, abolished beta-catenin downregulation.", "text_with_entity_marker": "Stable transfection of mutant [E1]plakoglobin[/E1] molecules showed that deletion of the [E2]N-cadherin[/E2] binding domain, but not the alpha-catenin binding domain, abolished beta-catenin downregulation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[30, 41]], "entity_1_idx_in_text_with_entity_marker": [34, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N-cadherin", "entity_2_idx": [[80, 90]], "entity_2_idx_in_text_with_entity_marker": [93, 103], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d550.s0_BioInfer.d550.s0.p4", "text": "Stable transfection of mutant plakoglobin molecules showed that deletion of the N-cadherin binding domain, but not the alpha-catenin binding domain, abolished beta-catenin downregulation.", "text_with_entity_marker": "Stable transfection of mutant [E1]plakoglobin[/E1] molecules showed that deletion of the N-cadherin binding domain, but not the [E2]alpha-catenin[/E2] binding domain, abolished beta-catenin downregulation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[30, 41]], "entity_1_idx_in_text_with_entity_marker": [34, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[119, 132]], "entity_2_idx_in_text_with_entity_marker": [132, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d550.s0_BioInfer.d550.s0.p5", "text": "Stable transfection of mutant plakoglobin molecules showed that deletion of the N-cadherin binding domain, but not the alpha-catenin binding domain, abolished beta-catenin downregulation.", "text_with_entity_marker": "Stable transfection of mutant [E1]plakoglobin[/E1] molecules showed that deletion of the N-cadherin binding domain, but not the alpha-catenin binding domain, abolished [E2]beta-catenin[/E2] downregulation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[30, 41]], "entity_1_idx_in_text_with_entity_marker": [34, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[159, 171]], "entity_2_idx_in_text_with_entity_marker": [172, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p41", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two [E1]actin[/E1]-related proteins, Arp2 and [E2]Arp3[/E2]; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[140, 145]], "entity_1_idx_in_text_with_entity_marker": [144, 149], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp3", "entity_2_idx": [[173, 177]], "entity_2_idx_in_text_with_entity_marker": [186, 190], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p51", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two [E1]actin[/E1]-related proteins, [E2]Arp2[/E2] and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[140, 145]], "entity_1_idx_in_text_with_entity_marker": [144, 149], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp2", "entity_2_idx": [[164, 168]], "entity_2_idx_in_text_with_entity_marker": [177, 181], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d507.s0_BioInfer.d507.s0.p0", "text": "Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 (AtFim1) is a member of the fimbrin/plastin family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].", "text_with_entity_marker": "Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 (AtFim1) is a member of the [E1]fimbrin/plastin[/E1] family of [E2]actin[/E2] filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "fimbrin/plastin", "entity_1_idx": [[151, 166]], "entity_1_idx_in_text_with_entity_marker": [155, 170], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[177, 182]], "entity_2_idx_in_text_with_entity_marker": [190, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d507.s0_BioInfer.d507.s0.p1", "text": "Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 (AtFim1) is a member of the fimbrin/plastin family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].", "text_with_entity_marker": "Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana [E1]fimbrin 1[/E1] (AtFim1) is a member of the [E2]fimbrin/plastin[/E2] family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "fimbrin 1", "entity_1_idx": [[113, 122]], "entity_1_idx_in_text_with_entity_marker": [117, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin/plastin", "entity_2_idx": [[151, 166]], "entity_2_idx_in_text_with_entity_marker": [164, 179], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d507.s0_BioInfer.d507.s0.p2", "text": "Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 (AtFim1) is a member of the fimbrin/plastin family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].", "text_with_entity_marker": "Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana fimbrin 1 ([E1]AtFim1[/E1]) is a member of the [E2]fimbrin/plastin[/E2] family of actin filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "AtFim1", "entity_1_idx": [[124, 130]], "entity_1_idx_in_text_with_entity_marker": [128, 134], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin/plastin", "entity_2_idx": [[151, 166]], "entity_2_idx_in_text_with_entity_marker": [164, 179], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d779.s0_BioInfer.d779.s0.p1", "text": "Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick cofilin and 66% identical to chick actin-depolymerizing factor (ADF), two structurally and functionally related proteins.", "text_with_entity_marker": "Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick [E1]cofilin[/E1] and 66% identical to chick [E2]actin-depolymerizing factor[/E2] (ADF), two structurally and functionally related proteins.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[138, 145]], "entity_1_idx_in_text_with_entity_marker": [142, 149], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-depolymerizing factor", "entity_2_idx": [[173, 200]], "entity_2_idx_in_text_with_entity_marker": [186, 213], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d779.s0_BioInfer.d779.s0.p2", "text": "Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick cofilin and 66% identical to chick actin-depolymerizing factor (ADF), two structurally and functionally related proteins.", "text_with_entity_marker": "Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick [E1]cofilin[/E1] and 66% identical to chick actin-depolymerizing factor ([E2]ADF[/E2]), two structurally and functionally related proteins.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[138, 145]], "entity_1_idx_in_text_with_entity_marker": [142, 149], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ADF", "entity_2_idx": [[202, 205]], "entity_2_idx_in_text_with_entity_marker": [215, 218], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d324.s0_BioInfer.d324.s0.p2", "text": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "text_with_entity_marker": "In contrast, [E1]act1-159[/E1] partially suppresses the temperature sensitivity of a [E2]tropomyosin[/E2] mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "act1-159", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "tropomyosin", "entity_2_idx": [[76, 87]], "entity_2_idx_in_text_with_entity_marker": [89, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d324.s0_BioInfer.d324.s0.p3", "text": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "text_with_entity_marker": "In contrast, act1-159 partially suppresses the temperature sensitivity of a [E1]tropomyosin[/E1] mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these [E2]actin[/E2]-binding proteins.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[76, 87]], "entity_1_idx_in_text_with_entity_marker": [80, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[238, 243]], "entity_2_idx_in_text_with_entity_marker": [251, 256], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d324.s0_BioInfer.d324.s0.p6", "text": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "text_with_entity_marker": "In contrast, [E1]act1-159[/E1] partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, [E2]Mdm20p[/E2], and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "act1-159", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Mdm20p", "entity_2_idx": [[148, 154]], "entity_2_idx_in_text_with_entity_marker": [161, 167], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d324.s0_BioInfer.d324.s0.p7", "text": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "text_with_entity_marker": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, [E1]Mdm20p[/E1], and tropomyosin null mutants, suggesting filament stabilizing functions for these [E2]actin[/E2]-binding proteins.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Mdm20p", "entity_1_idx": [[148, 154]], "entity_1_idx_in_text_with_entity_marker": [152, 158], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[238, 243]], "entity_2_idx_in_text_with_entity_marker": [251, 256], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d324.s0_BioInfer.d324.s0.p9", "text": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "text_with_entity_marker": "In contrast, [E1]act1-159[/E1] partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in [E2]fimbrin[/E2], Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "act1-159", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[139, 146]], "entity_2_idx_in_text_with_entity_marker": [152, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d324.s0_BioInfer.d324.s0.p10", "text": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "text_with_entity_marker": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in [E1]fimbrin[/E1], Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these [E2]actin[/E2]-binding proteins.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[139, 146]], "entity_1_idx_in_text_with_entity_marker": [143, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[238, 243]], "entity_2_idx_in_text_with_entity_marker": [251, 256], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d324.s0_BioInfer.d324.s0.p13", "text": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "text_with_entity_marker": "In contrast, [E1]act1-159[/E1] partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and [E2]tropomyosin[/E2] null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "act1-159", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "tropomyosin", "entity_2_idx": [[160, 171]], "entity_2_idx_in_text_with_entity_marker": [173, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d324.s0_BioInfer.d324.s0.p14", "text": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and tropomyosin null mutants, suggesting filament stabilizing functions for these actin-binding proteins.", "text_with_entity_marker": "In contrast, act1-159 partially suppresses the temperature sensitivity of a tropomyosin mutant, and the loss of cytoplasmic cables seen in fimbrin, Mdm20p, and [E1]tropomyosin[/E1] null mutants, suggesting filament stabilizing functions for these [E2]actin[/E2]-binding proteins.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[160, 171]], "entity_1_idx_in_text_with_entity_marker": [164, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[238, 243]], "entity_2_idx_in_text_with_entity_marker": [251, 256], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s0_BioInfer.d237.s0.p5", "text": "Here, specific interactions between human RAD51 and RAD52 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with RAD51 and RAD52 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.", "text_with_entity_marker": "Here, specific interactions between human [E1]RAD51[/E1] and [E2]RAD52[/E2] proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with RAD51 and RAD52 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD52", "entity_2_idx": [[52, 57]], "entity_2_idx_in_text_with_entity_marker": [65, 70], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s1_BioInfer.d237.s1.p0", "text": "Interaction of the yeast RAD51 and RAD52 proteins plays a crucial role in yeast DNA homologous recombination and DNA double-strand break repair.", "text_with_entity_marker": "Interaction of the yeast [E1]RAD51[/E1] and [E2]RAD52[/E2] proteins plays a crucial role in yeast DNA homologous recombination and DNA double-strand break repair.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[25, 30]], "entity_1_idx_in_text_with_entity_marker": [29, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD52", "entity_2_idx": [[35, 40]], "entity_2_idx_in_text_with_entity_marker": [48, 53], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s2_BioInfer.d237.s2.p0", "text": "Specific interactions between the human RAD51 and RAD52 proteins.", "text_with_entity_marker": "Specific interactions between the human [E1]RAD51[/E1] and [E2]RAD52[/E2] proteins.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[40, 45]], "entity_1_idx_in_text_with_entity_marker": [44, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD52", "entity_2_idx": [[50, 55]], "entity_2_idx_in_text_with_entity_marker": [63, 68], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s3_BioInfer.d237.s3.p0", "text": "The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.", "text_with_entity_marker": "The RAD51-interacting region (amino acids 291-330) of the human [E1]RAD52[/E1] protein shows no homology with the yeast [E2]RAD52[/E2] protein, indicating that the interaction between RAD51 and RAD52 is species-specific.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAD52", "entity_1_idx": [[64, 69]], "entity_1_idx_in_text_with_entity_marker": [68, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD52", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s3_BioInfer.d237.s3.p6", "text": "The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.", "text_with_entity_marker": "The [E1]RAD51[/E1]-interacting region (amino acids 291-330) of the human [E2]RAD52[/E2] protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD52", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s3_BioInfer.d237.s3.p7", "text": "The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between RAD51 and RAD52 is species-specific.", "text_with_entity_marker": "The RAD51-interacting region (amino acids 291-330) of the human RAD52 protein shows no homology with the yeast RAD52 protein, indicating that the interaction between [E1]RAD51[/E1] and [E2]RAD52[/E2] is species-specific.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[166, 171]], "entity_1_idx_in_text_with_entity_marker": [170, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD52", "entity_2_idx": [[176, 181]], "entity_2_idx_in_text_with_entity_marker": [189, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d237.s4_BioInfer.d237.s4.p0", "text": "These results suggest that RAD52 may modulate the catalytic activities of RAD51 protein such as homologous pairing and strand exchange through a direct physical interaction.", "text_with_entity_marker": "These results suggest that [E1]RAD52[/E1] may modulate the catalytic activities of [E2]RAD51[/E2] protein such as homologous pairing and strand exchange through a direct physical interaction.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAD52", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD51", "entity_2_idx": [[74, 79]], "entity_2_idx_in_text_with_entity_marker": [87, 92], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d216.s0_BioInfer.d216.s0.p0", "text": "From an analysis of profilin mutants, whose actin cytoskeleton is disrupted, we found that E-APC also requires actin filaments to associate with adhesive cell membranes in the ovary.", "text_with_entity_marker": "From an analysis of profilin mutants, whose actin cytoskeleton is disrupted, we found that [E1]E-APC[/E1] also requires [E2]actin[/E2] filaments to associate with adhesive cell membranes in the ovary.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-APC", "entity_1_idx": [[91, 96]], "entity_1_idx_in_text_with_entity_marker": [95, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[111, 116]], "entity_2_idx_in_text_with_entity_marker": [124, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d497.s0_BioInfer.d497.s0.p1", "text": "Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.", "text_with_entity_marker": "Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of [E1]profilin[/E1] and [E2]actin[/E2] raised the possibility that profilin might also regulate lipid metabolism.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[136, 144]], "entity_1_idx_in_text_with_entity_marker": [140, 148], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[149, 154]], "entity_2_idx_in_text_with_entity_marker": [162, 167], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d497.s0_BioInfer.d497.s0.p5", "text": "Profilin is generally thought to regulate actin polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.", "text_with_entity_marker": "[E1]Profilin[/E1] is generally thought to regulate [E2]actin[/E2] polymerization, but the observation that acidic phospholipids dissociate the complex of profilin and actin raised the possibility that profilin might also regulate lipid metabolism.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Profilin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[42, 47]], "entity_2_idx_in_text_with_entity_marker": [55, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d497.s1_BioInfer.d497.s1.p0", "text": "The actin-binding protein profilin binds to PIP2 and inhibits its hydrolysis by phospholipase C.", "text_with_entity_marker": "The [E1]actin-binding protein[/E1] [E2]profilin[/E2] binds to PIP2 and inhibits its hydrolysis by phospholipase C.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[4, 25]], "entity_1_idx_in_text_with_entity_marker": [8, 29], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[26, 34]], "entity_2_idx_in_text_with_entity_marker": [39, 47], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d497.s2_BioInfer.d497.s2.p0", "text": "The cellular concentrations and binding characteristics of these molecules are consistent with profilin being a negative regulator of the phosphoinositide signaling pathway in addition to its established function as an inhibitor of actin polymerization.", "text_with_entity_marker": "The cellular concentrations and binding characteristics of these molecules are consistent with [E1]profilin[/E1] being a negative regulator of the phosphoinositide signaling pathway in addition to its established function as an inhibitor of [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[95, 103]], "entity_1_idx_in_text_with_entity_marker": [99, 107], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[232, 237]], "entity_2_idx_in_text_with_entity_marker": [245, 250], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p32", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, [E1]p21[/E1](Cip1/WAF1), to the cyclin E-[E2]cdk2[/E2] complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[167, 171]], "entity_2_idx_in_text_with_entity_marker": [180, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p33", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "[E1]PF4[/E1]-dependent downregulation of [E2]cyclin E[/E2]-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PF4", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[32, 40]], "entity_2_idx_in_text_with_entity_marker": [45, 53], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p35", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of [E1]cyclin E[/E1]-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, [E2]p21[/E2](Cip1/WAF1), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[135, 138]], "entity_2_idx_in_text_with_entity_marker": [148, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d604.s0_BioInfer.d604.s0.p0", "text": "The deduced peptide sequence contained a nuclear localization signal and a putative actin-binding sequence as reported in NM-type cofilin.", "text_with_entity_marker": "The deduced peptide sequence contained a nuclear localization signal and a putative [E1]actin[/E1]-binding sequence as reported in [E2]NM-type cofilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[84, 89]], "entity_1_idx_in_text_with_entity_marker": [88, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NM-type cofilin", "entity_2_idx": [[122, 137]], "entity_2_idx_in_text_with_entity_marker": [135, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d345.s0_BioInfer.d345.s0.p25", "text": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "text_with_entity_marker": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor [E1]p27[/E1](KIP1) that is accompanied by an increase in [E2]p27[/E2](KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[170, 173]], "entity_1_idx_in_text_with_entity_marker": [174, 177], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p27", "entity_2_idx": [[218, 221]], "entity_2_idx_in_text_with_entity_marker": [231, 234], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d345.s0_BioInfer.d345.s0.p29", "text": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "text_with_entity_marker": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in [E1]p27[/E1](KIP1) specifically bound to [E2]cyclin E[/E2] and a concomitant decrease in cyclin E-associated kinase activity.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[218, 221]], "entity_1_idx_in_text_with_entity_marker": [222, 225], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[250, 258]], "entity_2_idx_in_text_with_entity_marker": [263, 271], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d345.s0_BioInfer.d345.s0.p30", "text": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "text_with_entity_marker": "In investigating the mechanism by which pRb induces senescence, we have found that [E1]pRb[/E1] causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27([E2]KIP1[/E2]) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "pRb", "entity_1_idx": [[83, 86]], "entity_1_idx_in_text_with_entity_marker": [87, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "KIP1", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d345.s0_BioInfer.d345.s0.p34", "text": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27(KIP1) that is accompanied by an increase in p27(KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "text_with_entity_marker": "In investigating the mechanism by which pRb induces senescence, we have found that pRb causes a posttranscriptional accumulation of the cyclin-dependent kinase inhibitor p27([E1]KIP1[/E1]) that is accompanied by an increase in [E2]p27[/E2](KIP1) specifically bound to cyclin E and a concomitant decrease in cyclin E-associated kinase activity.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "KIP1", "entity_1_idx": [[174, 178]], "entity_1_idx_in_text_with_entity_marker": [178, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p27", "entity_2_idx": [[218, 221]], "entity_2_idx_in_text_with_entity_marker": [231, 234], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d408.s0_BioInfer.d408.s0.p0", "text": "Localization of VASP to the leading edge of a migrating cell can lead to local accumulation of profilin, which in turn can supply actin monomers to growing filament ends.", "text_with_entity_marker": "Localization of VASP to the leading edge of a migrating cell can lead to local accumulation of [E1]profilin[/E1], which in turn can supply [E2]actin[/E2] monomers to growing filament ends.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[95, 103]], "entity_1_idx_in_text_with_entity_marker": [99, 107], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[130, 135]], "entity_2_idx_in_text_with_entity_marker": [143, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d408.s0_BioInfer.d408.s0.p1", "text": "Localization of VASP to the leading edge of a migrating cell can lead to local accumulation of profilin, which in turn can supply actin monomers to growing filament ends.", "text_with_entity_marker": "Localization of [E1]VASP[/E1] to the leading edge of a migrating cell can lead to local accumulation of [E2]profilin[/E2], which in turn can supply actin monomers to growing filament ends.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "VASP", "entity_1_idx": [[16, 20]], "entity_1_idx_in_text_with_entity_marker": [20, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[95, 103]], "entity_2_idx_in_text_with_entity_marker": [108, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s0_BioInfer.d35.s0.p0", "text": "Aip1p interacts with cofilin to disassemble actin filaments.", "text_with_entity_marker": "[E1]Aip1p[/E1] interacts with cofilin to disassemble [E2]actin[/E2] filaments.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Aip1p", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[44, 49]], "entity_2_idx_in_text_with_entity_marker": [57, 62], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s0_BioInfer.d35.s0.p1", "text": "Aip1p interacts with cofilin to disassemble actin filaments.", "text_with_entity_marker": "[E1]Aip1p[/E1] interacts with [E2]cofilin[/E2] to disassemble actin filaments.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Aip1p", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[21, 28]], "entity_2_idx_in_text_with_entity_marker": [34, 41], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s0_BioInfer.d35.s0.p2", "text": "Aip1p interacts with cofilin to disassemble actin filaments.", "text_with_entity_marker": "Aip1p interacts with [E1]cofilin[/E1] to disassemble [E2]actin[/E2] filaments.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[21, 28]], "entity_1_idx_in_text_with_entity_marker": [25, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[44, 49]], "entity_2_idx_in_text_with_entity_marker": [57, 62], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s1_BioInfer.d35.s1.p0", "text": "Aip1p localizes to cortical actin patches in yeast cells, and this localization is disrupted by specific actin and cofilin mutations.", "text_with_entity_marker": "Aip1p localizes to cortical [E1]actin[/E1] patches in yeast cells, and this localization is disrupted by specific [E2]actin[/E2] and cofilin mutations.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[28, 33]], "entity_1_idx_in_text_with_entity_marker": [32, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s1_BioInfer.d35.s1.p1", "text": "Aip1p localizes to cortical actin patches in yeast cells, and this localization is disrupted by specific actin and cofilin mutations.", "text_with_entity_marker": "[E1]Aip1p[/E1] localizes to cortical [E2]actin[/E2] patches in yeast cells, and this localization is disrupted by specific actin and cofilin mutations.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Aip1p", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[28, 33]], "entity_2_idx_in_text_with_entity_marker": [41, 46], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s1_BioInfer.d35.s1.p2", "text": "Aip1p localizes to cortical actin patches in yeast cells, and this localization is disrupted by specific actin and cofilin mutations.", "text_with_entity_marker": "Aip1p localizes to cortical [E1]actin[/E1] patches in yeast cells, and this localization is disrupted by specific actin and [E2]cofilin[/E2] mutations.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[28, 33]], "entity_1_idx_in_text_with_entity_marker": [32, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[115, 122]], "entity_2_idx_in_text_with_entity_marker": [128, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s2_BioInfer.d35.s2.p7", "text": "A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.", "text_with_entity_marker": "A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of [E1]actin[/E1], [E2]cofilin[/E2], and Aip1p in an apparent ternary complex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[113, 118]], "entity_1_idx_in_text_with_entity_marker": [117, 122], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[120, 127]], "entity_2_idx_in_text_with_entity_marker": [133, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s2_BioInfer.d35.s2.p8", "text": "A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.", "text_with_entity_marker": "A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of [E1]actin[/E1], cofilin, and [E2]Aip1p[/E2] in an apparent ternary complex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[113, 118]], "entity_1_idx_in_text_with_entity_marker": [117, 122], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Aip1p", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s2_BioInfer.d35.s2.p9", "text": "A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, cofilin, and Aip1p in an apparent ternary complex.", "text_with_entity_marker": "A two-hybrid-based approach using cofilin and actin mutants identified residues necessary for the interaction of actin, [E1]cofilin[/E1], and [E2]Aip1p[/E2] in an apparent ternary complex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[120, 127]], "entity_1_idx_in_text_with_entity_marker": [124, 131], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Aip1p", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d35.s3_BioInfer.d35.s3.p0", "text": "Here, we report that Aip1p also interacts with the ubiquitous actin depolymerizing factor cofilin.", "text_with_entity_marker": "Here, we report that Aip1p also interacts with the ubiquitous [E1]actin depolymerizing factor[/E1] [E2]cofilin[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "actin depolymerizing factor", "entity_1_idx": [[62, 89]], "entity_1_idx_in_text_with_entity_marker": [66, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[90, 97]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d593.s0_BioInfer.d593.s0.p0", "text": "The characteristics of the vitamin D-binding protein and profilin interactions with actin are similar.", "text_with_entity_marker": "The characteristics of the [E1]vitamin D-binding protein[/E1] and profilin interactions with [E2]actin[/E2] are similar.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "vitamin D-binding protein", "entity_1_idx": [[27, 52]], "entity_1_idx_in_text_with_entity_marker": [31, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[84, 89]], "entity_2_idx_in_text_with_entity_marker": [97, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d593.s0_BioInfer.d593.s0.p1", "text": "The characteristics of the vitamin D-binding protein and profilin interactions with actin are similar.", "text_with_entity_marker": "The characteristics of the vitamin D-binding protein and [E1]profilin[/E1] interactions with [E2]actin[/E2] are similar.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[57, 65]], "entity_1_idx_in_text_with_entity_marker": [61, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[84, 89]], "entity_2_idx_in_text_with_entity_marker": [97, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d593.s0_BioInfer.d593.s0.p2", "text": "The characteristics of the vitamin D-binding protein and profilin interactions with actin are similar.", "text_with_entity_marker": "The characteristics of the [E1]vitamin D-binding protein[/E1] and [E2]profilin[/E2] interactions with actin are similar.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "vitamin D-binding protein", "entity_1_idx": [[27, 52]], "entity_1_idx_in_text_with_entity_marker": [31, 56], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[57, 65]], "entity_2_idx_in_text_with_entity_marker": [70, 78], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p9", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[89, 102]], "entity_1_idx_in_text_with_entity_marker": [93, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[104, 116]], "entity_2_idx_in_text_with_entity_marker": [117, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p10", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, [E1]beta-catenin[/E1], and [E2]E-cadherin[/E2] were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[104, 116]], "entity_1_idx_in_text_with_entity_marker": [108, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[122, 132]], "entity_2_idx_in_text_with_entity_marker": [135, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p11", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that [E1]E-cadherin[/E1] and [E2]catenins[/E2] form a complex in mast cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[171, 181]], "entity_1_idx_in_text_with_entity_marker": [175, 185], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "catenins", "entity_2_idx": [[186, 194]], "entity_2_idx_in_text_with_entity_marker": [199, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d53.s0_BioInfer.d53.s0.p20", "text": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that alpha-catenin, beta-catenin, and E-cadherin were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "text_with_entity_marker": "Analyses of beta-catenin or E-cadherin immunoprecipitates from BMMC lysate revealed that [E1]alpha-catenin[/E1], beta-catenin, and [E2]E-cadherin[/E2] were co-precipitated, suggesting that E-cadherin and catenins form a complex in mast cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[89, 102]], "entity_1_idx_in_text_with_entity_marker": [93, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[122, 132]], "entity_2_idx_in_text_with_entity_marker": [135, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d213.s0_BioInfer.d213.s0.p0", "text": "Fluorescent actin analogs with a high affinity for profilin in vitro exhibit an enhanced gradient of assembly in living cells.", "text_with_entity_marker": "Fluorescent [E1]actin[/E1] analogs with a high affinity for [E2]profilin[/E2] in vitro exhibit an enhanced gradient of assembly in living cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[12, 17]], "entity_1_idx_in_text_with_entity_marker": [16, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[51, 59]], "entity_2_idx_in_text_with_entity_marker": [64, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d213.s1_BioInfer.d213.s1.p0", "text": "Three-dimensional fluorescence microscopy of the fluorescent analog of actin with a high affinity for profilin revealed that it incorporated into cortical cytoplasmic fibers and was also distributed diffusely in the non-cortical cytoplasm consistent with a bias of actin assembly near the surface of the cell.", "text_with_entity_marker": "Three-dimensional fluorescence microscopy of the fluorescent analog of [E1]actin[/E1] with a high affinity for [E2]profilin[/E2] revealed that it incorporated into cortical cytoplasmic fibers and was also distributed diffusely in the non-cortical cytoplasm consistent with a bias of actin assembly near the surface of the cell.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[71, 76]], "entity_1_idx_in_text_with_entity_marker": [75, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[102, 110]], "entity_2_idx_in_text_with_entity_marker": [115, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d213.s2_BioInfer.d213.s2.p1", "text": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.", "text_with_entity_marker": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of [E1]actin[/E1] that bound [E2]profilin[/E2], a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[103, 108]], "entity_1_idx_in_text_with_entity_marker": [107, 112], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[120, 128]], "entity_2_idx_in_text_with_entity_marker": [133, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d213.s2_BioInfer.d213.s2.p2", "text": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.", "text_with_entity_marker": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of [E1]actin[/E1] that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit [E2]DNase I[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[103, 108]], "entity_1_idx_in_text_with_entity_marker": [107, 112], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DNase I", "entity_2_idx": [[372, 379]], "entity_2_idx_in_text_with_entity_marker": [385, 392], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d213.s2_BioInfer.d213.s2.p4", "text": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.", "text_with_entity_marker": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound [E1]profilin[/E1], a protein that interacts with phosphoinositides and [E2]actin[/E2]-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[120, 128]], "entity_1_idx_in_text_with_entity_marker": [124, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d213.s2_BioInfer.d213.s2.p8", "text": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound profilin, a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled actin (Kd > 30 microM), yet retained the ability to inhibit DNase I.", "text_with_entity_marker": "To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of actin that bound [E1]profilin[/E1], a protein that interacts with phosphoinositides and actin-monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled [E2]actin[/E2] (Kd > 30 microM), yet retained the ability to inhibit DNase I.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[120, 128]], "entity_1_idx_in_text_with_entity_marker": [124, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[312, 317]], "entity_2_idx_in_text_with_entity_marker": [325, 330], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d789.s0_BioInfer.d789.s0.p0", "text": "Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.", "text_with_entity_marker": "Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects [E1]actin[/E1] filaments in these cells from Z. mays [E2]profilin[/E2] (ZmPRO5)-induced depolymerization, in a dose-dependent manner.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[161, 166]], "entity_1_idx_in_text_with_entity_marker": [165, 170], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[205, 213]], "entity_2_idx_in_text_with_entity_marker": [218, 226], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d789.s0_BioInfer.d789.s0.p4", "text": "Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.", "text_with_entity_marker": "Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that [E1]AtFim1[/E1] protects [E2]actin[/E2] filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "AtFim1", "entity_1_idx": [[145, 151]], "entity_1_idx_in_text_with_entity_marker": [149, 155], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[161, 166]], "entity_2_idx_in_text_with_entity_marker": [174, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d789.s0_BioInfer.d789.s0.p5", "text": "Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects actin filaments in these cells from Z. mays profilin (ZmPRO5)-induced depolymerization, in a dose-dependent manner.", "text_with_entity_marker": "Using the 'nuclear displacement assay' as a measure of the integrity of the actin cytoskeleton in living stamen hair cells, we demonstrated that AtFim1 protects [E1]actin[/E1] filaments in these cells from Z. mays profilin ([E2]ZmPRO5[/E2])-induced depolymerization, in a dose-dependent manner.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[161, 166]], "entity_1_idx_in_text_with_entity_marker": [165, 170], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ZmPRO5", "entity_2_idx": [[215, 221]], "entity_2_idx_in_text_with_entity_marker": [228, 234], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d619.s0_BioInfer.d619.s0.p2", "text": "The herpes simplex virus type 1 UL8 protein influences the intracellular localization of the UL52 but not the ICP8 or POL replication proteins in virus-infected cells.", "text_with_entity_marker": "The herpes simplex virus type 1 [E1]UL8[/E1] protein influences the intracellular localization of the UL52 but not the [E2]ICP8[/E2] or POL replication proteins in virus-infected cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ICP8", "entity_2_idx": [[110, 114]], "entity_2_idx_in_text_with_entity_marker": [123, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d619.s0_BioInfer.d619.s0.p4", "text": "The herpes simplex virus type 1 UL8 protein influences the intracellular localization of the UL52 but not the ICP8 or POL replication proteins in virus-infected cells.", "text_with_entity_marker": "The herpes simplex virus type 1 [E1]UL8[/E1] protein influences the intracellular localization of the [E2]UL52[/E2] but not the ICP8 or POL replication proteins in virus-infected cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[93, 97]], "entity_2_idx_in_text_with_entity_marker": [106, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d619.s0_BioInfer.d619.s0.p5", "text": "The herpes simplex virus type 1 UL8 protein influences the intracellular localization of the UL52 but not the ICP8 or POL replication proteins in virus-infected cells.", "text_with_entity_marker": "The herpes simplex virus type 1 [E1]UL8[/E1] protein influences the intracellular localization of the UL52 but not the ICP8 or [E2]POL[/E2] replication proteins in virus-infected cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "POL", "entity_2_idx": [[118, 121]], "entity_2_idx_in_text_with_entity_marker": [131, 134], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p3", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed [E1]profilins[/E1] form 3-D crystals under the same conditions as native [E2]profilins[/E2]; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[303, 312]], "entity_1_idx_in_text_with_entity_marker": [307, 316], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilins", "entity_2_idx": [[367, 376]], "entity_2_idx_in_text_with_entity_marker": [380, 389], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p10", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to [E1]actin[/E1] in the same way as native, conventionally purified [E2]profilin[/E2] without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[201, 206]], "entity_1_idx_in_text_with_entity_marker": [205, 210], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[258, 266]], "entity_2_idx_in_text_with_entity_marker": [271, 279], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p28", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human [E1]profilins[/E1] rebind quantitatively to poly-L-proline and bind to [E2]actin[/E2] in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[139, 148]], "entity_1_idx_in_text_with_entity_marker": [143, 152], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[201, 206]], "entity_2_idx_in_text_with_entity_marker": [214, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d535.s0_BioInfer.d535.s0.p41", "text": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.", "text_with_entity_marker": "Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba [E1]profilins[/E1] inhibit [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[515, 524]], "entity_1_idx_in_text_with_entity_marker": [519, 528], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[533, 538]], "entity_2_idx_in_text_with_entity_marker": [546, 551], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d729.s0_BioInfer.d729.s0.p0", "text": "The two proteins were found to differ in their interaction with actin, like destrin and cofilin isolated from porcine brain.", "text_with_entity_marker": "The two proteins were found to differ in their interaction with actin, like [E1]destrin[/E1] and [E2]cofilin[/E2] isolated from porcine brain.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "destrin", "entity_1_idx": [[76, 83]], "entity_1_idx_in_text_with_entity_marker": [80, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[88, 95]], "entity_2_idx_in_text_with_entity_marker": [101, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d729.s0_BioInfer.d729.s0.p1", "text": "The two proteins were found to differ in their interaction with actin, like destrin and cofilin isolated from porcine brain.", "text_with_entity_marker": "The two proteins were found to differ in their interaction with [E1]actin[/E1], like destrin and [E2]cofilin[/E2] isolated from porcine brain.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[64, 69]], "entity_1_idx_in_text_with_entity_marker": [68, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[88, 95]], "entity_2_idx_in_text_with_entity_marker": [101, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d729.s0_BioInfer.d729.s0.p2", "text": "The two proteins were found to differ in their interaction with actin, like destrin and cofilin isolated from porcine brain.", "text_with_entity_marker": "The two proteins were found to differ in their interaction with [E1]actin[/E1], like [E2]destrin[/E2] and cofilin isolated from porcine brain.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[64, 69]], "entity_1_idx_in_text_with_entity_marker": [68, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "destrin", "entity_2_idx": [[76, 83]], "entity_2_idx_in_text_with_entity_marker": [89, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d516.s0_BioInfer.d516.s0.p0", "text": "Reinvestigation of the inhibition of actin polymerization by profilin.", "text_with_entity_marker": "Reinvestigation of the inhibition of [E1]actin[/E1] polymerization by [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[37, 42]], "entity_1_idx_in_text_with_entity_marker": [41, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[61, 69]], "entity_2_idx_in_text_with_entity_marker": [74, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d516.s1_BioInfer.d516.s1.p14", "text": "The very much lower affinity of profilin for modified actin explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of profilin and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "text_with_entity_marker": "The very much lower affinity of [E1]profilin[/E1] for modified [E2]actin[/E2] explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled actin in the presence of profilin and the apparently weak inhibition by profilin of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled actin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[54, 59]], "entity_2_idx_in_text_with_entity_marker": [67, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d278.s0_BioInfer.d278.s0.p2", "text": "However, these rod structures were not observed in response to TSH, forskolin, or TPA, suggesting that dephosphorylation of cofilin correlates with the reorganization of actin microfilaments but not with the nuclear transport of cofilin.", "text_with_entity_marker": "However, these rod structures were not observed in response to TSH, forskolin, or TPA, suggesting that dephosphorylation of [E1]cofilin[/E1] correlates with the reorganization of [E2]actin[/E2] microfilaments but not with the nuclear transport of cofilin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[124, 131]], "entity_1_idx_in_text_with_entity_marker": [128, 135], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[170, 175]], "entity_2_idx_in_text_with_entity_marker": [183, 188], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d278.s0_BioInfer.d278.s0.p4", "text": "However, these rod structures were not observed in response to TSH, forskolin, or TPA, suggesting that dephosphorylation of cofilin correlates with the reorganization of actin microfilaments but not with the nuclear transport of cofilin.", "text_with_entity_marker": "However, these rod structures were not observed in response to TSH, forskolin, or TPA, suggesting that dephosphorylation of [E1]cofilin[/E1] correlates with the reorganization of actin microfilaments but not with the nuclear transport of [E2]cofilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[124, 131]], "entity_1_idx_in_text_with_entity_marker": [128, 135], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[229, 236]], "entity_2_idx_in_text_with_entity_marker": [242, 249], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d278.s1_BioInfer.d278.s1.p0", "text": "This suggests that dephosphorylation of cofilin and destrin/ADF by TSH could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.", "text_with_entity_marker": "This suggests that dephosphorylation of cofilin and destrin/[E1]ADF[/E1] by [E2]TSH[/E2] could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[60, 63]], "entity_1_idx_in_text_with_entity_marker": [64, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TSH", "entity_2_idx": [[67, 70]], "entity_2_idx_in_text_with_entity_marker": [80, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d278.s1_BioInfer.d278.s1.p1", "text": "This suggests that dephosphorylation of cofilin and destrin/ADF by TSH could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.", "text_with_entity_marker": "This suggests that dephosphorylation of cofilin and destrin/[E1]ADF[/E1] by TSH could be implicated in the disruption of [E2]actin[/E2]-containing stress fibers and in the reorganization of microfilaments induced by this hormone.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[60, 63]], "entity_1_idx_in_text_with_entity_marker": [64, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[112, 117]], "entity_2_idx_in_text_with_entity_marker": [125, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d278.s1_BioInfer.d278.s1.p4", "text": "This suggests that dephosphorylation of cofilin and destrin/ADF by TSH could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.", "text_with_entity_marker": "This suggests that dephosphorylation of cofilin and destrin/ADF by [E1]TSH[/E1] could be implicated in the disruption of [E2]actin[/E2]-containing stress fibers and in the reorganization of microfilaments induced by this hormone.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "TSH", "entity_1_idx": [[67, 70]], "entity_1_idx_in_text_with_entity_marker": [71, 74], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[112, 117]], "entity_2_idx_in_text_with_entity_marker": [125, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d278.s1_BioInfer.d278.s1.p5", "text": "This suggests that dephosphorylation of cofilin and destrin/ADF by TSH could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.", "text_with_entity_marker": "This suggests that dephosphorylation of cofilin and [E1]destrin[/E1]/ADF by [E2]TSH[/E2] could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "destrin", "entity_1_idx": [[52, 59]], "entity_1_idx_in_text_with_entity_marker": [56, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TSH", "entity_2_idx": [[67, 70]], "entity_2_idx_in_text_with_entity_marker": [80, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d278.s1_BioInfer.d278.s1.p6", "text": "This suggests that dephosphorylation of cofilin and destrin/ADF by TSH could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.", "text_with_entity_marker": "This suggests that dephosphorylation of [E1]cofilin[/E1] and destrin/ADF by [E2]TSH[/E2] could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[40, 47]], "entity_1_idx_in_text_with_entity_marker": [44, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TSH", "entity_2_idx": [[67, 70]], "entity_2_idx_in_text_with_entity_marker": [80, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d278.s1_BioInfer.d278.s1.p7", "text": "This suggests that dephosphorylation of cofilin and destrin/ADF by TSH could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.", "text_with_entity_marker": "This suggests that dephosphorylation of cofilin and [E1]destrin[/E1]/ADF by TSH could be implicated in the disruption of [E2]actin[/E2]-containing stress fibers and in the reorganization of microfilaments induced by this hormone.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "destrin", "entity_1_idx": [[52, 59]], "entity_1_idx_in_text_with_entity_marker": [56, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[112, 117]], "entity_2_idx_in_text_with_entity_marker": [125, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d278.s1_BioInfer.d278.s1.p8", "text": "This suggests that dephosphorylation of cofilin and destrin/ADF by TSH could be implicated in the disruption of actin-containing stress fibers and in the reorganization of microfilaments induced by this hormone.", "text_with_entity_marker": "This suggests that dephosphorylation of [E1]cofilin[/E1] and destrin/ADF by TSH could be implicated in the disruption of [E2]actin[/E2]-containing stress fibers and in the reorganization of microfilaments induced by this hormone.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[40, 47]], "entity_1_idx_in_text_with_entity_marker": [44, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[112, 117]], "entity_2_idx_in_text_with_entity_marker": [125, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d170.s0_BioInfer.d170.s0.p0", "text": "Detection of a sequence involved in actin-binding and phosphoinositide-binding in the N-terminal side of cofilin.", "text_with_entity_marker": "Detection of a sequence involved in [E1]actin[/E1]-binding and phosphoinositide-binding in the N-terminal side of [E2]cofilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[36, 41]], "entity_1_idx_in_text_with_entity_marker": [40, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[105, 112]], "entity_2_idx_in_text_with_entity_marker": [118, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d170.s1_BioInfer.d170.s1.p0", "text": "The truncated cofilin molecules produced in E. coli were purified and examined for their actin-binding and PIP2-binding ability.", "text_with_entity_marker": "The truncated [E1]cofilin[/E1] molecules produced in E. coli were purified and examined for their [E2]actin[/E2]-binding and PIP2-binding ability.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[14, 21]], "entity_1_idx_in_text_with_entity_marker": [18, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[89, 94]], "entity_2_idx_in_text_with_entity_marker": [102, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d650.s0_BioInfer.d650.s0.p1", "text": "The mutants ranged in affinity, from those that only weakly affected polymerization of actin to one that bound actin more strongly than wild-type profilin.", "text_with_entity_marker": "The mutants ranged in affinity, from those that only weakly affected polymerization of actin to one that bound [E1]actin[/E1] more strongly than wild-type [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[111, 116]], "entity_1_idx_in_text_with_entity_marker": [115, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[146, 154]], "entity_2_idx_in_text_with_entity_marker": [159, 167], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d650.s1_BioInfer.d650.s1.p0", "text": "The role of profilin in actin polymerization and nucleotide exchange.", "text_with_entity_marker": "The role of [E1]profilin[/E1] in [E2]actin[/E2] polymerization and nucleotide exchange.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[12, 20]], "entity_1_idx_in_text_with_entity_marker": [16, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[24, 29]], "entity_2_idx_in_text_with_entity_marker": [37, 42], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d603.s0_BioInfer.d603.s0.p1", "text": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.", "text_with_entity_marker": "The cytoplasmic domain of [E1]E-cadherin[/E1] cannot directly associate with [E2]alpha-catenin[/E2] but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[26, 36]], "entity_1_idx_in_text_with_entity_marker": [30, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[68, 81]], "entity_2_idx_in_text_with_entity_marker": [81, 94], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d603.s0_BioInfer.d603.s0.p6", "text": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.", "text_with_entity_marker": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin ([E1]plakoglobin[/E1]) to [E2]E-cadherin[/E2] is less efficient.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[172, 183]], "entity_1_idx_in_text_with_entity_marker": [176, 187], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[188, 198]], "entity_2_idx_in_text_with_entity_marker": [201, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d603.s0_BioInfer.d603.s0.p11", "text": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.", "text_with_entity_marker": "The cytoplasmic domain of [E1]E-cadherin[/E1] cannot directly associate with alpha-catenin but interacts with high affinity with [E2]beta-catenin[/E2], whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[26, 36]], "entity_1_idx_in_text_with_entity_marker": [30, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[120, 132]], "entity_2_idx_in_text_with_entity_marker": [133, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d603.s0_BioInfer.d603.s0.p12", "text": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of gamma-catenin (plakoglobin) to E-cadherin is less efficient.", "text_with_entity_marker": "The cytoplasmic domain of E-cadherin cannot directly associate with alpha-catenin but interacts with high affinity with beta-catenin, whereas the binding of [E1]gamma-catenin[/E1] (plakoglobin) to [E2]E-cadherin[/E2] is less efficient.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "gamma-catenin", "entity_1_idx": [[157, 170]], "entity_1_idx_in_text_with_entity_marker": [161, 174], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[188, 198]], "entity_2_idx_in_text_with_entity_marker": [201, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d603.s1_BioInfer.d603.s1.p0", "text": "alpha- and beta-catenin assemble into a 1:1 heterodimeric complex.", "text_with_entity_marker": "[E1]alpha-[/E1] and [E2]beta-catenin[/E2] assemble into a 1:1 heterodimeric complex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-", "entity_1_idx": [[0, 6], [16, 23]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[11, 23]], "entity_2_idx_in_text_with_entity_marker": [24, 36], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d505.s0_BioInfer.d505.s0.p0", "text": "Pyrenyliodoacetamide labeling of cysteine 374 of muscle actin reduces the affinity for profilin 10-fold.", "text_with_entity_marker": "Pyrenyliodoacetamide labeling of cysteine 374 of [E1]muscle actin[/E1] reduces the affinity for [E2]profilin[/E2] 10-fold.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "muscle actin", "entity_1_idx": [[49, 61]], "entity_1_idx_in_text_with_entity_marker": [53, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[87, 95]], "entity_2_idx_in_text_with_entity_marker": [100, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d505.s1_BioInfer.d505.s1.p0", "text": "Replacement of serine 38 with cysteine created a unique site where labeling with rhodamine did not alter the affinity of profilin for actin.", "text_with_entity_marker": "Replacement of serine 38 with cysteine created a unique site where labeling with rhodamine did not alter the affinity of [E1]profilin[/E1] for [E2]actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[121, 129]], "entity_1_idx_in_text_with_entity_marker": [125, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[134, 139]], "entity_2_idx_in_text_with_entity_marker": [147, 152], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d505.s2_BioInfer.d505.s2.p1", "text": "Three methods, fluorescence anisotropy of rhodamine-labeled profilin, intrinsic fluorescence and nucleotide exchange, give the same affinity, Kd = 0.1 microM, for Acanthamoeba profilins binding amoeba actin monomers with bound Mg-ATP.", "text_with_entity_marker": "Three methods, fluorescence anisotropy of rhodamine-labeled profilin, intrinsic fluorescence and nucleotide exchange, give the same affinity, Kd = 0.1 microM, for Acanthamoeba [E1]profilins[/E1] binding amoeba [E2]actin[/E2] monomers with bound Mg-ATP.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[176, 185]], "entity_1_idx_in_text_with_entity_marker": [180, 189], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[201, 206]], "entity_2_idx_in_text_with_entity_marker": [214, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d824.s0_BioInfer.d824.s0.p0", "text": "We studied the roles of cofilin, an actin-binding phosphoprotein, in superoxide production of neutrophil-like HL-60 cells triggered by opsonized zymosan (OZ).", "text_with_entity_marker": "We studied the roles of [E1]cofilin[/E1], an [E2]actin[/E2]-binding phosphoprotein, in superoxide production of neutrophil-like HL-60 cells triggered by opsonized zymosan (OZ).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[24, 31]], "entity_1_idx_in_text_with_entity_marker": [28, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[36, 41]], "entity_2_idx_in_text_with_entity_marker": [49, 54], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p0", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind [E1]actin[/E1] monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and [E2]thymosin beta4[/E2] (Tbeta4).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[115, 120]], "entity_1_idx_in_text_with_entity_marker": [119, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin beta4", "entity_2_idx": [[190, 204]], "entity_2_idx_in_text_with_entity_marker": [203, 217], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p1", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind [E1]actin[/E1] monomers, actin depolymerizing factor (ADF), [E2]gelsolin[/E2], profilin, and thymosin beta4 (Tbeta4).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[115, 120]], "entity_1_idx_in_text_with_entity_marker": [119, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[166, 174]], "entity_2_idx_in_text_with_entity_marker": [179, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p2", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind [E1]actin[/E1] monomers, actin depolymerizing factor ([E2]ADF[/E2]), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[115, 120]], "entity_1_idx_in_text_with_entity_marker": [119, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ADF", "entity_2_idx": [[160, 163]], "entity_2_idx_in_text_with_entity_marker": [173, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p3", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind [E1]actin[/E1] monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 ([E2]Tbeta4[/E2]).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[115, 120]], "entity_1_idx_in_text_with_entity_marker": [119, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Tbeta4", "entity_2_idx": [[206, 212]], "entity_2_idx_in_text_with_entity_marker": [219, 225], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p5", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind [E1]actin[/E1] monomers, actin depolymerizing factor (ADF), gelsolin, [E2]profilin[/E2], and thymosin beta4 (Tbeta4).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[115, 120]], "entity_1_idx_in_text_with_entity_marker": [119, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[176, 184]], "entity_2_idx_in_text_with_entity_marker": [189, 197], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d142.s0_BioInfer.d142.s0.p6", "text": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind actin monomers, actin depolymerizing factor (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "text_with_entity_marker": "Chick embryo fibroblasts contain about 75-100 microM unpolymerized actin and at least four proteins which can bind [E1]actin[/E1] monomers, [E2]actin depolymerizing factor[/E2] (ADF), gelsolin, profilin, and thymosin beta4 (Tbeta4).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[115, 120]], "entity_1_idx_in_text_with_entity_marker": [119, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin depolymerizing factor", "entity_2_idx": [[131, 158]], "entity_2_idx_in_text_with_entity_marker": [144, 171], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d744.s0_BioInfer.d744.s0.p0", "text": "This process involves other actin-binding proteins, such as cofilin and coronin.", "text_with_entity_marker": "This process involves other [E1]actin-binding proteins[/E1], such as cofilin and [E2]coronin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding proteins", "entity_1_idx": [[28, 50]], "entity_1_idx_in_text_with_entity_marker": [32, 54], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "coronin", "entity_2_idx": [[72, 79]], "entity_2_idx_in_text_with_entity_marker": [85, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d744.s0_BioInfer.d744.s0.p2", "text": "This process involves other actin-binding proteins, such as cofilin and coronin.", "text_with_entity_marker": "This process involves other [E1]actin-binding proteins[/E1], such as [E2]cofilin[/E2] and coronin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding proteins", "entity_1_idx": [[28, 50]], "entity_1_idx_in_text_with_entity_marker": [32, 54], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cofilin", "entity_2_idx": [[60, 67]], "entity_2_idx_in_text_with_entity_marker": [73, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d70.s0_BioInfer.d70.s0.p1", "text": "Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.", "text_with_entity_marker": "[E1]Aprotinin[/E1] inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and [E2]myosin heavy chain[/E2] associated with cytoskeletons.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Aprotinin", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[355, 373]], "entity_2_idx_in_text_with_entity_marker": [368, 386], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d70.s0_BioInfer.d70.s0.p4", "text": "Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.", "text_with_entity_marker": "[E1]Aprotinin[/E1] inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by [E2]thrombin[/E2] (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Aprotinin", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thrombin", "entity_2_idx": [[189, 197]], "entity_2_idx_in_text_with_entity_marker": [202, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d70.s0_BioInfer.d70.s0.p8", "text": "Aprotinin inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of actin and myosin heavy chain associated with cytoskeletons.", "text_with_entity_marker": "[E1]Aprotinin[/E1] inhibited platelet aggregation induced by thrombin (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by thrombin (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of [E2]actin[/E2] and myosin heavy chain associated with cytoskeletons.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Aprotinin", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[345, 350]], "entity_2_idx_in_text_with_entity_marker": [358, 363], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d381.s0_BioInfer.d381.s0.p1", "text": "In this study we demonstrate that histone H3 and histone H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.", "text_with_entity_marker": "In this study we demonstrate that [E1]histone[/E1] [E2]H3[/E2] and histone H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[34, 41]], "entity_1_idx_in_text_with_entity_marker": [38, 45], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[42, 44]], "entity_2_idx_in_text_with_entity_marker": [55, 57], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d381.s0_BioInfer.d381.s0.p3", "text": "In this study we demonstrate that histone H3 and histone H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.", "text_with_entity_marker": "In this study we demonstrate that histone [E1]H3[/E1] and histone [E2]H4[/E2] synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[42, 44]], "entity_1_idx_in_text_with_entity_marker": [46, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[57, 59]], "entity_2_idx_in_text_with_entity_marker": [70, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d381.s0_BioInfer.d381.s0.p4", "text": "In this study we demonstrate that histone H3 and histone H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.", "text_with_entity_marker": "In this study we demonstrate that histone H3 and [E1]histone[/E1] [E2]H4[/E2] synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[49, 56]], "entity_1_idx_in_text_with_entity_marker": [53, 60], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[57, 59]], "entity_2_idx_in_text_with_entity_marker": [70, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d363.s0_BioInfer.d363.s0.p0", "text": "Interestingly, two major actin-binding proteins found in brain, gelsolin and profilin, specifically interact with phosphatidylinositol 4,5-bisphosphate, and may themselves play a role in regulating phosphoinositide turnover.", "text_with_entity_marker": "Interestingly, two major [E1]actin-binding proteins[/E1] found in brain, gelsolin and [E2]profilin[/E2], specifically interact with phosphatidylinositol 4,5-bisphosphate, and may themselves play a role in regulating phosphoinositide turnover.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding proteins", "entity_1_idx": [[25, 47]], "entity_1_idx_in_text_with_entity_marker": [29, 51], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[77, 85]], "entity_2_idx_in_text_with_entity_marker": [90, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d363.s0_BioInfer.d363.s0.p1", "text": "Interestingly, two major actin-binding proteins found in brain, gelsolin and profilin, specifically interact with phosphatidylinositol 4,5-bisphosphate, and may themselves play a role in regulating phosphoinositide turnover.", "text_with_entity_marker": "Interestingly, two major [E1]actin-binding proteins[/E1] found in brain, [E2]gelsolin[/E2] and profilin, specifically interact with phosphatidylinositol 4,5-bisphosphate, and may themselves play a role in regulating phosphoinositide turnover.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding proteins", "entity_1_idx": [[25, 47]], "entity_1_idx_in_text_with_entity_marker": [29, 51], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "gelsolin", "entity_2_idx": [[64, 72]], "entity_2_idx_in_text_with_entity_marker": [77, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p10", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, [E1]FADD[/E1] and [E2]RAIDD[/E2] - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "FADD", "entity_1_idx": [[138, 142]], "entity_1_idx_in_text_with_entity_marker": [142, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAIDD", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p13", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 ([E1]TNFR1[/E1]) and the Fas receptor recruit complexes formed by the interactions between [E2]RIP kinase[/E2], TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TNFR1", "entity_1_idx": [[38, 43]], "entity_1_idx_in_text_with_entity_marker": [42, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP kinase", "entity_2_idx": [[119, 129]], "entity_2_idx_in_text_with_entity_marker": [132, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p14", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 ([E1]TNFR1[/E1]) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, [E2]FADD[/E2] and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TNFR1", "entity_1_idx": [[38, 43]], "entity_1_idx_in_text_with_entity_marker": [42, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p16", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 (TNFR1) and the [E1]Fas[/E1] receptor recruit complexes formed by the interactions between [E2]RIP kinase[/E2], TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[53, 56]], "entity_1_idx_in_text_with_entity_marker": [57, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP kinase", "entity_2_idx": [[119, 129]], "entity_2_idx_in_text_with_entity_marker": [132, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p17", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 (TNFR1) and the [E1]Fas[/E1] receptor recruit complexes formed by the interactions between RIP kinase, TRADD, [E2]FADD[/E2] and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[53, 56]], "entity_1_idx_in_text_with_entity_marker": [57, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p18", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The [E1]tumor necrosis factor receptor 1[/E1] (TNFR1) and the Fas receptor recruit complexes formed by the interactions between [E2]RIP kinase[/E2], TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "tumor necrosis factor receptor 1", "entity_1_idx": [[4, 36]], "entity_1_idx_in_text_with_entity_marker": [8, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP kinase", "entity_2_idx": [[119, 129]], "entity_2_idx_in_text_with_entity_marker": [132, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p19", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The [E1]tumor necrosis factor receptor 1[/E1] (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, [E2]FADD[/E2] and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "tumor necrosis factor receptor 1", "entity_1_idx": [[4, 36]], "entity_1_idx_in_text_with_entity_marker": [8, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d727.s0_BioInfer.d727.s0.p20", "text": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between RIP kinase, TRADD, FADD and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "text_with_entity_marker": "The tumor necrosis factor receptor 1 (TNFR1) and the Fas receptor recruit complexes formed by the interactions between [E1]RIP kinase[/E1], TRADD, [E2]FADD[/E2] and RAIDD - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RIP kinase", "entity_1_idx": [[119, 129]], "entity_1_idx_in_text_with_entity_marker": [123, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d452.s0_BioInfer.d452.s0.p0", "text": "N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the actin-binding proteins, profilin, and gelsolin.", "text_with_entity_marker": "N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the [E1]actin-binding proteins[/E1], [E2]profilin[/E2], and gelsolin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding proteins", "entity_1_idx": [[230, 252]], "entity_1_idx_in_text_with_entity_marker": [234, 256], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[254, 262]], "entity_2_idx_in_text_with_entity_marker": [267, 275], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d452.s0_BioInfer.d452.s0.p2", "text": "N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the actin-binding proteins, profilin, and gelsolin.", "text_with_entity_marker": "N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the [E1]actin-binding proteins[/E1], profilin, and [E2]gelsolin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding proteins", "entity_1_idx": [[230, 252]], "entity_1_idx_in_text_with_entity_marker": [234, 256], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "gelsolin", "entity_2_idx": [[268, 276]], "entity_2_idx_in_text_with_entity_marker": [281, 289], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d452.s0_BioInfer.d452.s0.p3", "text": "N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the actin-binding proteins, profilin, and gelsolin.", "text_with_entity_marker": "N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of [E1]actin[/E1] assembly through its association with the actin-binding proteins, [E2]profilin[/E2], and gelsolin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[182, 187]], "entity_1_idx_in_text_with_entity_marker": [186, 191], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[254, 262]], "entity_2_idx_in_text_with_entity_marker": [267, 275], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d452.s0_BioInfer.d452.s0.p5", "text": "N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the actin-binding proteins, profilin, and gelsolin.", "text_with_entity_marker": "N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of [E1]actin[/E1] assembly through its association with the actin-binding proteins, profilin, and [E2]gelsolin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[182, 187]], "entity_1_idx_in_text_with_entity_marker": [186, 191], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[268, 276]], "entity_2_idx_in_text_with_entity_marker": [281, 289], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d498.s0_BioInfer.d498.s0.p0", "text": "Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.", "text_with_entity_marker": "Profilins also bind polyphosphoinositides, which can disrupt the [E1]profilin[/E1]-[E2]actin[/E2] complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[65, 73]], "entity_1_idx_in_text_with_entity_marker": [69, 77], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[74, 79]], "entity_2_idx_in_text_with_entity_marker": [87, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d498.s0_BioInfer.d498.s0.p2", "text": "Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.", "text_with_entity_marker": "[E1]Profilins[/E1] also bind polyphosphoinositides, which can disrupt the profilin-[E2]actin[/E2] complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Profilins", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[74, 79]], "entity_2_idx_in_text_with_entity_marker": [87, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d498.s0_BioInfer.d498.s0.p5", "text": "Profilins also bind polyphosphoinositides, which can disrupt the profilin-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.", "text_with_entity_marker": "[E1]Profilins[/E1] also bind polyphosphoinositides, which can disrupt the [E2]profilin[/E2]-actin complex, and proline-rich ligands which localize profilin to sites requiring extensive actin filament accumulation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Profilins", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[65, 73]], "entity_2_idx_in_text_with_entity_marker": [78, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d7.s0_BioInfer.d7.s0.p4", "text": "Acanthamoeba profilin has similar but weaker effects on muscle actin, requiring 5 to 10 times more profilin than with amoeba actin.", "text_with_entity_marker": "Acanthamoeba [E1]profilin[/E1] has similar but weaker effects on [E2]muscle actin[/E2], requiring 5 to 10 times more profilin than with amoeba actin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "muscle actin", "entity_2_idx": [[56, 68]], "entity_2_idx_in_text_with_entity_marker": [69, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d7.s1_BioInfer.d7.s1.p0", "text": "Acanthamoeba profilin strongly inhibits in a concentration-dependent fashion the rate and extent of Acanthamoeba actin polymerization in 50 mM KCl.", "text_with_entity_marker": "Acanthamoeba [E1]profilin[/E1] strongly inhibits in a concentration-dependent fashion the rate and extent of Acanthamoeba [E2]actin[/E2] polymerization in 50 mM KCl.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[113, 118]], "entity_2_idx_in_text_with_entity_marker": [126, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d7.s2_BioInfer.d7.s2.p0", "text": "Addition of profilin to polymerized actin causes it to depolymerize until a new steady-state, dependent on profilin concentration, is achieved.", "text_with_entity_marker": "Addition of [E1]profilin[/E1] to polymerized [E2]actin[/E2] causes it to depolymerize until a new steady-state, dependent on profilin concentration, is achieved.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[12, 20]], "entity_1_idx_in_text_with_entity_marker": [16, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[36, 41]], "entity_2_idx_in_text_with_entity_marker": [49, 54], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d7.s4_BioInfer.d7.s4.p0", "text": "MgCl2 strongly inhibits these effects of profilin, most likely by binding to the high-affinity divalent cation site on the actin.", "text_with_entity_marker": "MgCl2 strongly inhibits these effects of [E1]profilin[/E1], most likely by binding to the high-affinity divalent cation site on the [E2]actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[41, 49]], "entity_1_idx_in_text_with_entity_marker": [45, 53], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[123, 128]], "entity_2_idx_in_text_with_entity_marker": [136, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d307.s0_BioInfer.d307.s0.p2", "text": "In Acanthamoeba actin polymerization is regulated, at least in part, by profilin, which binds to actin monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.", "text_with_entity_marker": "In Acanthamoeba [E1]actin[/E1] polymerization is regulated, at least in part, by profilin, which binds to actin monomers, and by [E2]capping protein[/E2], which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "capping protein", "entity_2_idx": [[120, 135]], "entity_2_idx_in_text_with_entity_marker": [133, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d307.s0_BioInfer.d307.s0.p3", "text": "In Acanthamoeba actin polymerization is regulated, at least in part, by profilin, which binds to actin monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.", "text_with_entity_marker": "In Acanthamoeba actin polymerization is regulated, at least in part, by [E1]profilin[/E1], which binds to [E2]actin[/E2] monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[72, 80]], "entity_1_idx_in_text_with_entity_marker": [76, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[97, 102]], "entity_2_idx_in_text_with_entity_marker": [110, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d307.s0_BioInfer.d307.s0.p5", "text": "In Acanthamoeba actin polymerization is regulated, at least in part, by profilin, which binds to actin monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.", "text_with_entity_marker": "In Acanthamoeba [E1]actin[/E1] polymerization is regulated, at least in part, by [E2]profilin[/E2], which binds to actin monomers, and by capping protein, which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[72, 80]], "entity_2_idx_in_text_with_entity_marker": [85, 93], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p13", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, alpha-catenin, and [E1]beta-catenin[/E1] expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or [E2]c-erbB2[/E2] expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[63, 75]], "entity_1_idx_in_text_with_entity_marker": [67, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-erbB2", "entity_2_idx": [[214, 221]], "entity_2_idx_in_text_with_entity_marker": [227, 234], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p14", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, alpha-catenin, and [E1]beta-catenin[/E1] expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, [E2]p53[/E2] expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[63, 75]], "entity_1_idx_in_text_with_entity_marker": [67, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[179, 182]], "entity_2_idx_in_text_with_entity_marker": [192, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p20", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, [E1]alpha-catenin[/E1], and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or [E2]c-erbB2[/E2] expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[44, 57]], "entity_1_idx_in_text_with_entity_marker": [48, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-erbB2", "entity_2_idx": [[214, 221]], "entity_2_idx_in_text_with_entity_marker": [227, 234], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p23", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, [E1]alpha-catenin[/E1], and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, [E2]p53[/E2] expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[44, 57]], "entity_1_idx_in_text_with_entity_marker": [48, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[179, 182]], "entity_2_idx_in_text_with_entity_marker": [192, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s0_BioInfer.d379.s0.p0", "text": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "text_with_entity_marker": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the [E1]MSH2[/E1] protein and the MSH3 and [E2]MSH6[/E2] proteins.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[286, 290]], "entity_1_idx_in_text_with_entity_marker": [290, 294], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MSH6", "entity_2_idx": [[316, 320]], "entity_2_idx_in_text_with_entity_marker": [329, 333], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s0_BioInfer.d379.s0.p1", "text": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the MSH2 protein and the MSH3 and MSH6 proteins.", "text_with_entity_marker": "In this study the role of MSH2, MSH3, and MSH6 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of msh2, msh3, and msh6 mutations and by studying the physical interaction between the [E1]MSH2[/E1] protein and the [E2]MSH3[/E2] and MSH6 proteins.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[286, 290]], "entity_1_idx_in_text_with_entity_marker": [290, 294], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MSH3", "entity_2_idx": [[307, 311]], "entity_2_idx_in_text_with_entity_marker": [320, 324], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p5", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of [E1]MSH2[/E1]-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or [E2]MSH2[/E2] and MSH3.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[60, 64]], "entity_1_idx_in_text_with_entity_marker": [64, 68], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[272, 276]], "entity_2_idx_in_text_with_entity_marker": [285, 289], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p10", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of [E1]MSH2[/E1]-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either [E2]MSH2[/E2] and MSH6 or MSH2 and MSH3.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[60, 64]], "entity_1_idx_in_text_with_entity_marker": [64, 68], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[255, 259]], "entity_2_idx_in_text_with_entity_marker": [268, 272], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p14", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of [E1]MSH2[/E1]-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and [E2]MSH6[/E2] or MSH2 and MSH3.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[60, 64]], "entity_1_idx_in_text_with_entity_marker": [64, 68], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH6", "entity_2_idx": [[264, 268]], "entity_2_idx_in_text_with_entity_marker": [277, 281], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p17", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of [E1]MSH2[/E1]-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and [E2]MSH3[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[60, 64]], "entity_1_idx_in_text_with_entity_marker": [64, 68], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH3", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p19", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of [E1]MSH2[/E1]-dependent mismatch repair: one that recognized single-base mispairs and requires [E2]MSH2[/E2] and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[60, 64]], "entity_1_idx_in_text_with_entity_marker": [64, 68], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[146, 150]], "entity_2_idx_in_text_with_entity_marker": [159, 163], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s2_BioInfer.d379.s2.p20", "text": "The results indicate that S. cerevisiae has two pathways of MSH2-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and MSH6, and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "text_with_entity_marker": "The results indicate that S. cerevisiae has two pathways of [E1]MSH2[/E1]-dependent mismatch repair: one that recognized single-base mispairs and requires MSH2 and [E2]MSH6[/E2], and a second that recognizes insertion/deletion mispairs and requires a combination of either MSH2 and MSH6 or MSH2 and MSH3.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MSH2", "entity_1_idx": [[60, 64]], "entity_1_idx_in_text_with_entity_marker": [64, 68], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH6", "entity_2_idx": [[155, 159]], "entity_2_idx_in_text_with_entity_marker": [168, 172], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d174.s0_BioInfer.d174.s0.p1", "text": "Direct binding of the verprolin-homology domain in N-WASP to actin is essential for cytoskeletal reorganization.", "text_with_entity_marker": "Direct binding of the [E1]verprolin[/E1]-homology domain in [E2]N-WASP[/E2] to actin is essential for cytoskeletal reorganization.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "verprolin", "entity_1_idx": [[22, 31]], "entity_1_idx_in_text_with_entity_marker": [26, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N-WASP", "entity_2_idx": [[51, 57]], "entity_2_idx_in_text_with_entity_marker": [64, 70], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d174.s0_BioInfer.d174.s0.p2", "text": "Direct binding of the verprolin-homology domain in N-WASP to actin is essential for cytoskeletal reorganization.", "text_with_entity_marker": "Direct binding of the verprolin-homology domain in [E1]N-WASP[/E1] to [E2]actin[/E2] is essential for cytoskeletal reorganization.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "N-WASP", "entity_1_idx": [[51, 57]], "entity_1_idx_in_text_with_entity_marker": [55, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[61, 66]], "entity_2_idx_in_text_with_entity_marker": [74, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d174.s1_BioInfer.d174.s1.p0", "text": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.", "text_with_entity_marker": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein ([E1]WASP[/E1]) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of [E2]verprolin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "WASP", "entity_1_idx": [[120, 124]], "entity_1_idx_in_text_with_entity_marker": [124, 128], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "verprolin", "entity_2_idx": [[242, 251]], "entity_2_idx_in_text_with_entity_marker": [255, 264], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d174.s1_BioInfer.d174.s1.p2", "text": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.", "text_with_entity_marker": "Recently, two mammalian proteins previously shown to regulate the [E1]actin[/E1] cytoskeleton, Wiskott-Aldrich Syndrome Protein ([E2]WASP[/E2]) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[66, 71]], "entity_1_idx_in_text_with_entity_marker": [70, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "WASP", "entity_2_idx": [[120, 124]], "entity_2_idx_in_text_with_entity_marker": [133, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d174.s1_BioInfer.d174.s1.p4", "text": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.", "text_with_entity_marker": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons ([E1]N-WASP[/E1]), were found to possess short peptide motifs homologous to one part of [E2]verprolin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "N-WASP", "entity_1_idx": [[164, 170]], "entity_1_idx_in_text_with_entity_marker": [168, 174], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "verprolin", "entity_2_idx": [[242, 251]], "entity_2_idx_in_text_with_entity_marker": [255, 264], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d174.s1_BioInfer.d174.s1.p6", "text": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.", "text_with_entity_marker": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, [E1]Wiskott-Aldrich Syndrome Protein[/E1] (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of [E2]verprolin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Wiskott-Aldrich Syndrome Protein", "entity_1_idx": [[86, 118]], "entity_1_idx_in_text_with_entity_marker": [90, 122], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "verprolin", "entity_2_idx": [[242, 251]], "entity_2_idx_in_text_with_entity_marker": [255, 264], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d174.s1_BioInfer.d174.s1.p7", "text": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.", "text_with_entity_marker": "Recently, two mammalian proteins previously shown to regulate the [E1]actin[/E1] cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons ([E2]N-WASP[/E2]), were found to possess short peptide motifs homologous to one part of verprolin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[66, 71]], "entity_1_idx_in_text_with_entity_marker": [70, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N-WASP", "entity_2_idx": [[164, 170]], "entity_2_idx_in_text_with_entity_marker": [177, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d174.s1_BioInfer.d174.s1.p9", "text": "Recently, two mammalian proteins previously shown to regulate the actin cytoskeleton, Wiskott-Aldrich Syndrome Protein (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.", "text_with_entity_marker": "Recently, two mammalian proteins previously shown to regulate the [E1]actin[/E1] cytoskeleton, [E2]Wiskott-Aldrich Syndrome Protein[/E2] (WASP) and its homolog expressed in neurons (N-WASP), were found to possess short peptide motifs homologous to one part of verprolin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[66, 71]], "entity_1_idx_in_text_with_entity_marker": [70, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Wiskott-Aldrich Syndrome Protein", "entity_2_idx": [[86, 118]], "entity_2_idx_in_text_with_entity_marker": [99, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s0_BioInfer.d465.s0.p2", "text": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "text_with_entity_marker": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the [E1]helicase-primase[/E1] components (UL5, UL8, and [E2]UL52[/E2]), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[115, 131]], "entity_1_idx_in_text_with_entity_marker": [119, 135], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL52", "entity_2_idx": [[158, 162]], "entity_2_idx_in_text_with_entity_marker": [171, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s0_BioInfer.d465.s0.p19", "text": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "text_with_entity_marker": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the [E1]helicase-primase[/E1] components ([E2]UL5[/E2], UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[115, 131]], "entity_1_idx_in_text_with_entity_marker": [119, 135], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL5", "entity_2_idx": [[144, 147]], "entity_2_idx_in_text_with_entity_marker": [157, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d465.s0_BioInfer.d465.s0.p20", "text": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the helicase-primase components (UL5, UL8, and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "text_with_entity_marker": "On the basis of these results, we present a model for prereplicative site formation in infected cells in which the [E1]helicase-primase[/E1] components (UL5, [E2]UL8[/E2], and UL52), the origin-binding protein (UL9), and the viral single-stranded DNA-binding protein (ICP8) assemble together to initiate the process.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[115, 131]], "entity_1_idx_in_text_with_entity_marker": [119, 135], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL8", "entity_2_idx": [[149, 152]], "entity_2_idx_in_text_with_entity_marker": [162, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d224.s0_BioInfer.d224.s0.p0", "text": "Furthermore, this inactivating effect of calmodulin can be prevented by coexpressing a region of the cytoskeletal protein alpha-actinin2 known to interact with the CO region of NR1.", "text_with_entity_marker": "Furthermore, this inactivating effect of [E1]calmodulin[/E1] can be prevented by coexpressing a region of the cytoskeletal protein [E2]alpha-actinin2[/E2] known to interact with the CO region of NR1.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "calmodulin", "entity_1_idx": [[41, 51]], "entity_1_idx_in_text_with_entity_marker": [45, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-actinin2", "entity_2_idx": [[122, 136]], "entity_2_idx_in_text_with_entity_marker": [135, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d224.s0_BioInfer.d224.s0.p2", "text": "Furthermore, this inactivating effect of calmodulin can be prevented by coexpressing a region of the cytoskeletal protein alpha-actinin2 known to interact with the CO region of NR1.", "text_with_entity_marker": "Furthermore, this inactivating effect of calmodulin can be prevented by coexpressing a region of the cytoskeletal protein [E1]alpha-actinin2[/E1] known to interact with the CO region of [E2]NR1[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-actinin2", "entity_1_idx": [[122, 136]], "entity_1_idx_in_text_with_entity_marker": [126, 140], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NR1", "entity_2_idx": [[177, 180]], "entity_2_idx_in_text_with_entity_marker": [190, 193], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d162.s0_BioInfer.d162.s0.p1", "text": "Data is presented to suggest that the G1 cyclin D1 and the cyclin-dependent kinase inhibitor p27KIP1 may be involved in subversion of the G1/S traverse by signaling pathways activated by HER-2 function.", "text_with_entity_marker": "Data is presented to suggest that the G1 [E1]cyclin D1[/E1] and the cyclin-dependent kinase inhibitor p27KIP1 may be involved in subversion of the G1/S traverse by signaling pathways activated by [E2]HER-2[/E2] function.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin D1", "entity_1_idx": [[41, 50]], "entity_1_idx_in_text_with_entity_marker": [45, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HER-2", "entity_2_idx": [[187, 192]], "entity_2_idx_in_text_with_entity_marker": [200, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d162.s0_BioInfer.d162.s0.p3", "text": "Data is presented to suggest that the G1 cyclin D1 and the cyclin-dependent kinase inhibitor p27KIP1 may be involved in subversion of the G1/S traverse by signaling pathways activated by HER-2 function.", "text_with_entity_marker": "Data is presented to suggest that the G1 cyclin D1 and the cyclin-dependent kinase inhibitor [E1]p27KIP1[/E1] may be involved in subversion of the G1/S traverse by signaling pathways activated by [E2]HER-2[/E2] function.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27KIP1", "entity_1_idx": [[93, 100]], "entity_1_idx_in_text_with_entity_marker": [97, 104], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HER-2", "entity_2_idx": [[187, 192]], "entity_2_idx_in_text_with_entity_marker": [200, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d162.s0_BioInfer.d162.s0.p4", "text": "Data is presented to suggest that the G1 cyclin D1 and the cyclin-dependent kinase inhibitor p27KIP1 may be involved in subversion of the G1/S traverse by signaling pathways activated by HER-2 function.", "text_with_entity_marker": "Data is presented to suggest that the G1 cyclin D1 and the [E1]cyclin-dependent kinase inhibitor[/E1] [E2]p27KIP1[/E2] may be involved in subversion of the G1/S traverse by signaling pathways activated by HER-2 function.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[59, 92]], "entity_1_idx_in_text_with_entity_marker": [63, 96], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p27KIP1", "entity_2_idx": [[93, 100]], "entity_2_idx_in_text_with_entity_marker": [106, 113], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d638.s1_BioInfer.d638.s1.p0", "text": "The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and profilin.", "text_with_entity_marker": "The tandem repeat domain in the Listeria monocytogenes [E1]ActA[/E1] protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "ActA", "entity_1_idx": [[55, 59]], "entity_1_idx_in_text_with_entity_marker": [59, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[212, 220]], "entity_2_idx_in_text_with_entity_marker": [225, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d638.s1_BioInfer.d638.s1.p3", "text": "The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and profilin.", "text_with_entity_marker": "The tandem repeat domain in the Listeria monocytogenes [E1]ActA[/E1] protein controls the rate of [E2]actin[/E2]-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and profilin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "ActA", "entity_1_idx": [[55, 59]], "entity_1_idx_in_text_with_entity_marker": [59, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[89, 94]], "entity_2_idx_in_text_with_entity_marker": [102, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d638.s1_BioInfer.d638.s1.p4", "text": "The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and profilin.", "text_with_entity_marker": "The tandem repeat domain in the Listeria monocytogenes [E1]ActA[/E1] protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of [E2]vasodilator-stimulated phosphoprotein[/E2] and profilin.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ActA", "entity_1_idx": [[55, 59]], "entity_1_idx_in_text_with_entity_marker": [59, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vasodilator-stimulated phosphoprotein", "entity_2_idx": [[170, 207]], "entity_2_idx_in_text_with_entity_marker": [183, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d338.s0_BioInfer.d338.s0.p2", "text": "Inhibition of actin polymerization by a synthetic dodecapeptide patterned on the sequence around the actin-binding site of cofilin.", "text_with_entity_marker": "Inhibition of actin polymerization by a synthetic dodecapeptide patterned on the sequence around the [E1]actin[/E1]-binding site of [E2]cofilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[101, 106]], "entity_1_idx_in_text_with_entity_marker": [105, 110], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[123, 130]], "entity_2_idx_in_text_with_entity_marker": [136, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d386.s0_BioInfer.d386.s0.p0", "text": "In vitro, actin purified from some of these mutants is defective in polymerization or binding fimbrin.", "text_with_entity_marker": "In vitro, [E1]actin[/E1] purified from some of these mutants is defective in polymerization or binding [E2]fimbrin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[10, 15]], "entity_1_idx_in_text_with_entity_marker": [14, 19], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[94, 101]], "entity_2_idx_in_text_with_entity_marker": [107, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d89.s0_BioInfer.d89.s0.p0", "text": "BACKGROUND: Although profilin is believed to be an essential regulator of the actin cytoskeleton in most cells, its precise role in mammalian cells remains unknown.", "text_with_entity_marker": "BACKGROUND: Although [E1]profilin[/E1] is believed to be an essential regulator of the [E2]actin[/E2] cytoskeleton in most cells, its precise role in mammalian cells remains unknown.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[21, 29]], "entity_1_idx_in_text_with_entity_marker": [25, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[78, 83]], "entity_2_idx_in_text_with_entity_marker": [91, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d778.s0_BioInfer.d778.s0.p0", "text": "Two actin binding proteins, actin depolymerizing factor and cofilin, are associated with Hirano bodies.", "text_with_entity_marker": "Two actin binding proteins, [E1]actin depolymerizing factor[/E1] and [E2]cofilin[/E2], are associated with Hirano bodies.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "actin depolymerizing factor", "entity_1_idx": [[28, 55]], "entity_1_idx_in_text_with_entity_marker": [32, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[60, 67]], "entity_2_idx_in_text_with_entity_marker": [73, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d778.s0_BioInfer.d778.s0.p1", "text": "Two actin binding proteins, actin depolymerizing factor and cofilin, are associated with Hirano bodies.", "text_with_entity_marker": "Two [E1]actin binding proteins[/E1], [E2]actin depolymerizing factor[/E2] and cofilin, are associated with Hirano bodies.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "actin binding proteins", "entity_1_idx": [[4, 26]], "entity_1_idx_in_text_with_entity_marker": [8, 30], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin depolymerizing factor", "entity_2_idx": [[28, 55]], "entity_2_idx_in_text_with_entity_marker": [41, 68], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d778.s0_BioInfer.d778.s0.p2", "text": "Two actin binding proteins, actin depolymerizing factor and cofilin, are associated with Hirano bodies.", "text_with_entity_marker": "Two [E1]actin binding proteins[/E1], actin depolymerizing factor and [E2]cofilin[/E2], are associated with Hirano bodies.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin binding proteins", "entity_1_idx": [[4, 26]], "entity_1_idx_in_text_with_entity_marker": [8, 30], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cofilin", "entity_2_idx": [[60, 67]], "entity_2_idx_in_text_with_entity_marker": [73, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d361.s0_BioInfer.d361.s0.p11", "text": "Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "text_with_entity_marker": "Interactions of [E1]ADF[/E1]/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched [E2]actin[/E2] filament networks.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[16, 19]], "entity_1_idx_in_text_with_entity_marker": [20, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d361.s0_BioInfer.d361.s0.p12", "text": "Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "text_with_entity_marker": "Interactions of [E1]ADF[/E1]/cofilin, Arp2/3 complex, [E2]capping protein[/E2] and profilin in remodeling of branched actin filament networks.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[16, 19]], "entity_1_idx_in_text_with_entity_marker": [20, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "capping protein", "entity_2_idx": [[45, 60]], "entity_2_idx_in_text_with_entity_marker": [58, 73], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d361.s0_BioInfer.d361.s0.p13", "text": "Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "text_with_entity_marker": "Interactions of [E1]ADF[/E1]/cofilin, [E2]Arp2[/E2]/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[16, 19]], "entity_1_idx_in_text_with_entity_marker": [20, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp2", "entity_2_idx": [[29, 33]], "entity_2_idx_in_text_with_entity_marker": [42, 46], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d361.s0_BioInfer.d361.s0.p14", "text": "Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "text_with_entity_marker": "Interactions of [E1]ADF[/E1]/cofilin, Arp2/3 complex, capping protein and [E2]profilin[/E2] in remodeling of branched actin filament networks.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[16, 19]], "entity_1_idx_in_text_with_entity_marker": [20, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[65, 73]], "entity_2_idx_in_text_with_entity_marker": [78, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d361.s0_BioInfer.d361.s0.p15", "text": "Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "text_with_entity_marker": "Interactions of ADF/cofilin, Arp2/3 complex, [E1]capping protein[/E1] and profilin in remodeling of branched [E2]actin[/E2] filament networks.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "capping protein", "entity_1_idx": [[45, 60]], "entity_1_idx_in_text_with_entity_marker": [49, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d361.s0_BioInfer.d361.s0.p16", "text": "Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "text_with_entity_marker": "Interactions of ADF/cofilin, [E1]Arp2[/E1]/3 complex, capping protein and profilin in remodeling of branched [E2]actin[/E2] filament networks.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Arp2", "entity_1_idx": [[29, 33]], "entity_1_idx_in_text_with_entity_marker": [33, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d361.s0_BioInfer.d361.s0.p17", "text": "Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "text_with_entity_marker": "Interactions of ADF/cofilin, Arp2/3 complex, capping protein and [E1]profilin[/E1] in remodeling of branched [E2]actin[/E2] filament networks.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[65, 73]], "entity_1_idx_in_text_with_entity_marker": [69, 77], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d361.s0_BioInfer.d361.s0.p18", "text": "Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "text_with_entity_marker": "Interactions of ADF/cofilin, [E1]Arp2[/E1]/3 complex, [E2]capping protein[/E2] and profilin in remodeling of branched actin filament networks.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Arp2", "entity_1_idx": [[29, 33]], "entity_1_idx_in_text_with_entity_marker": [33, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "capping protein", "entity_2_idx": [[45, 60]], "entity_2_idx_in_text_with_entity_marker": [58, 73], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d361.s0_BioInfer.d361.s0.p19", "text": "Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "text_with_entity_marker": "Interactions of ADF/cofilin, Arp2/3 complex, [E1]capping protein[/E1] and [E2]profilin[/E2] in remodeling of branched actin filament networks.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "capping protein", "entity_1_idx": [[45, 60]], "entity_1_idx_in_text_with_entity_marker": [49, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[65, 73]], "entity_2_idx_in_text_with_entity_marker": [78, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d361.s0_BioInfer.d361.s0.p20", "text": "Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "text_with_entity_marker": "Interactions of ADF/cofilin, [E1]Arp2[/E1]/3 complex, capping protein and [E2]profilin[/E2] in remodeling of branched actin filament networks.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Arp2", "entity_1_idx": [[29, 33]], "entity_1_idx_in_text_with_entity_marker": [33, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[65, 73]], "entity_2_idx_in_text_with_entity_marker": [78, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d802.s0_BioInfer.d802.s0.p1", "text": "We examined whether levels of alpha-smooth-muscle actin or proliferating cell nuclear antigen correlated with myosin heavy-chain levels in the glomeruli of rats with puromycin aminonucleoside nephrosis.", "text_with_entity_marker": "We examined whether levels of alpha-smooth-muscle actin or [E1]proliferating cell nuclear antigen[/E1] correlated with [E2]myosin heavy-chain[/E2] levels in the glomeruli of rats with puromycin aminonucleoside nephrosis.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "proliferating cell nuclear antigen", "entity_1_idx": [[59, 93]], "entity_1_idx_in_text_with_entity_marker": [63, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy-chain", "entity_2_idx": [[110, 128]], "entity_2_idx_in_text_with_entity_marker": [123, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d802.s0_BioInfer.d802.s0.p2", "text": "We examined whether levels of alpha-smooth-muscle actin or proliferating cell nuclear antigen correlated with myosin heavy-chain levels in the glomeruli of rats with puromycin aminonucleoside nephrosis.", "text_with_entity_marker": "We examined whether levels of [E1]alpha-smooth-muscle actin[/E1] or proliferating cell nuclear antigen correlated with [E2]myosin heavy-chain[/E2] levels in the glomeruli of rats with puromycin aminonucleoside nephrosis.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-smooth-muscle actin", "entity_1_idx": [[30, 55]], "entity_1_idx_in_text_with_entity_marker": [34, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy-chain", "entity_2_idx": [[110, 128]], "entity_2_idx_in_text_with_entity_marker": [123, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d272.s1_BioInfer.d272.s1.p4", "text": "These results suggest that muscle-specific processing of tropomyosin transcripts can continue to occur in the absence of myogenin expression unlike the expression of muscle actin and myosin heavy chain mRNAs.", "text_with_entity_marker": "These results suggest that muscle-specific processing of [E1]tropomyosin[/E1] transcripts can continue to occur in the absence of [E2]myogenin[/E2] expression unlike the expression of muscle actin and myosin heavy chain mRNAs.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[57, 68]], "entity_1_idx_in_text_with_entity_marker": [61, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myogenin", "entity_2_idx": [[121, 129]], "entity_2_idx_in_text_with_entity_marker": [134, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d532.s0_BioInfer.d532.s0.p0", "text": "Ser-133 phosphorylation enhances CREB activity by promoting interaction with a 265-kDa CREB binding protein referred to as CBP (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859).", "text_with_entity_marker": "Ser-133 phosphorylation enhances [E1]CREB[/E1] activity by promoting interaction with a 265-kDa CREB binding protein referred to as [E2]CBP[/E2] (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CREB", "entity_1_idx": [[33, 37]], "entity_1_idx_in_text_with_entity_marker": [37, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[123, 126]], "entity_2_idx_in_text_with_entity_marker": [136, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d532.s0_BioInfer.d532.s0.p2", "text": "Ser-133 phosphorylation enhances CREB activity by promoting interaction with a 265-kDa CREB binding protein referred to as CBP (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859).", "text_with_entity_marker": "Ser-133 phosphorylation enhances [E1]CREB[/E1] activity by promoting interaction with a 265-kDa [E2]CREB binding protein[/E2] referred to as CBP (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CREB", "entity_1_idx": [[33, 37]], "entity_1_idx_in_text_with_entity_marker": [37, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CREB binding protein", "entity_2_idx": [[87, 107]], "entity_2_idx_in_text_with_entity_marker": [100, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p10", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and [E1]histone[/E1] [E2]H4[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[330, 337]], "entity_1_idx_in_text_with_entity_marker": [334, 341], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[338, 340]], "entity_2_idx_in_text_with_entity_marker": [351, 353], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p27", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three [E1]histone[/E1] [E2]H3[/E2] variants and histone H4.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[306, 313]], "entity_1_idx_in_text_with_entity_marker": [310, 317], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[314, 316]], "entity_2_idx_in_text_with_entity_marker": [327, 329], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p51", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: [E1]histone[/E1] [E2]H1(0)[/E2], four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[158, 165]], "entity_1_idx_in_text_with_entity_marker": [162, 169], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H1(0)", "entity_2_idx": [[166, 171]], "entity_2_idx_in_text_with_entity_marker": [179, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p73", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, [E1]histone[/E1] [E2]H2A.2[/E2], oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[218, 225]], "entity_1_idx_in_text_with_entity_marker": [222, 229], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2A.2", "entity_2_idx": [[226, 231]], "entity_2_idx_in_text_with_entity_marker": [239, 244], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p82", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, [E1]histone[/E1] [E2]H2A.1[/E2], histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[203, 210]], "entity_1_idx_in_text_with_entity_marker": [207, 214], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2A.1", "entity_2_idx": [[211, 216]], "entity_2_idx_in_text_with_entity_marker": [224, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p98", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four [E1]histone[/E1] [E2]H1[/E2] subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[178, 185]], "entity_1_idx_in_text_with_entity_marker": [182, 189], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H1", "entity_2_idx": [[186, 188]], "entity_2_idx_in_text_with_entity_marker": [199, 201], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p116", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, [E1]histone[/E1] [E2]H2A.X[/E2], histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[257, 264]], "entity_1_idx_in_text_with_entity_marker": [261, 268], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2A.X", "entity_2_idx": [[265, 270]], "entity_2_idx_in_text_with_entity_marker": [278, 283], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p121", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, [E1]histone[/E1] [E2]H2B[/E2], three histone H3 variants and histone H4.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[287, 294]], "entity_1_idx_in_text_with_entity_marker": [291, 298], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2B", "entity_2_idx": [[295, 298]], "entity_2_idx_in_text_with_entity_marker": [308, 311], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p140", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, [E1]histone[/E1] [E2]H2A.Z[/E2], histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[272, 279]], "entity_1_idx_in_text_with_entity_marker": [276, 283], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2A.Z", "entity_2_idx": [[280, 285]], "entity_2_idx_in_text_with_entity_marker": [293, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p180", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized [E1]histone[/E1] [E2]H2A.2[/E2], histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[242, 249]], "entity_1_idx_in_text_with_entity_marker": [246, 253], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2A.2", "entity_2_idx": [[250, 255]], "entity_2_idx_in_text_with_entity_marker": [263, 268], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d764.s0_BioInfer.d764.s0.p4", "text": "To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.", "text_with_entity_marker": "To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two anti[E1]muscle actin[/E1] antibodies, [E2]HHF35[/E2] and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "muscle actin", "entity_1_idx": [[187, 199]], "entity_1_idx_in_text_with_entity_marker": [191, 203], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HHF35", "entity_2_idx": [[212, 217]], "entity_2_idx_in_text_with_entity_marker": [225, 230], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d764.s0_BioInfer.d764.s0.p14", "text": "To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two antimuscle actin antibodies, HHF35 and CGA7, and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.", "text_with_entity_marker": "To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two anti[E1]muscle actin[/E1] antibodies, HHF35 and [E2]CGA7[/E2], and two anti-SMC myosin heavy chain markers, anti-SM1 and anti-SM2 antibodies and related antibodies.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "muscle actin", "entity_1_idx": [[187, 199]], "entity_1_idx_in_text_with_entity_marker": [191, 203], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CGA7", "entity_2_idx": [[222, 226]], "entity_2_idx_in_text_with_entity_marker": [235, 239], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d342.s0_BioInfer.d342.s0.p1", "text": "Inhibition of the interactions of cofilin, destrin, and deoxyribonuclease I with actin by phosphoinositides.", "text_with_entity_marker": "Inhibition of the interactions of [E1]cofilin[/E1], destrin, and deoxyribonuclease I with [E2]actin[/E2] by phosphoinositides.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[34, 41]], "entity_1_idx_in_text_with_entity_marker": [38, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[81, 86]], "entity_2_idx_in_text_with_entity_marker": [94, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d342.s0_BioInfer.d342.s0.p3", "text": "Inhibition of the interactions of cofilin, destrin, and deoxyribonuclease I with actin by phosphoinositides.", "text_with_entity_marker": "Inhibition of the interactions of cofilin, destrin, and [E1]deoxyribonuclease I[/E1] with [E2]actin[/E2] by phosphoinositides.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "deoxyribonuclease I", "entity_1_idx": [[56, 75]], "entity_1_idx_in_text_with_entity_marker": [60, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[81, 86]], "entity_2_idx_in_text_with_entity_marker": [94, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d342.s0_BioInfer.d342.s0.p5", "text": "Inhibition of the interactions of cofilin, destrin, and deoxyribonuclease I with actin by phosphoinositides.", "text_with_entity_marker": "Inhibition of the interactions of cofilin, [E1]destrin[/E1], and deoxyribonuclease I with [E2]actin[/E2] by phosphoinositides.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "destrin", "entity_1_idx": [[43, 50]], "entity_1_idx_in_text_with_entity_marker": [47, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[81, 86]], "entity_2_idx_in_text_with_entity_marker": [94, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d64.s0_BioInfer.d64.s0.p0", "text": "An atomic model of actin filaments cross-linked by fimbrin and its implications for bundle assembly and function.", "text_with_entity_marker": "An atomic model of [E1]actin[/E1] filaments cross-linked by [E2]fimbrin[/E2] and its implications for bundle assembly and function.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[19, 24]], "entity_1_idx_in_text_with_entity_marker": [23, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[51, 58]], "entity_2_idx_in_text_with_entity_marker": [64, 71], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d597.s0_BioInfer.d597.s0.p0", "text": "The concentration of beta-catenin was constant during the follicular phase, whereas the content of alpha-catenin decreased in granulosa cells after treatment with diethylstilboestrol or hCG.", "text_with_entity_marker": "The concentration of [E1]beta-catenin[/E1] was constant during the follicular phase, whereas the content of [E2]alpha-catenin[/E2] decreased in granulosa cells after treatment with diethylstilboestrol or hCG.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[21, 33]], "entity_1_idx_in_text_with_entity_marker": [25, 37], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[99, 112]], "entity_2_idx_in_text_with_entity_marker": [112, 125], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d597.s1_BioInfer.d597.s1.p0", "text": "alpha- and beta-catenin were present in most ovarian cells at all stages of folliculogenesis.", "text_with_entity_marker": "[E1]alpha-[/E1] and [E2]beta-catenin[/E2] were present in most ovarian cells at all stages of folliculogenesis.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-", "entity_1_idx": [[0, 6], [16, 23]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[11, 23]], "entity_2_idx_in_text_with_entity_marker": [24, 36], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d293.s0_BioInfer.d293.s0.p0", "text": "Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for desmin and nonmuscle myosin heavy chain II-B.", "text_with_entity_marker": "Immunohistochemical studies showed a strong reactivity of most LAM cells for [E1]alpha-smooth muscle actin[/E1] and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for [E2]desmin[/E2] and nonmuscle myosin heavy chain II-B.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[77, 102]], "entity_1_idx_in_text_with_entity_marker": [81, 106], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[206, 212]], "entity_2_idx_in_text_with_entity_marker": [219, 225], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d293.s0_BioInfer.d293.s0.p1", "text": "Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for desmin and nonmuscle myosin heavy chain II-B.", "text_with_entity_marker": "Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for [E1]desmin[/E1] and [E2]nonmuscle myosin heavy chain II-B[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "desmin", "entity_1_idx": [[206, 212]], "entity_1_idx_in_text_with_entity_marker": [210, 216], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "nonmuscle myosin heavy chain II-B", "entity_2_idx": [[217, 250]], "entity_2_idx_in_text_with_entity_marker": [230, 263], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d293.s0_BioInfer.d293.s0.p2", "text": "Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for desmin and nonmuscle myosin heavy chain II-B.", "text_with_entity_marker": "Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and [E1]smooth muscle myosin heavy chain[/E1] and a weak to moderate reactivity of a lesser number of cells for [E2]desmin[/E2] and nonmuscle myosin heavy chain II-B.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "smooth muscle myosin heavy chain", "entity_1_idx": [[107, 139]], "entity_1_idx_in_text_with_entity_marker": [111, 143], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[206, 212]], "entity_2_idx_in_text_with_entity_marker": [219, 225], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d293.s0_BioInfer.d293.s0.p3", "text": "Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for desmin and nonmuscle myosin heavy chain II-B.", "text_with_entity_marker": "Immunohistochemical studies showed a strong reactivity of most LAM cells for [E1]alpha-smooth muscle actin[/E1] and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for desmin and [E2]nonmuscle myosin heavy chain II-B[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[77, 102]], "entity_1_idx_in_text_with_entity_marker": [81, 106], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "nonmuscle myosin heavy chain II-B", "entity_2_idx": [[217, 250]], "entity_2_idx_in_text_with_entity_marker": [230, 263], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d293.s0_BioInfer.d293.s0.p4", "text": "Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for desmin and nonmuscle myosin heavy chain II-B.", "text_with_entity_marker": "Immunohistochemical studies showed a strong reactivity of most LAM cells for [E1]alpha-smooth muscle actin[/E1] and [E2]smooth muscle myosin heavy chain[/E2] and a weak to moderate reactivity of a lesser number of cells for desmin and nonmuscle myosin heavy chain II-B.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[77, 102]], "entity_1_idx_in_text_with_entity_marker": [81, 106], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[107, 139]], "entity_2_idx_in_text_with_entity_marker": [120, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d293.s0_BioInfer.d293.s0.p5", "text": "Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for desmin and nonmuscle myosin heavy chain II-B.", "text_with_entity_marker": "Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and [E1]smooth muscle myosin heavy chain[/E1] and a weak to moderate reactivity of a lesser number of cells for desmin and [E2]nonmuscle myosin heavy chain II-B[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "smooth muscle myosin heavy chain", "entity_1_idx": [[107, 139]], "entity_1_idx_in_text_with_entity_marker": [111, 143], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "nonmuscle myosin heavy chain II-B", "entity_2_idx": [[217, 250]], "entity_2_idx_in_text_with_entity_marker": [230, 263], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d128.s0_BioInfer.d128.s0.p0", "text": "Cardiac hypertrophy and the steady state level of the \"fetal\" genes, ANP, alpha-skeletal actin (alpha-skA), and beta myosin heavy chain (beta-MHC) mRNAs were assessed.", "text_with_entity_marker": "Cardiac hypertrophy and the steady state level of the \"fetal\" genes, ANP, [E1]alpha-skeletal actin[/E1] (alpha-skA), and beta myosin heavy chain ([E2]beta-MHC[/E2]) mRNAs were assessed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-skeletal actin", "entity_1_idx": [[74, 94]], "entity_1_idx_in_text_with_entity_marker": [78, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-MHC", "entity_2_idx": [[137, 145]], "entity_2_idx_in_text_with_entity_marker": [150, 158], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d128.s0_BioInfer.d128.s0.p1", "text": "Cardiac hypertrophy and the steady state level of the \"fetal\" genes, ANP, alpha-skeletal actin (alpha-skA), and beta myosin heavy chain (beta-MHC) mRNAs were assessed.", "text_with_entity_marker": "Cardiac hypertrophy and the steady state level of the \"fetal\" genes, ANP, alpha-skeletal actin (alpha-skA), and [E1]beta myosin heavy chain[/E1] ([E2]beta-MHC[/E2]) mRNAs were assessed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta myosin heavy chain", "entity_1_idx": [[112, 135]], "entity_1_idx_in_text_with_entity_marker": [116, 139], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-MHC", "entity_2_idx": [[137, 145]], "entity_2_idx_in_text_with_entity_marker": [150, 158], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d128.s0_BioInfer.d128.s0.p2", "text": "Cardiac hypertrophy and the steady state level of the \"fetal\" genes, ANP, alpha-skeletal actin (alpha-skA), and beta myosin heavy chain (beta-MHC) mRNAs were assessed.", "text_with_entity_marker": "Cardiac hypertrophy and the steady state level of the \"fetal\" genes, [E1]ANP[/E1], alpha-skeletal actin (alpha-skA), and beta myosin heavy chain ([E2]beta-MHC[/E2]) mRNAs were assessed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ANP", "entity_1_idx": [[69, 72]], "entity_1_idx_in_text_with_entity_marker": [73, 76], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-MHC", "entity_2_idx": [[137, 145]], "entity_2_idx_in_text_with_entity_marker": [150, 158], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d128.s0_BioInfer.d128.s0.p3", "text": "Cardiac hypertrophy and the steady state level of the \"fetal\" genes, ANP, alpha-skeletal actin (alpha-skA), and beta myosin heavy chain (beta-MHC) mRNAs were assessed.", "text_with_entity_marker": "Cardiac hypertrophy and the steady state level of the \"fetal\" genes, ANP, alpha-skeletal actin ([E1]alpha-skA[/E1]), and beta myosin heavy chain ([E2]beta-MHC[/E2]) mRNAs were assessed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-skA", "entity_1_idx": [[96, 105]], "entity_1_idx_in_text_with_entity_marker": [100, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-MHC", "entity_2_idx": [[137, 145]], "entity_2_idx_in_text_with_entity_marker": [150, 158], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d128.s0_BioInfer.d128.s0.p4", "text": "Cardiac hypertrophy and the steady state level of the \"fetal\" genes, ANP, alpha-skeletal actin (alpha-skA), and beta myosin heavy chain (beta-MHC) mRNAs were assessed.", "text_with_entity_marker": "Cardiac hypertrophy and the steady state level of the \"fetal\" genes, ANP, [E1]alpha-skeletal actin[/E1] (alpha-skA), and [E2]beta myosin heavy chain[/E2] (beta-MHC) mRNAs were assessed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-skeletal actin", "entity_1_idx": [[74, 94]], "entity_1_idx_in_text_with_entity_marker": [78, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta myosin heavy chain", "entity_2_idx": [[112, 135]], "entity_2_idx_in_text_with_entity_marker": [125, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d128.s0_BioInfer.d128.s0.p5", "text": "Cardiac hypertrophy and the steady state level of the \"fetal\" genes, ANP, alpha-skeletal actin (alpha-skA), and beta myosin heavy chain (beta-MHC) mRNAs were assessed.", "text_with_entity_marker": "Cardiac hypertrophy and the steady state level of the \"fetal\" genes, [E1]ANP[/E1], [E2]alpha-skeletal actin[/E2] (alpha-skA), and beta myosin heavy chain (beta-MHC) mRNAs were assessed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ANP", "entity_1_idx": [[69, 72]], "entity_1_idx_in_text_with_entity_marker": [73, 76], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-skeletal actin", "entity_2_idx": [[74, 94]], "entity_2_idx_in_text_with_entity_marker": [87, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d128.s0_BioInfer.d128.s0.p6", "text": "Cardiac hypertrophy and the steady state level of the \"fetal\" genes, ANP, alpha-skeletal actin (alpha-skA), and beta myosin heavy chain (beta-MHC) mRNAs were assessed.", "text_with_entity_marker": "Cardiac hypertrophy and the steady state level of the \"fetal\" genes, ANP, [E1]alpha-skeletal actin[/E1] ([E2]alpha-skA[/E2]), and beta myosin heavy chain (beta-MHC) mRNAs were assessed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-skeletal actin", "entity_1_idx": [[74, 94]], "entity_1_idx_in_text_with_entity_marker": [78, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-skA", "entity_2_idx": [[96, 105]], "entity_2_idx_in_text_with_entity_marker": [109, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d128.s0_BioInfer.d128.s0.p7", "text": "Cardiac hypertrophy and the steady state level of the \"fetal\" genes, ANP, alpha-skeletal actin (alpha-skA), and beta myosin heavy chain (beta-MHC) mRNAs were assessed.", "text_with_entity_marker": "Cardiac hypertrophy and the steady state level of the \"fetal\" genes, [E1]ANP[/E1], alpha-skeletal actin (alpha-skA), and [E2]beta myosin heavy chain[/E2] (beta-MHC) mRNAs were assessed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ANP", "entity_1_idx": [[69, 72]], "entity_1_idx_in_text_with_entity_marker": [73, 76], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta myosin heavy chain", "entity_2_idx": [[112, 135]], "entity_2_idx_in_text_with_entity_marker": [125, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d128.s0_BioInfer.d128.s0.p8", "text": "Cardiac hypertrophy and the steady state level of the \"fetal\" genes, ANP, alpha-skeletal actin (alpha-skA), and beta myosin heavy chain (beta-MHC) mRNAs were assessed.", "text_with_entity_marker": "Cardiac hypertrophy and the steady state level of the \"fetal\" genes, ANP, alpha-skeletal actin ([E1]alpha-skA[/E1]), and [E2]beta myosin heavy chain[/E2] (beta-MHC) mRNAs were assessed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-skA", "entity_1_idx": [[96, 105]], "entity_1_idx_in_text_with_entity_marker": [100, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta myosin heavy chain", "entity_2_idx": [[112, 135]], "entity_2_idx_in_text_with_entity_marker": [125, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d128.s0_BioInfer.d128.s0.p9", "text": "Cardiac hypertrophy and the steady state level of the \"fetal\" genes, ANP, alpha-skeletal actin (alpha-skA), and beta myosin heavy chain (beta-MHC) mRNAs were assessed.", "text_with_entity_marker": "Cardiac hypertrophy and the steady state level of the \"fetal\" genes, [E1]ANP[/E1], alpha-skeletal actin ([E2]alpha-skA[/E2]), and beta myosin heavy chain (beta-MHC) mRNAs were assessed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ANP", "entity_1_idx": [[69, 72]], "entity_1_idx_in_text_with_entity_marker": [73, 76], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-skA", "entity_2_idx": [[96, 105]], "entity_2_idx_in_text_with_entity_marker": [109, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s2_BioInfer.d73.s2.p8", "text": "Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, RAD55 or RAD57.", "text_with_entity_marker": "Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, [E1]RAD54[/E1], RAD55 or [E2]RAD57[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD54", "entity_1_idx": [[180, 185]], "entity_1_idx_in_text_with_entity_marker": [184, 189], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD57", "entity_2_idx": [[196, 201]], "entity_2_idx_in_text_with_entity_marker": [209, 214], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d73.s2_BioInfer.d73.s2.p9", "text": "Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes RAD51, RAD52, RAD54, RAD55 or RAD57.", "text_with_entity_marker": "Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes [E1]RAD51[/E1], RAD52, [E2]RAD54[/E2], RAD55 or RAD57.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[166, 171]], "entity_1_idx_in_text_with_entity_marker": [170, 175], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD54", "entity_2_idx": [[180, 185]], "entity_2_idx_in_text_with_entity_marker": [193, 198], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d188.s0_BioInfer.d188.s0.p0", "text": "Electrical stimulation of cardiocyte contraction did not enhance alpha-cardiac actin or myosin heavy chain (alpha+beta) mRNA transcript levels relative to 28S rRNA during the period of rapid growth that occurred over the first 48 hours.", "text_with_entity_marker": "Electrical stimulation of cardiocyte contraction did not enhance alpha-cardiac actin or [E1-E2]myosin heavy chain[/E1-E2] (alpha+beta) mRNA transcript levels relative to 28S rRNA during the period of rapid growth that occurred over the first 48 hours.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[88, 106], [108, 113]], "entity_1_idx_in_text_with_entity_marker": [95, 113], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[88, 106], [114, 118]], "entity_2_idx_in_text_with_entity_marker": [95, 113], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d188.s0_BioInfer.d188.s0.p1", "text": "Electrical stimulation of cardiocyte contraction did not enhance alpha-cardiac actin or myosin heavy chain (alpha+beta) mRNA transcript levels relative to 28S rRNA during the period of rapid growth that occurred over the first 48 hours.", "text_with_entity_marker": "Electrical stimulation of cardiocyte contraction did not enhance [E1]alpha-cardiac actin[/E1] or [E2]myosin heavy chain[/E2] (alpha+beta) mRNA transcript levels relative to 28S rRNA during the period of rapid growth that occurred over the first 48 hours.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-cardiac actin", "entity_1_idx": [[65, 84]], "entity_1_idx_in_text_with_entity_marker": [69, 88], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[88, 106], [114, 118]], "entity_2_idx_in_text_with_entity_marker": [101, 119], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d188.s0_BioInfer.d188.s0.p2", "text": "Electrical stimulation of cardiocyte contraction did not enhance alpha-cardiac actin or myosin heavy chain (alpha+beta) mRNA transcript levels relative to 28S rRNA during the period of rapid growth that occurred over the first 48 hours.", "text_with_entity_marker": "Electrical stimulation of cardiocyte contraction did not enhance alpha-cardiac actin or [E1]myosin heavy chain[/E1] (alpha+beta) mRNA transcript levels relative to [E2]28S rRNA[/E2] during the period of rapid growth that occurred over the first 48 hours.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[88, 106], [114, 118]], "entity_1_idx_in_text_with_entity_marker": [92, 110], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "28S rRNA", "entity_2_idx": [[155, 163]], "entity_2_idx_in_text_with_entity_marker": [168, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d188.s0_BioInfer.d188.s0.p3", "text": "Electrical stimulation of cardiocyte contraction did not enhance alpha-cardiac actin or myosin heavy chain (alpha+beta) mRNA transcript levels relative to 28S rRNA during the period of rapid growth that occurred over the first 48 hours.", "text_with_entity_marker": "Electrical stimulation of cardiocyte contraction did not enhance [E1]alpha-cardiac actin[/E1] or [E2]myosin heavy chain[/E2] (alpha+beta) mRNA transcript levels relative to 28S rRNA during the period of rapid growth that occurred over the first 48 hours.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-cardiac actin", "entity_1_idx": [[65, 84]], "entity_1_idx_in_text_with_entity_marker": [69, 88], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[88, 106], [108, 113]], "entity_2_idx_in_text_with_entity_marker": [101, 119], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d188.s0_BioInfer.d188.s0.p4", "text": "Electrical stimulation of cardiocyte contraction did not enhance alpha-cardiac actin or myosin heavy chain (alpha+beta) mRNA transcript levels relative to 28S rRNA during the period of rapid growth that occurred over the first 48 hours.", "text_with_entity_marker": "Electrical stimulation of cardiocyte contraction did not enhance alpha-cardiac actin or [E1]myosin heavy chain[/E1] (alpha+beta) mRNA transcript levels relative to [E2]28S rRNA[/E2] during the period of rapid growth that occurred over the first 48 hours.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[88, 106], [108, 113]], "entity_1_idx_in_text_with_entity_marker": [92, 110], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "28S rRNA", "entity_2_idx": [[155, 163]], "entity_2_idx_in_text_with_entity_marker": [168, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d188.s0_BioInfer.d188.s0.p5", "text": "Electrical stimulation of cardiocyte contraction did not enhance alpha-cardiac actin or myosin heavy chain (alpha+beta) mRNA transcript levels relative to 28S rRNA during the period of rapid growth that occurred over the first 48 hours.", "text_with_entity_marker": "Electrical stimulation of cardiocyte contraction did not enhance [E1]alpha-cardiac actin[/E1] or myosin heavy chain (alpha+beta) mRNA transcript levels relative to [E2]28S rRNA[/E2] during the period of rapid growth that occurred over the first 48 hours.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-cardiac actin", "entity_1_idx": [[65, 84]], "entity_1_idx_in_text_with_entity_marker": [69, 88], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "28S rRNA", "entity_2_idx": [[155, 163]], "entity_2_idx_in_text_with_entity_marker": [168, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d752.s0_BioInfer.d752.s0.p0", "text": "Thus, beta-catenin, E-cadherin, and alpha-catenin have similar prognostic values.", "text_with_entity_marker": "Thus, [E1]beta-catenin[/E1], E-cadherin, and [E2]alpha-catenin[/E2] have similar prognostic values.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[6, 18]], "entity_1_idx_in_text_with_entity_marker": [10, 22], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[36, 49]], "entity_2_idx_in_text_with_entity_marker": [49, 62], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d752.s0_BioInfer.d752.s0.p1", "text": "Thus, beta-catenin, E-cadherin, and alpha-catenin have similar prognostic values.", "text_with_entity_marker": "Thus, beta-catenin, [E1]E-cadherin[/E1], and [E2]alpha-catenin[/E2] have similar prognostic values.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[20, 30]], "entity_1_idx_in_text_with_entity_marker": [24, 34], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[36, 49]], "entity_2_idx_in_text_with_entity_marker": [49, 62], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d752.s0_BioInfer.d752.s0.p2", "text": "Thus, beta-catenin, E-cadherin, and alpha-catenin have similar prognostic values.", "text_with_entity_marker": "Thus, [E1]beta-catenin[/E1], [E2]E-cadherin[/E2], and alpha-catenin have similar prognostic values.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[6, 18]], "entity_1_idx_in_text_with_entity_marker": [10, 22], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[20, 30]], "entity_2_idx_in_text_with_entity_marker": [33, 43], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p0", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large ([E1]L[/E1]; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion ([E2]F0[/E2]; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "L", "entity_1_idx": [[170, 171]], "entity_1_idx_in_text_with_entity_marker": [174, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[260, 262]], "entity_2_idx_in_text_with_entity_marker": [273, 275], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p1", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large ([E1]L[/E1]; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), [E2]fusion[/E2] (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "L", "entity_1_idx": [[170, 171]], "entity_1_idx_in_text_with_entity_marker": [174, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion", "entity_2_idx": [[252, 258], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [265, 271], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p2", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large ([E1]L[/E1]; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and [E2]non-structural[/E2] (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "L", "entity_1_idx": [[170, 171]], "entity_1_idx_in_text_with_entity_marker": [174, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "non-structural", "entity_2_idx": [[324, 338], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [337, 351], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p3", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large ([E1]L[/E1]; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), [E2]matrix[/E2] (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "L", "entity_1_idx": [[170, 171]], "entity_1_idx_in_text_with_entity_marker": [174, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[301, 307], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [314, 320], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p4", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large ([E1]L[/E1]; 190 kDa), haemagglutinin neuraminidase ([E2]HN[/E2]; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "L", "entity_1_idx": [[170, 171]], "entity_1_idx_in_text_with_entity_marker": [174, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[213, 215]], "entity_2_idx_in_text_with_entity_marker": [226, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p5", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the [E1]large[/E1] ([E2]L[/E2]; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "large", "entity_1_idx": [[163, 168], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[170, 171]], "entity_2_idx_in_text_with_entity_marker": [183, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p6", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large ([E1]L[/E1]; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), [E2]nucleocapsid[/E2] (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "L", "entity_1_idx": [[170, 171]], "entity_1_idx_in_text_with_entity_marker": [174, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid", "entity_2_idx": [[226, 238], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [239, 251], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p7", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large ([E1]L[/E1]; 190 kDa), [E2]haemagglutinin neuraminidase[/E2] (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "L", "entity_1_idx": [[170, 171]], "entity_1_idx_in_text_with_entity_marker": [174, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "haemagglutinin neuraminidase", "entity_2_idx": [[183, 211], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [196, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p8", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large ([E1]L[/E1]; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), [E2]phosphoprotein[/E2] (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "L", "entity_1_idx": [[170, 171]], "entity_1_idx_in_text_with_entity_marker": [174, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[273, 287], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [286, 300], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p9", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large ([E1]L[/E1]; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein ([E2]P[/E2]; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "L", "entity_1_idx": [[170, 171]], "entity_1_idx_in_text_with_entity_marker": [174, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[289, 290]], "entity_2_idx_in_text_with_entity_marker": [302, 303], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d6.s2_BioInfer.d6.s2.p0", "text": "We speculate that nonfilamentous actin and profilin, both of which form shear-sensitive structures, can be modeled as flocculant materials.", "text_with_entity_marker": "We speculate that nonfilamentous [E1]actin[/E1] and [E2]profilin[/E2], both of which form shear-sensitive structures, can be modeled as flocculant materials.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[33, 38]], "entity_1_idx_in_text_with_entity_marker": [37, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[43, 51]], "entity_2_idx_in_text_with_entity_marker": [56, 64], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s1_BioInfer.d33.s1.p0", "text": "Loss of normal surface E-cadherin, alpha-catenin, beta-catenin and gamma-catenin expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).", "text_with_entity_marker": "Loss of normal surface [E1]E-cadherin[/E1], alpha-catenin, [E2]beta-catenin[/E2] and gamma-catenin expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[23, 33]], "entity_1_idx_in_text_with_entity_marker": [27, 37], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[50, 62]], "entity_2_idx_in_text_with_entity_marker": [63, 75], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s1_BioInfer.d33.s1.p1", "text": "Loss of normal surface E-cadherin, alpha-catenin, beta-catenin and gamma-catenin expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).", "text_with_entity_marker": "Loss of normal surface E-cadherin, alpha-catenin, [E1]beta-catenin[/E1] and [E2]gamma-catenin[/E2] expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[50, 62]], "entity_1_idx_in_text_with_entity_marker": [54, 66], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[67, 80]], "entity_2_idx_in_text_with_entity_marker": [80, 93], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s1_BioInfer.d33.s1.p2", "text": "Loss of normal surface E-cadherin, alpha-catenin, beta-catenin and gamma-catenin expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).", "text_with_entity_marker": "Loss of normal surface E-cadherin, [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2] and gamma-catenin expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[35, 48]], "entity_1_idx_in_text_with_entity_marker": [39, 52], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[50, 62]], "entity_2_idx_in_text_with_entity_marker": [63, 75], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s1_BioInfer.d33.s1.p3", "text": "Loss of normal surface E-cadherin, alpha-catenin, beta-catenin and gamma-catenin expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).", "text_with_entity_marker": "Loss of normal surface [E1]E-cadherin[/E1], alpha-catenin, beta-catenin and [E2]gamma-catenin[/E2] expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[23, 33]], "entity_1_idx_in_text_with_entity_marker": [27, 37], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[67, 80]], "entity_2_idx_in_text_with_entity_marker": [80, 93], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s1_BioInfer.d33.s1.p4", "text": "Loss of normal surface E-cadherin, alpha-catenin, beta-catenin and gamma-catenin expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).", "text_with_entity_marker": "Loss of normal surface [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2], beta-catenin and gamma-catenin expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[23, 33]], "entity_1_idx_in_text_with_entity_marker": [27, 37], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[35, 48]], "entity_2_idx_in_text_with_entity_marker": [48, 61], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s1_BioInfer.d33.s1.p5", "text": "Loss of normal surface E-cadherin, alpha-catenin, beta-catenin and gamma-catenin expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).", "text_with_entity_marker": "Loss of normal surface E-cadherin, [E1]alpha-catenin[/E1], beta-catenin and [E2]gamma-catenin[/E2] expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[35, 48]], "entity_1_idx_in_text_with_entity_marker": [39, 52], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[67, 80]], "entity_2_idx_in_text_with_entity_marker": [80, 93], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s2_BioInfer.d33.s2.p0", "text": "MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.", "text_with_entity_marker": "MATERIALS AND METHODS: We used an [E1]avidin[/E1]-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, [E2]beta-catenin[/E2], gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "avidin", "entity_1_idx": [[34, 40]], "entity_1_idx_in_text_with_entity_marker": [38, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[130, 142]], "entity_2_idx_in_text_with_entity_marker": [143, 155], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s2_BioInfer.d33.s2.p1", "text": "MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.", "text_with_entity_marker": "MATERIALS AND METHODS: We used an [E1]avidin[/E1]-biotin immunoperoxidase technique to examine the cellular localization of [E2]alpha-catenin[/E2], beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "avidin", "entity_1_idx": [[34, 40]], "entity_1_idx_in_text_with_entity_marker": [38, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[115, 128]], "entity_2_idx_in_text_with_entity_marker": [128, 141], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s2_BioInfer.d33.s2.p2", "text": "MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.", "text_with_entity_marker": "MATERIALS AND METHODS: We used an [E1]avidin[/E1]-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and [E2]E-cadherin[/E2] in 68 TCC and 14 normal bladder biopsies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "avidin", "entity_1_idx": [[34, 40]], "entity_1_idx_in_text_with_entity_marker": [38, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[162, 172]], "entity_2_idx_in_text_with_entity_marker": [175, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d33.s2_BioInfer.d33.s2.p3", "text": "MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.", "text_with_entity_marker": "MATERIALS AND METHODS: We used an [E1]avidin[/E1]-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, [E2]gamma-catenin[/E2] and E-cadherin in 68 TCC and 14 normal bladder biopsies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "avidin", "entity_1_idx": [[34, 40]], "entity_1_idx_in_text_with_entity_marker": [38, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[144, 157]], "entity_2_idx_in_text_with_entity_marker": [157, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p30", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of [E1]myosin heavy chain[/E1] (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, [E2]connexin 43[/E2] (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[76, 94]], "entity_1_idx_in_text_with_entity_marker": [80, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "connexin 43", "entity_2_idx": [[155, 166]], "entity_2_idx_in_text_with_entity_marker": [168, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p31", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), [E1]troponin I[/E1] (TnI) isoforms, [E2]connexin 43[/E2] (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "troponin I", "entity_1_idx": [[128, 138]], "entity_1_idx_in_text_with_entity_marker": [132, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "connexin 43", "entity_2_idx": [[155, 166]], "entity_2_idx_in_text_with_entity_marker": [168, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p32", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), [E1]myosin light chain[/E1] (MLC), troponin I (TnI) isoforms, [E2]connexin 43[/E2] (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain", "entity_1_idx": [[102, 120]], "entity_1_idx_in_text_with_entity_marker": [106, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "connexin 43", "entity_2_idx": [[155, 166]], "entity_2_idx_in_text_with_entity_marker": [168, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p33", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, [E1]connexin 43[/E1] (Cx43), [E2]desmin[/E2] and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "connexin 43", "entity_1_idx": [[155, 166]], "entity_1_idx_in_text_with_entity_marker": [159, 170], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "desmin", "entity_2_idx": [[175, 181]], "entity_2_idx_in_text_with_entity_marker": [188, 194], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p34", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain ([E1]MHC[/E1]), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and [E2]alpha-smooth muscle actin[/E2] (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MHC", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[186, 211]], "entity_2_idx_in_text_with_entity_marker": [199, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p35", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain ([E1]MHC[/E1]), myosin light chain (MLC), troponin I ([E2]TnI[/E2]) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MHC", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TnI", "entity_2_idx": [[140, 143]], "entity_2_idx_in_text_with_entity_marker": [153, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p36", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of [E1]myosin heavy chain[/E1] ([E2]MHC[/E2]), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[76, 94]], "entity_1_idx_in_text_with_entity_marker": [80, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p37", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain ([E1]MHC[/E1]), myosin light chain (MLC), [E2]troponin I[/E2] (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MHC", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "troponin I", "entity_2_idx": [[128, 138]], "entity_2_idx_in_text_with_entity_marker": [141, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p38", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain ([E1]MHC[/E1]), [E2]myosin light chain[/E2] (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MHC", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin light chain", "entity_2_idx": [[102, 120]], "entity_2_idx_in_text_with_entity_marker": [115, 133], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p39", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain ([E1]MHC[/E1]), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), [E2]desmin[/E2] and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MHC", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "desmin", "entity_2_idx": [[175, 181]], "entity_2_idx_in_text_with_entity_marker": [188, 194], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p10", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, [E1]UL5[/E1], UL8, UL9, UL42, UL52, SSB, and [E2]Pol[/E2], that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[213, 216]], "entity_1_idx_in_text_with_entity_marker": [217, 220], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Pol", "entity_2_idx": [[249, 252]], "entity_2_idx_in_text_with_entity_marker": [262, 265], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p11", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, [E1]UL42[/E1], [E2]UL52[/E2], SSB, and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL42", "entity_1_idx": [[228, 232]], "entity_1_idx_in_text_with_entity_marker": [232, 236], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[234, 238]], "entity_2_idx_in_text_with_entity_marker": [247, 251], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p12", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, [E1]UL8[/E1], UL9, [E2]UL42[/E2], UL52, SSB, and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL8", "entity_1_idx": [[218, 221]], "entity_1_idx_in_text_with_entity_marker": [222, 225], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[228, 232]], "entity_2_idx_in_text_with_entity_marker": [241, 245], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p13", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, [E1]UL9[/E1], [E2]UL42[/E2], UL52, SSB, and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL9", "entity_1_idx": [[223, 226]], "entity_1_idx_in_text_with_entity_marker": [227, 230], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[228, 232]], "entity_2_idx_in_text_with_entity_marker": [241, 245], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p14", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, [E1]UL5[/E1], UL8, UL9, [E2]UL42[/E2], UL52, SSB, and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[213, 216]], "entity_1_idx_in_text_with_entity_marker": [217, 220], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[228, 232]], "entity_2_idx_in_text_with_entity_marker": [241, 245], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p15", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, [E1]UL8[/E1], UL9, UL42, [E2]UL52[/E2], SSB, and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL8", "entity_1_idx": [[218, 221]], "entity_1_idx_in_text_with_entity_marker": [222, 225], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[234, 238]], "entity_2_idx_in_text_with_entity_marker": [247, 251], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p16", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, [E1]UL9[/E1], UL42, [E2]UL52[/E2], SSB, and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL9", "entity_1_idx": [[223, 226]], "entity_1_idx_in_text_with_entity_marker": [227, 230], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[234, 238]], "entity_2_idx_in_text_with_entity_marker": [247, 251], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p17", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, [E1]UL5[/E1], UL8, UL9, UL42, [E2]UL52[/E2], SSB, and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[213, 216]], "entity_1_idx_in_text_with_entity_marker": [217, 220], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[234, 238]], "entity_2_idx_in_text_with_entity_marker": [247, 251], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p18", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, [E1]UL8[/E1], [E2]UL9[/E2], UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL8", "entity_1_idx": [[218, 221]], "entity_1_idx_in_text_with_entity_marker": [222, 225], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL9", "entity_2_idx": [[223, 226]], "entity_2_idx_in_text_with_entity_marker": [236, 239], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p19", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, [E1]UL5[/E1], [E2]UL8[/E2], UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[213, 216]], "entity_1_idx_in_text_with_entity_marker": [217, 220], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL8", "entity_2_idx": [[218, 221]], "entity_2_idx_in_text_with_entity_marker": [231, 234], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p20", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, [E1]UL5[/E1], UL8, [E2]UL9[/E2], UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[213, 216]], "entity_1_idx_in_text_with_entity_marker": [217, 220], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL9", "entity_2_idx": [[223, 226]], "entity_2_idx_in_text_with_entity_marker": [236, 239], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p30", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions [E1]RAD9[/E1], RAD17, RAD24, and [E2]MEC3[/E2], indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD9", "entity_1_idx": [[150, 154]], "entity_1_idx_in_text_with_entity_marker": [154, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p31", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions [E1]RAD9[/E1], [E2]RAD17[/E2], RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD9", "entity_1_idx": [[150, 154]], "entity_1_idx_in_text_with_entity_marker": [154, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p32", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the [E1]srs2Delta[/E1] rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions [E2]RAD9[/E2], RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "srs2Delta", "entity_1_idx": [[17, 26]], "entity_1_idx_in_text_with_entity_marker": [21, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD9", "entity_2_idx": [[150, 154]], "entity_2_idx_in_text_with_entity_marker": [163, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p33", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta [E1]rad54Delta[/E1] and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions [E2]RAD9[/E2], RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "rad54Delta", "entity_1_idx": [[27, 37]], "entity_1_idx_in_text_with_entity_marker": [31, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD9", "entity_2_idx": [[150, 154]], "entity_2_idx_in_text_with_entity_marker": [163, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p34", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and [E1]srs2Delta[/E1] rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions [E2]RAD9[/E2], RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "srs2Delta", "entity_1_idx": [[42, 51]], "entity_1_idx_in_text_with_entity_marker": [46, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD9", "entity_2_idx": [[150, 154]], "entity_2_idx_in_text_with_entity_marker": [163, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p35", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta [E1]rdh54Delta[/E1] double mutants can also be rescued by mutations in the DNA damage checkpoint functions [E2]RAD9[/E2], RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "rdh54Delta", "entity_1_idx": [[52, 62]], "entity_1_idx_in_text_with_entity_marker": [56, 66], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD9", "entity_2_idx": [[150, 154]], "entity_2_idx_in_text_with_entity_marker": [163, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p36", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions [E1]RAD9[/E1], RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and [E2]srs2[/E2] rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD9", "entity_1_idx": [[150, 154]], "entity_1_idx_in_text_with_entity_marker": [154, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[215, 219]], "entity_2_idx_in_text_with_entity_marker": [228, 232], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p37", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions [E1]RAD9[/E1], RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 [E2]rdh54[/E2] mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD9", "entity_1_idx": [[150, 154]], "entity_1_idx_in_text_with_entity_marker": [154, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54", "entity_2_idx": [[220, 225]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p38", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, [E1]RAD17[/E1], RAD24, and [E2]MEC3[/E2], indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD17", "entity_1_idx": [[156, 161]], "entity_1_idx_in_text_with_entity_marker": [160, 165], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p39", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the [E1]srs2Delta[/E1] rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and [E2]MEC3[/E2], indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "srs2Delta", "entity_1_idx": [[17, 26]], "entity_1_idx_in_text_with_entity_marker": [21, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d321.s0_BioInfer.d321.s0.p0", "text": "In cancerous tissues, the frequency of reduced expression of beta-catenin (28 of 86, 33%) was similar to that of E-cadherin (19 of 86, 22%), but less than that of alpha-catenin (47 of 86, 55%).", "text_with_entity_marker": "In cancerous tissues, the frequency of reduced expression of beta-catenin (28 of 86, 33%) was similar to that of [E1]E-cadherin[/E1] (19 of 86, 22%), but less than that of [E2]alpha-catenin[/E2] (47 of 86, 55%).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[113, 123]], "entity_1_idx_in_text_with_entity_marker": [117, 127], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[163, 176]], "entity_2_idx_in_text_with_entity_marker": [176, 189], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d321.s0_BioInfer.d321.s0.p1", "text": "In cancerous tissues, the frequency of reduced expression of beta-catenin (28 of 86, 33%) was similar to that of E-cadherin (19 of 86, 22%), but less than that of alpha-catenin (47 of 86, 55%).", "text_with_entity_marker": "In cancerous tissues, the frequency of reduced expression of [E1]beta-catenin[/E1] (28 of 86, 33%) was similar to that of [E2]E-cadherin[/E2] (19 of 86, 22%), but less than that of alpha-catenin (47 of 86, 55%).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[61, 73]], "entity_1_idx_in_text_with_entity_marker": [65, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[113, 123]], "entity_2_idx_in_text_with_entity_marker": [126, 136], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d321.s0_BioInfer.d321.s0.p2", "text": "In cancerous tissues, the frequency of reduced expression of beta-catenin (28 of 86, 33%) was similar to that of E-cadherin (19 of 86, 22%), but less than that of alpha-catenin (47 of 86, 55%).", "text_with_entity_marker": "In cancerous tissues, the frequency of reduced expression of [E1]beta-catenin[/E1] (28 of 86, 33%) was similar to that of E-cadherin (19 of 86, 22%), but less than that of [E2]alpha-catenin[/E2] (47 of 86, 55%).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[61, 73]], "entity_1_idx_in_text_with_entity_marker": [65, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[163, 176]], "entity_2_idx_in_text_with_entity_marker": [176, 189], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d321.s1_BioInfer.d321.s1.p0", "text": "In this study, we immunohistochemically investigated the expression of beta-catenin as well as E-cadherin and alpha-catenin in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors.", "text_with_entity_marker": "In this study, we immunohistochemically investigated the expression of [E1]beta-catenin[/E1] as well as E-cadherin and [E2]alpha-catenin[/E2] in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[71, 83]], "entity_1_idx_in_text_with_entity_marker": [75, 87], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[110, 123]], "entity_2_idx_in_text_with_entity_marker": [123, 136], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d321.s1_BioInfer.d321.s1.p1", "text": "In this study, we immunohistochemically investigated the expression of beta-catenin as well as E-cadherin and alpha-catenin in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors.", "text_with_entity_marker": "In this study, we immunohistochemically investigated the expression of [E1]beta-catenin[/E1] as well as [E2]E-cadherin[/E2] and alpha-catenin in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[71, 83]], "entity_1_idx_in_text_with_entity_marker": [75, 87], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[95, 105]], "entity_2_idx_in_text_with_entity_marker": [108, 118], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d321.s1_BioInfer.d321.s1.p2", "text": "In this study, we immunohistochemically investigated the expression of beta-catenin as well as E-cadherin and alpha-catenin in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors.", "text_with_entity_marker": "In this study, we immunohistochemically investigated the expression of beta-catenin as well as [E1]E-cadherin[/E1] and [E2]alpha-catenin[/E2] in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[95, 105]], "entity_1_idx_in_text_with_entity_marker": [99, 109], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[110, 123]], "entity_2_idx_in_text_with_entity_marker": [123, 136], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d60.s1_BioInfer.d60.s1.p0", "text": "In this study, cell cycle-dependent expression of human and rodent RAD51 and RAD52 proteins was monitored using two approaches.", "text_with_entity_marker": "In this study, cell cycle-dependent expression of human and rodent [E1]RAD51[/E1] and [E2]RAD52[/E2] proteins was monitored using two approaches.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[67, 72]], "entity_1_idx_in_text_with_entity_marker": [71, 76], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[77, 82]], "entity_2_idx_in_text_with_entity_marker": [90, 95], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d667.s0_BioInfer.d667.s0.p0", "text": "The primary purpose of this study was to determine the relationship between myosin heavy chain (MHC) and actin contents and maximum isometric tetanic force (Po) in mouse extensor digitorum longus (EDL) muscles following eccentric contraction-induced injury.", "text_with_entity_marker": "The primary purpose of this study was to determine the relationship between myosin heavy chain ([E1]MHC[/E1]) and [E2]actin[/E2] contents and maximum isometric tetanic force (Po) in mouse extensor digitorum longus (EDL) muscles following eccentric contraction-induced injury.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MHC", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d667.s0_BioInfer.d667.s0.p1", "text": "The primary purpose of this study was to determine the relationship between myosin heavy chain (MHC) and actin contents and maximum isometric tetanic force (Po) in mouse extensor digitorum longus (EDL) muscles following eccentric contraction-induced injury.", "text_with_entity_marker": "The primary purpose of this study was to determine the relationship between [E1]myosin heavy chain[/E1] (MHC) and [E2]actin[/E2] contents and maximum isometric tetanic force (Po) in mouse extensor digitorum longus (EDL) muscles following eccentric contraction-induced injury.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[76, 94]], "entity_1_idx_in_text_with_entity_marker": [80, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d667.s0_BioInfer.d667.s0.p2", "text": "The primary purpose of this study was to determine the relationship between myosin heavy chain (MHC) and actin contents and maximum isometric tetanic force (Po) in mouse extensor digitorum longus (EDL) muscles following eccentric contraction-induced injury.", "text_with_entity_marker": "The primary purpose of this study was to determine the relationship between [E1]myosin heavy chain[/E1] ([E2]MHC[/E2]) and actin contents and maximum isometric tetanic force (Po) in mouse extensor digitorum longus (EDL) muscles following eccentric contraction-induced injury.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[76, 94]], "entity_1_idx_in_text_with_entity_marker": [80, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p5", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, [E1]TRAIL[/E1], FADD, TRADD, RIP, FAF, FAP, and [E2]caspase-8[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRAIL", "entity_1_idx": [[160, 165]], "entity_1_idx_in_text_with_entity_marker": [164, 169], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "caspase-8", "entity_2_idx": [[199, 208]], "entity_2_idx_in_text_with_entity_marker": [212, 221], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p6", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, [E1]TRAIL[/E1], [E2]FADD[/E2], TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRAIL", "entity_1_idx": [[160, 165]], "entity_1_idx_in_text_with_entity_marker": [164, 169], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FADD", "entity_2_idx": [[167, 171]], "entity_2_idx_in_text_with_entity_marker": [180, 184], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p7", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, [E1]Fas ligand[/E1], TNFR-1, [E2]TRAIL[/E2], FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas ligand", "entity_1_idx": [[140, 150]], "entity_1_idx_in_text_with_entity_marker": [144, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAIL", "entity_2_idx": [[160, 165]], "entity_2_idx_in_text_with_entity_marker": [173, 178], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p8", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, [E1]TNFR-1[/E1], [E2]TRAIL[/E2], FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNFR-1", "entity_1_idx": [[152, 158]], "entity_1_idx_in_text_with_entity_marker": [156, 162], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAIL", "entity_2_idx": [[160, 165]], "entity_2_idx_in_text_with_entity_marker": [173, 178], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p9", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for [E1]Fas[/E1], Fas ligand, TNFR-1, [E2]TRAIL[/E2], FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAIL", "entity_2_idx": [[160, 165]], "entity_2_idx_in_text_with_entity_marker": [173, 178], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p10", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, [E1]ribonuclease[/E1] protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, [E2]FAF[/E2], FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ribonuclease", "entity_1_idx": [[57, 69]], "entity_1_idx_in_text_with_entity_marker": [61, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[185, 188]], "entity_2_idx_in_text_with_entity_marker": [198, 201], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p11", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, [E1]ribonuclease[/E1] protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, [E2]FAP[/E2], and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ribonuclease", "entity_1_idx": [[57, 69]], "entity_1_idx_in_text_with_entity_marker": [61, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[190, 193]], "entity_2_idx_in_text_with_entity_marker": [203, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p12", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, [E1]ribonuclease[/E1] protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, [E2]TRADD[/E2], RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ribonuclease", "entity_1_idx": [[57, 69]], "entity_1_idx_in_text_with_entity_marker": [61, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRADD", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p13", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, [E1]ribonuclease[/E1] protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, [E2]RIP[/E2], FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ribonuclease", "entity_1_idx": [[57, 69]], "entity_1_idx_in_text_with_entity_marker": [61, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[180, 183]], "entity_2_idx_in_text_with_entity_marker": [193, 196], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p14", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, [E1]ribonuclease[/E1] protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and [E2]caspase-8[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ribonuclease", "entity_1_idx": [[57, 69]], "entity_1_idx_in_text_with_entity_marker": [61, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "caspase-8", "entity_2_idx": [[199, 208]], "entity_2_idx_in_text_with_entity_marker": [212, 221], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p45", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, [E1]FADD[/E1], TRADD, RIP, FAF, FAP, and [E2]caspase-8[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FADD", "entity_1_idx": [[167, 171]], "entity_1_idx_in_text_with_entity_marker": [171, 175], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "caspase-8", "entity_2_idx": [[199, 208]], "entity_2_idx_in_text_with_entity_marker": [212, 221], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p46", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, [E1]Fas ligand[/E1], TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and [E2]caspase-8[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas ligand", "entity_1_idx": [[140, 150]], "entity_1_idx_in_text_with_entity_marker": [144, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "caspase-8", "entity_2_idx": [[199, 208]], "entity_2_idx_in_text_with_entity_marker": [212, 221], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p47", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, [E1]TNFR-1[/E1], TRAIL, FADD, TRADD, RIP, FAF, FAP, and [E2]caspase-8[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNFR-1", "entity_1_idx": [[152, 158]], "entity_1_idx_in_text_with_entity_marker": [156, 162], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "caspase-8", "entity_2_idx": [[199, 208]], "entity_2_idx_in_text_with_entity_marker": [212, 221], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p48", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for [E1]Fas[/E1], Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and [E2]caspase-8[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "caspase-8", "entity_2_idx": [[199, 208]], "entity_2_idx_in_text_with_entity_marker": [212, 221], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p49", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, [E1]Fas ligand[/E1], TNFR-1, TRAIL, [E2]FADD[/E2], TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas ligand", "entity_1_idx": [[140, 150]], "entity_1_idx_in_text_with_entity_marker": [144, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FADD", "entity_2_idx": [[167, 171]], "entity_2_idx_in_text_with_entity_marker": [180, 184], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p50", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, [E1]TNFR-1[/E1], TRAIL, [E2]FADD[/E2], TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNFR-1", "entity_1_idx": [[152, 158]], "entity_1_idx_in_text_with_entity_marker": [156, 162], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FADD", "entity_2_idx": [[167, 171]], "entity_2_idx_in_text_with_entity_marker": [180, 184], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p51", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for [E1]Fas[/E1], Fas ligand, TNFR-1, TRAIL, [E2]FADD[/E2], TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FADD", "entity_2_idx": [[167, 171]], "entity_2_idx_in_text_with_entity_marker": [180, 184], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p52", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, [E1]Fas ligand[/E1], [E2]TNFR-1[/E2], TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas ligand", "entity_1_idx": [[140, 150]], "entity_1_idx_in_text_with_entity_marker": [144, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TNFR-1", "entity_2_idx": [[152, 158]], "entity_2_idx_in_text_with_entity_marker": [165, 171], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p53", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for [E1]Fas[/E1], [E2]Fas ligand[/E2], TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Fas ligand", "entity_2_idx": [[140, 150]], "entity_2_idx_in_text_with_entity_marker": [153, 163], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p54", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for [E1]Fas[/E1], Fas ligand, [E2]TNFR-1[/E2], TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TNFR-1", "entity_2_idx": [[152, 158]], "entity_2_idx_in_text_with_entity_marker": [165, 171], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p70", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on [E1]fibronectin[/E1] (b) showed reduced adhesion to [E2]laminin[/E2], but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fibronectin", "entity_1_idx": [[142, 153]], "entity_1_idx_in_text_with_entity_marker": [146, 157], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "laminin", "entity_2_idx": [[185, 192]], "entity_2_idx_in_text_with_entity_marker": [198, 205], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p71", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on [E1]fibronectin[/E1] (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a [E2]vinculin[/E2] (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fibronectin", "entity_1_idx": [[142, 153]], "entity_1_idx_in_text_with_entity_marker": [146, 157], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p72", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of [E1]beta1 integrin[/E1], although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or [E2]paxillin[/E2]-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta1 integrin", "entity_1_idx": [[251, 265]], "entity_1_idx_in_text_with_entity_marker": [255, 269], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "paxillin", "entity_2_idx": [[465, 473]], "entity_2_idx_in_text_with_entity_marker": [478, 486], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p73", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to [E1]laminin[/E1], but not fibronectin (c) expressed much reduced levels of [E2]beta1 integrin[/E2], although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "laminin", "entity_1_idx": [[185, 192]], "entity_1_idx_in_text_with_entity_marker": [189, 196], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta1 integrin", "entity_2_idx": [[251, 265]], "entity_2_idx_in_text_with_entity_marker": [264, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p74", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of [E1]beta1 integrin[/E1], although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a [E2]vinculin[/E2] (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta1 integrin", "entity_1_idx": [[251, 265]], "entity_1_idx_in_text_with_entity_marker": [255, 269], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p75", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to [E1]laminin[/E1], but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or [E2]paxillin[/E2]-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "laminin", "entity_1_idx": [[185, 192]], "entity_1_idx_in_text_with_entity_marker": [189, 196], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "paxillin", "entity_2_idx": [[465, 473]], "entity_2_idx_in_text_with_entity_marker": [478, 486], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p76", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a [E1]vinculin[/E1] (-/-) ES cell mutant (e) were unable to assemble vinculin or [E2]paxillin[/E2]-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vinculin", "entity_1_idx": [[395, 403]], "entity_1_idx_in_text_with_entity_marker": [399, 407], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "paxillin", "entity_2_idx": [[465, 473]], "entity_2_idx_in_text_with_entity_marker": [478, 486], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d730.s0_BioInfer.d730.s0.p77", "text": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to laminin, but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a vinculin (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "text_with_entity_marker": "The undifferentiated cells (a) were unable to spread on gelatin or laminin and grew as rounded colonies, although they were able to spread on fibronectin (b) showed reduced adhesion to [E1]laminin[/E1], but not fibronectin (c) expressed much reduced levels of beta1 integrin, although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a [E2]vinculin[/E2] (-/-) ES cell mutant (e) were unable to assemble vinculin or paxillin-containing focal adhesions or actin stress fibers on fibronectin, whereas vinculin (-/-) ES cells were able to assemble talin-containing focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "laminin", "entity_1_idx": [[185, 192]], "entity_1_idx_in_text_with_entity_marker": [189, 196], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[395, 403]], "entity_2_idx_in_text_with_entity_marker": [408, 416], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d311.s0_BioInfer.d311.s0.p0", "text": "In addition to their role in mismatch repair (MMR), the MSH2 and MSH3 gene products are required to remove 3' nonhomologous DNA tails during genetic recombination.", "text_with_entity_marker": "In addition to their role in mismatch repair (MMR), the [E1]MSH2[/E1] and [E2]MSH3[/E2] gene products are required to remove 3' nonhomologous DNA tails during genetic recombination.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH2", "entity_1_idx": [[56, 60]], "entity_1_idx_in_text_with_entity_marker": [60, 64], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[65, 69]], "entity_2_idx_in_text_with_entity_marker": [78, 82], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p10", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, [E1]nestin[/E1], myosin heavy chain, sarcomeric actin, Myf-5, MyoD and [E2]myogenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nestin", "entity_1_idx": [[128, 134]], "entity_1_idx_in_text_with_entity_marker": [132, 138], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myogenin", "entity_2_idx": [[190, 198]], "entity_2_idx_in_text_with_entity_marker": [203, 211], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p11", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, [E1]myosin heavy chain[/E1], sarcomeric actin, Myf-5, MyoD and [E2]myogenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[136, 154]], "entity_1_idx_in_text_with_entity_marker": [140, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myogenin", "entity_2_idx": [[190, 198]], "entity_2_idx_in_text_with_entity_marker": [203, 211], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p12", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and [E1]MyoD[/E1] mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and [E2]myogenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MyoD", "entity_1_idx": [[70, 74]], "entity_1_idx_in_text_with_entity_marker": [74, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myogenin", "entity_2_idx": [[190, 198]], "entity_2_idx_in_text_with_entity_marker": [203, 211], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p13", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with [E1]desmin[/E1], nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and [E2]myogenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "desmin", "entity_1_idx": [[120, 126]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myogenin", "entity_2_idx": [[190, 198]], "entity_2_idx_in_text_with_entity_marker": [203, 211], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p14", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned [E1]Myf-5[/E1] and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and [E2]myogenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Myf-5", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myogenin", "entity_2_idx": [[190, 198]], "entity_2_idx_in_text_with_entity_marker": [203, 211], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p15", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, [E1]sarcomeric actin[/E1], [E2]Myf-5[/E2], MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "sarcomeric actin", "entity_1_idx": [[156, 172]], "entity_1_idx_in_text_with_entity_marker": [160, 176], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Myf-5", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p16", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, [E1]nestin[/E1], myosin heavy chain, [E2]sarcomeric actin[/E2], Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nestin", "entity_1_idx": [[128, 134]], "entity_1_idx_in_text_with_entity_marker": [132, 138], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "sarcomeric actin", "entity_2_idx": [[156, 172]], "entity_2_idx_in_text_with_entity_marker": [169, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p17", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, [E1]myosin heavy chain[/E1], [E2]sarcomeric actin[/E2], Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[136, 154]], "entity_1_idx_in_text_with_entity_marker": [140, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "sarcomeric actin", "entity_2_idx": [[156, 172]], "entity_2_idx_in_text_with_entity_marker": [169, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p18", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and [E1]MyoD[/E1] mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, [E2]sarcomeric actin[/E2], Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MyoD", "entity_1_idx": [[70, 74]], "entity_1_idx_in_text_with_entity_marker": [74, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "sarcomeric actin", "entity_2_idx": [[156, 172]], "entity_2_idx_in_text_with_entity_marker": [169, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p19", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with [E1]desmin[/E1], nestin, myosin heavy chain, [E2]sarcomeric actin[/E2], Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "desmin", "entity_1_idx": [[120, 126]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "sarcomeric actin", "entity_2_idx": [[156, 172]], "entity_2_idx_in_text_with_entity_marker": [169, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p50", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein ([E1]M[/E1]) gene sequences; another, M and fusion protein (F0) gene sequences; and another, [E2]F0[/E2] and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "M", "entity_1_idx": [[252, 253]], "entity_1_idx_in_text_with_entity_marker": [256, 257], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[335, 337]], "entity_2_idx_in_text_with_entity_marker": [348, 350], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p51", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein ([E1]P[/E1]) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, [E2]F0[/E2] and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[200, 201]], "entity_1_idx_in_text_with_entity_marker": [204, 205], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[335, 337]], "entity_2_idx_in_text_with_entity_marker": [348, 350], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p52", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and [E1]membrane protein[/E1] (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, [E2]F0[/E2] and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "membrane protein", "entity_1_idx": [[234, 250]], "entity_1_idx_in_text_with_entity_marker": [238, 254], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[335, 337]], "entity_2_idx_in_text_with_entity_marker": [348, 350], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p53", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein ([E1]F0[/E1]) gene sequences; and another, [E2]F0[/E2] and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F0", "entity_1_idx": [[302, 304]], "entity_1_idx_in_text_with_entity_marker": [306, 308], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[335, 337]], "entity_2_idx_in_text_with_entity_marker": [348, 350], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p54", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and [E1]fusion protein[/E1] (F0) gene sequences; and another, [E2]F0[/E2] and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion protein", "entity_1_idx": [[286, 300]], "entity_1_idx_in_text_with_entity_marker": [290, 304], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[335, 337]], "entity_2_idx_in_text_with_entity_marker": [348, 350], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p55", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, [E1]F0[/E1] and hemagglutinin-neuraminidase protein ([E2]HN[/E2]) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F0", "entity_1_idx": [[335, 337]], "entity_1_idx_in_text_with_entity_marker": [339, 341], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HN", "entity_2_idx": [[379, 381]], "entity_2_idx_in_text_with_entity_marker": [392, 394], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p56", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, [E1]F0[/E1] and [E2]hemagglutinin-neuraminidase protein[/E2] (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F0", "entity_1_idx": [[335, 337]], "entity_1_idx_in_text_with_entity_marker": [339, 341], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "hemagglutinin-neuraminidase protein", "entity_2_idx": [[342, 377]], "entity_2_idx_in_text_with_entity_marker": [355, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p57", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein ([E1]P[/E1]) gene sequences; another, P and membrane protein ([E2]M[/E2]) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[200, 201]], "entity_1_idx_in_text_with_entity_marker": [204, 205], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[252, 253]], "entity_2_idx_in_text_with_entity_marker": [265, 266], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p58", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and [E1]membrane protein[/E1] ([E2]M[/E2]) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "membrane protein", "entity_1_idx": [[234, 250]], "entity_1_idx_in_text_with_entity_marker": [238, 254], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[252, 253]], "entity_2_idx_in_text_with_entity_marker": [265, 266], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p59", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein ([E1]M[/E1]) gene sequences; another, M and fusion protein ([E2]F0[/E2]) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "M", "entity_1_idx": [[252, 253]], "entity_1_idx_in_text_with_entity_marker": [256, 257], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[302, 304]], "entity_2_idx_in_text_with_entity_marker": [315, 317], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d327.s0_BioInfer.d327.s0.p0", "text": "In contrast, the RAD51 and RAD52 genes are essential for homothallic mating-type switching.", "text_with_entity_marker": "In contrast, the [E1]RAD51[/E1] and [E2]RAD52[/E2] genes are essential for homothallic mating-type switching.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[17, 22]], "entity_1_idx_in_text_with_entity_marker": [21, 26], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[27, 32]], "entity_2_idx_in_text_with_entity_marker": [40, 45], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p0", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, [E1]RAD17[/E1], RAD24, MEC1, [E2]MEC2[/E2] and MEC3.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD17", "entity_1_idx": [[124, 129]], "entity_1_idx_in_text_with_entity_marker": [128, 133], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC2", "entity_2_idx": [[144, 148]], "entity_2_idx_in_text_with_entity_marker": [157, 161], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p1", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, [E1]RAD24[/E1], MEC1, [E2]MEC2[/E2] and MEC3.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD24", "entity_1_idx": [[131, 136]], "entity_1_idx_in_text_with_entity_marker": [135, 140], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC2", "entity_2_idx": [[144, 148]], "entity_2_idx_in_text_with_entity_marker": [157, 161], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p2", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes [E1]RAD9[/E1], RAD17, RAD24, MEC1, [E2]MEC2[/E2] and MEC3.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD9", "entity_1_idx": [[118, 122]], "entity_1_idx_in_text_with_entity_marker": [122, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC2", "entity_2_idx": [[144, 148]], "entity_2_idx_in_text_with_entity_marker": [157, 161], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p3", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, [E1]MEC2[/E1] and [E2]MEC3[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC2", "entity_1_idx": [[144, 148]], "entity_1_idx_in_text_with_entity_marker": [148, 152], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p4", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, [E1]MEC1[/E1], [E2]MEC2[/E2] and MEC3.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC1", "entity_1_idx": [[138, 142]], "entity_1_idx_in_text_with_entity_marker": [142, 146], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC2", "entity_2_idx": [[144, 148]], "entity_2_idx_in_text_with_entity_marker": [157, 161], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p5", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, [E1]RAD17[/E1], [E2]RAD24[/E2], MEC1, MEC2 and MEC3.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD17", "entity_1_idx": [[124, 129]], "entity_1_idx_in_text_with_entity_marker": [128, 133], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p6", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes [E1]RAD9[/E1], [E2]RAD17[/E2], RAD24, MEC1, MEC2 and MEC3.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD9", "entity_1_idx": [[118, 122]], "entity_1_idx_in_text_with_entity_marker": [122, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[124, 129]], "entity_2_idx_in_text_with_entity_marker": [137, 142], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p7", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, [E1]RAD17[/E1], RAD24, MEC1, MEC2 and [E2]MEC3[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD17", "entity_1_idx": [[124, 129]], "entity_1_idx_in_text_with_entity_marker": [128, 133], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p8", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, [E1]RAD17[/E1], RAD24, [E2]MEC1[/E2], MEC2 and MEC3.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD17", "entity_1_idx": [[124, 129]], "entity_1_idx_in_text_with_entity_marker": [128, 133], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC1", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p9", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes [E1]RAD9[/E1], RAD17, [E2]RAD24[/E2], MEC1, MEC2 and MEC3.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD9", "entity_1_idx": [[118, 122]], "entity_1_idx_in_text_with_entity_marker": [122, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p10", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, [E1]RAD24[/E1], MEC1, MEC2 and [E2]MEC3[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD24", "entity_1_idx": [[131, 136]], "entity_1_idx_in_text_with_entity_marker": [135, 140], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p11", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, [E1]RAD24[/E1], [E2]MEC1[/E2], MEC2 and MEC3.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD24", "entity_1_idx": [[131, 136]], "entity_1_idx_in_text_with_entity_marker": [135, 140], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC1", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p12", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes [E1]RAD9[/E1], RAD17, RAD24, MEC1, MEC2 and [E2]MEC3[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD9", "entity_1_idx": [[118, 122]], "entity_1_idx_in_text_with_entity_marker": [122, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p13", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes [E1]RAD9[/E1], RAD17, RAD24, [E2]MEC1[/E2], MEC2 and MEC3.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD9", "entity_1_idx": [[118, 122]], "entity_1_idx_in_text_with_entity_marker": [122, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC1", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d366.s0_BioInfer.d366.s0.p14", "text": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, MEC1, MEC2 and MEC3.", "text_with_entity_marker": "In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes RAD9, RAD17, RAD24, [E1]MEC1[/E1], MEC2 and [E2]MEC3[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC1", "entity_1_idx": [[138, 142]], "entity_1_idx_in_text_with_entity_marker": [142, 146], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[153, 157]], "entity_2_idx_in_text_with_entity_marker": [166, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p10", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), [E1]phosphoprotein[/E1] (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, [E2]F[/E2]: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[46, 60], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [50, 64], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "F", "entity_2_idx": [[287, 288]], "entity_2_idx_in_text_with_entity_marker": [300, 301], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p11", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and [E1]large protein[/E1] (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, [E2]F[/E2]: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "large protein", "entity_1_idx": [[94, 107]], "entity_1_idx_in_text_with_entity_marker": [98, 111], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "F", "entity_2_idx": [[287, 288]], "entity_2_idx_in_text_with_entity_marker": [300, 301], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p12", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix ([E1]M[/E1]), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, [E2]F[/E2]: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "M", "entity_1_idx": [[74, 75]], "entity_1_idx_in_text_with_entity_marker": [78, 79], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "F", "entity_2_idx": [[287, 288]], "entity_2_idx_in_text_with_entity_marker": [300, 301], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p13", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position [E1]N[/E1]: 1301-1700, P: 1751-2190, M: 3571-4057, [E2]F[/E2]: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N", "entity_1_idx": [[245, 246]], "entity_1_idx_in_text_with_entity_marker": [249, 250], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "F", "entity_2_idx": [[287, 288]], "entity_2_idx_in_text_with_entity_marker": [300, 301], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p14", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, [E1]P[/E1]: 1751-2190, M: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[259, 260]], "entity_1_idx_in_text_with_entity_marker": [263, 264], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p15", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein ([E1]L[/E1]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, [E2]P[/E2]: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "L", "entity_1_idx": [[109, 110]], "entity_1_idx_in_text_with_entity_marker": [113, 114], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "P", "entity_2_idx": [[259, 260]], "entity_2_idx_in_text_with_entity_marker": [272, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p16", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, [E1]P[/E1]: 1751-2190, [E2]M[/E2]: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[259, 260]], "entity_1_idx_in_text_with_entity_marker": [263, 264], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "M", "entity_2_idx": [[273, 274]], "entity_2_idx_in_text_with_entity_marker": [286, 287], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p17", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), [E1]fusion[/E1] (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, [E2]P[/E2]: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[78, 84], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [82, 88], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "P", "entity_2_idx": [[259, 260]], "entity_2_idx_in_text_with_entity_marker": [272, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p18", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein ([E1]P[/E1]), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, [E2]P[/E2]: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[62, 63]], "entity_1_idx_in_text_with_entity_marker": [66, 67], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "P", "entity_2_idx": [[259, 260]], "entity_2_idx_in_text_with_entity_marker": [272, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p19", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid ([E1]N[/E1]), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, [E2]P[/E2]: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N", "entity_1_idx": [[42, 43]], "entity_1_idx_in_text_with_entity_marker": [46, 47], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "P", "entity_2_idx": [[259, 260]], "entity_2_idx_in_text_with_entity_marker": [272, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p80", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid ([E1]N[/E1]), [E2]phosphoprotein[/E2] (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N", "entity_1_idx": [[42, 43]], "entity_1_idx_in_text_with_entity_marker": [46, 47], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "phosphoprotein", "entity_2_idx": [[46, 60], [100, 107]], "entity_2_idx_in_text_with_entity_marker": [59, 73], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p81", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid ([E1]N[/E1]), phosphoprotein (P), matrix (M), fusion (F), and [E2]large protein[/E2] (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N", "entity_1_idx": [[42, 43]], "entity_1_idx_in_text_with_entity_marker": [46, 47], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "large protein", "entity_2_idx": [[94, 107]], "entity_2_idx_in_text_with_entity_marker": [107, 120], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p82", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid ([E1]N[/E1]), phosphoprotein (P), matrix ([E2]M[/E2]), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N", "entity_1_idx": [[42, 43]], "entity_1_idx_in_text_with_entity_marker": [46, 47], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "M", "entity_2_idx": [[74, 75]], "entity_2_idx_in_text_with_entity_marker": [87, 88], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p83", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid ([E1]N[/E1]), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position [E2]N[/E2]: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N", "entity_1_idx": [[42, 43]], "entity_1_idx_in_text_with_entity_marker": [46, 47], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "N", "entity_2_idx": [[245, 246]], "entity_2_idx_in_text_with_entity_marker": [258, 259], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p84", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of [E1]nucleocapsid[/E1] (N), phosphoprotein (P), matrix (M), fusion ([E2]F[/E2]), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid", "entity_1_idx": [[28, 40], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [32, 44], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "F", "entity_2_idx": [[86, 87]], "entity_2_idx_in_text_with_entity_marker": [99, 100], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p85", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), [E1]matrix[/E1] (M), fusion ([E2]F[/E2]), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "matrix", "entity_1_idx": [[66, 72], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [70, 76], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "F", "entity_2_idx": [[86, 87]], "entity_2_idx_in_text_with_entity_marker": [99, 100], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p86", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), [E1]phosphoprotein[/E1] (P), matrix (M), fusion ([E2]F[/E2]), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[46, 60], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [50, 64], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "F", "entity_2_idx": [[86, 87]], "entity_2_idx_in_text_with_entity_marker": [99, 100], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p87", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion ([E1]F[/E1]), and [E2]large protein[/E2] (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F", "entity_1_idx": [[86, 87]], "entity_1_idx_in_text_with_entity_marker": [90, 91], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "large protein", "entity_2_idx": [[94, 107]], "entity_2_idx_in_text_with_entity_marker": [107, 120], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p88", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix ([E1]M[/E1]), fusion ([E2]F[/E2]), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "M", "entity_1_idx": [[74, 75]], "entity_1_idx_in_text_with_entity_marker": [78, 79], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "F", "entity_2_idx": [[86, 87]], "entity_2_idx_in_text_with_entity_marker": [99, 100], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p89", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion ([E1]F[/E1]), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position [E2]N[/E2]: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F", "entity_1_idx": [[86, 87]], "entity_1_idx_in_text_with_entity_marker": [90, 91], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "N", "entity_2_idx": [[245, 246]], "entity_2_idx_in_text_with_entity_marker": [258, 259], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p0", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, [E1]MEC1[/E1], MEC3 and [E2]RAD53[/E2] checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC1", "entity_1_idx": [[77, 81]], "entity_1_idx_in_text_with_entity_marker": [81, 85], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD53", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p1", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, [E1]RAD17[/E1], MEC1, MEC3 and [E2]RAD53[/E2] checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD17", "entity_1_idx": [[70, 75]], "entity_1_idx_in_text_with_entity_marker": [74, 79], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD53", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p2", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae [E1]RAD9[/E1], RAD24, RAD17, MEC1, MEC3 and [E2]RAD53[/E2] checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD9", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD53", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p3", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, [E1]MEC3[/E1] and [E2]RAD53[/E2] checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC3", "entity_1_idx": [[83, 87]], "entity_1_idx_in_text_with_entity_marker": [87, 91], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD53", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p4", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae RAD9, [E1]RAD24[/E1], RAD17, MEC1, MEC3 and [E2]RAD53[/E2] checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD24", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD53", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p5", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, [E1]RAD17[/E1], [E2]MEC1[/E2], MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD17", "entity_1_idx": [[70, 75]], "entity_1_idx_in_text_with_entity_marker": [74, 79], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC1", "entity_2_idx": [[77, 81]], "entity_2_idx_in_text_with_entity_marker": [90, 94], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p6", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae [E1]RAD9[/E1], RAD24, RAD17, [E2]MEC1[/E2], MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD9", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC1", "entity_2_idx": [[77, 81]], "entity_2_idx_in_text_with_entity_marker": [90, 94], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p7", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, [E1]MEC1[/E1], [E2]MEC3[/E2] and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC1", "entity_1_idx": [[77, 81]], "entity_1_idx_in_text_with_entity_marker": [81, 85], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[83, 87]], "entity_2_idx_in_text_with_entity_marker": [96, 100], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p8", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae RAD9, [E1]RAD24[/E1], RAD17, [E2]MEC1[/E2], MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD24", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC1", "entity_2_idx": [[77, 81]], "entity_2_idx_in_text_with_entity_marker": [90, 94], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p9", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae [E1]RAD9[/E1], RAD24, [E2]RAD17[/E2], MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD9", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[70, 75]], "entity_2_idx_in_text_with_entity_marker": [83, 88], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p10", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, [E1]RAD17[/E1], MEC1, [E2]MEC3[/E2] and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD17", "entity_1_idx": [[70, 75]], "entity_1_idx_in_text_with_entity_marker": [74, 79], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[83, 87]], "entity_2_idx_in_text_with_entity_marker": [96, 100], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p11", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae RAD9, [E1]RAD24[/E1], [E2]RAD17[/E2], MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD24", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[70, 75]], "entity_2_idx_in_text_with_entity_marker": [83, 88], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p12", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae [E1]RAD9[/E1], RAD24, RAD17, MEC1, [E2]MEC3[/E2] and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD9", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[83, 87]], "entity_2_idx_in_text_with_entity_marker": [96, 100], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p13", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae [E1]RAD9[/E1], [E2]RAD24[/E2], RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD9", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD24", "entity_2_idx": [[63, 68]], "entity_2_idx_in_text_with_entity_marker": [76, 81], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d383.s0_BioInfer.d383.s0.p14", "text": "In this work we report that the Saccharomyces cerevisiae RAD9, RAD24, RAD17, MEC1, MEC3 and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "text_with_entity_marker": "In this work we report that the Saccharomyces cerevisiae RAD9, [E1]RAD24[/E1], RAD17, MEC1, [E2]MEC3[/E2] and RAD53 checkpoint genes are required for efficient non-homologous end joining (NHEJ).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD24", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MEC3", "entity_2_idx": [[83, 87]], "entity_2_idx_in_text_with_entity_marker": [96, 100], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d586.s0_BioInfer.d586.s0.p0", "text": "The RAD54 and RAD51 genes are involved in genetic recombination and double-strand break repair in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "The [E1]RAD54[/E1] and [E2]RAD51[/E2] genes are involved in genetic recombination and double-strand break repair in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD54", "entity_1_idx": [[4, 9]], "entity_1_idx_in_text_with_entity_marker": [8, 13], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[14, 19]], "entity_2_idx_in_text_with_entity_marker": [27, 32], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d491.s0_BioInfer.d491.s0.p0", "text": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "text_with_entity_marker": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, [E1]desmin[/E1], and [E2]smoothelin[/E2], a recently described late differentiation marker of vascular SMCs.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "desmin", "entity_1_idx": [[209, 215]], "entity_1_idx_in_text_with_entity_marker": [213, 219], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smoothelin", "entity_2_idx": [[221, 231]], "entity_2_idx_in_text_with_entity_marker": [234, 244], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d491.s0_BioInfer.d491.s0.p1", "text": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "text_with_entity_marker": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of [E1]SM myosin heavy chain[/E1] isoforms 1 and 2, [E2]desmin[/E2], and smoothelin, a recently described late differentiation marker of vascular SMCs.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SM myosin heavy chain", "entity_1_idx": [[169, 190], [200, 201]], "entity_1_idx_in_text_with_entity_marker": [173, 194], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[209, 215]], "entity_2_idx_in_text_with_entity_marker": [222, 228], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d491.s0_BioInfer.d491.s0.p2", "text": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "text_with_entity_marker": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of [E1]SM myosin heavy chain[/E1] isoforms 1 and 2, [E2]desmin[/E2], and smoothelin, a recently described late differentiation marker of vascular SMCs.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SM myosin heavy chain", "entity_1_idx": [[169, 190], [206, 207]], "entity_1_idx_in_text_with_entity_marker": [173, 194], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[209, 215]], "entity_2_idx_in_text_with_entity_marker": [222, 228], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d491.s0_BioInfer.d491.s0.p3", "text": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "text_with_entity_marker": "Porcine arterial SMCs in culture not only express high levels of [E1]alpha-smooth muscle[/E1] (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, [E2]desmin[/E2], and smoothelin, a recently described late differentiation marker of vascular SMCs.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle", "entity_1_idx": [[65, 84], [90, 95]], "entity_1_idx_in_text_with_entity_marker": [69, 88], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[209, 215]], "entity_2_idx_in_text_with_entity_marker": [222, 228], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d491.s0_BioInfer.d491.s0.p4", "text": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "text_with_entity_marker": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of [E1]SM myosin heavy chain[/E1] isoforms 1 and 2, desmin, and [E2]smoothelin[/E2], a recently described late differentiation marker of vascular SMCs.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SM myosin heavy chain", "entity_1_idx": [[169, 190], [200, 201]], "entity_1_idx_in_text_with_entity_marker": [173, 194], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smoothelin", "entity_2_idx": [[221, 231]], "entity_2_idx_in_text_with_entity_marker": [234, 244], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d491.s0_BioInfer.d491.s0.p5", "text": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "text_with_entity_marker": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of [E1]SM myosin heavy chain[/E1] isoforms 1 and 2, desmin, and [E2]smoothelin[/E2], a recently described late differentiation marker of vascular SMCs.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SM myosin heavy chain", "entity_1_idx": [[169, 190], [206, 207]], "entity_1_idx_in_text_with_entity_marker": [173, 194], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smoothelin", "entity_2_idx": [[221, 231]], "entity_2_idx_in_text_with_entity_marker": [234, 244], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d491.s0_BioInfer.d491.s0.p6", "text": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "text_with_entity_marker": "Porcine arterial SMCs in culture not only express high levels of [E1]alpha-smooth muscle[/E1] (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, desmin, and [E2]smoothelin[/E2], a recently described late differentiation marker of vascular SMCs.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle", "entity_1_idx": [[65, 84], [90, 95]], "entity_1_idx_in_text_with_entity_marker": [69, 88], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smoothelin", "entity_2_idx": [[221, 231]], "entity_2_idx_in_text_with_entity_marker": [234, 244], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d491.s0_BioInfer.d491.s0.p7", "text": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "text_with_entity_marker": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of [E1-E2]SM myosin heavy chain[/E1-E2] isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SM myosin heavy chain", "entity_1_idx": [[169, 190], [206, 207]], "entity_1_idx_in_text_with_entity_marker": [176, 197], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SM myosin heavy chain", "entity_2_idx": [[169, 190], [200, 201]], "entity_2_idx_in_text_with_entity_marker": [176, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d491.s0_BioInfer.d491.s0.p8", "text": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "text_with_entity_marker": "Porcine arterial SMCs in culture not only express high levels of [E1]alpha-smooth muscle[/E1] (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of [E2]SM myosin heavy chain[/E2] isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle", "entity_1_idx": [[65, 84], [90, 95]], "entity_1_idx_in_text_with_entity_marker": [69, 88], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SM myosin heavy chain", "entity_2_idx": [[169, 190], [200, 201]], "entity_2_idx_in_text_with_entity_marker": [182, 203], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d491.s0_BioInfer.d491.s0.p9", "text": "Porcine arterial SMCs in culture not only express high levels of alpha-smooth muscle (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of SM myosin heavy chain isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "text_with_entity_marker": "Porcine arterial SMCs in culture not only express high levels of [E1]alpha-smooth muscle[/E1] (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of [E2]SM myosin heavy chain[/E2] isoforms 1 and 2, desmin, and smoothelin, a recently described late differentiation marker of vascular SMCs.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle", "entity_1_idx": [[65, 84], [90, 95]], "entity_1_idx_in_text_with_entity_marker": [69, 88], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SM myosin heavy chain", "entity_2_idx": [[169, 190], [206, 207]], "entity_2_idx_in_text_with_entity_marker": [182, 203], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d11.s0_BioInfer.d11.s0.p0", "text": "A common feature of these talin-positive domains is the deep membrane infoldings, where bundles of actin filaments are inserted into the membrane.", "text_with_entity_marker": "A common feature of these [E1]talin[/E1]-positive domains is the deep membrane infoldings, where bundles of [E2]actin[/E2] filaments are inserted into the membrane.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "talin", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[99, 104]], "entity_2_idx_in_text_with_entity_marker": [112, 117], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p10", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, [E1]beta-catenin[/E1], and gamma-catenin, but not with antibodies to [E2]P-cadherin[/E2], alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[99, 111]], "entity_1_idx_in_text_with_entity_marker": [103, 115], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "P-cadherin", "entity_2_idx": [[159, 169]], "entity_2_idx_in_text_with_entity_marker": [172, 182], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p11", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and [E1]gamma-catenin[/E1], but not with antibodies to P-cadherin, alpha-catenin, or with [E2]pan-desmocollin[/E2] and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gamma-catenin", "entity_1_idx": [[117, 130]], "entity_1_idx_in_text_with_entity_marker": [121, 134], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pan-desmocollin", "entity_2_idx": [[194, 209]], "entity_2_idx_in_text_with_entity_marker": [207, 222], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p12", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to [E1]E-cadherin[/E1], beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with [E2]pan-desmocollin[/E2] and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[87, 97]], "entity_1_idx_in_text_with_entity_marker": [91, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pan-desmocollin", "entity_2_idx": [[194, 209]], "entity_2_idx_in_text_with_entity_marker": [207, 222], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p13", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, [E1]alpha-catenin[/E1], or with [E2]pan-desmocollin[/E2] and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[171, 184]], "entity_1_idx_in_text_with_entity_marker": [175, 188], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pan-desmocollin", "entity_2_idx": [[194, 209]], "entity_2_idx_in_text_with_entity_marker": [207, 222], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p14", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, [E1]beta-catenin[/E1], and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with [E2]pan-desmocollin[/E2] and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[99, 111]], "entity_1_idx_in_text_with_entity_marker": [103, 115], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "pan-desmocollin", "entity_2_idx": [[194, 209]], "entity_2_idx_in_text_with_entity_marker": [207, 222], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p15", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to [E1]E-cadherin[/E1], beta-catenin, and [E2]gamma-catenin[/E2], but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[87, 97]], "entity_1_idx_in_text_with_entity_marker": [91, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[117, 130]], "entity_2_idx_in_text_with_entity_marker": [130, 143], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p16", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and [E1]gamma-catenin[/E1], but not with antibodies to P-cadherin, [E2]alpha-catenin[/E2], or with pan-desmocollin and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gamma-catenin", "entity_1_idx": [[117, 130]], "entity_1_idx_in_text_with_entity_marker": [121, 134], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[171, 184]], "entity_2_idx_in_text_with_entity_marker": [184, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p17", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, [E1]beta-catenin[/E1], and [E2]gamma-catenin[/E2], but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[99, 111]], "entity_1_idx_in_text_with_entity_marker": [103, 115], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[117, 130]], "entity_2_idx_in_text_with_entity_marker": [130, 143], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p18", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to [E1]E-cadherin[/E1], beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, [E2]alpha-catenin[/E2], or with pan-desmocollin and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[87, 97]], "entity_1_idx_in_text_with_entity_marker": [91, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[171, 184]], "entity_2_idx_in_text_with_entity_marker": [184, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p19", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to [E1]E-cadherin[/E1], [E2]beta-catenin[/E2], and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[87, 97]], "entity_1_idx_in_text_with_entity_marker": [91, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[99, 111]], "entity_2_idx_in_text_with_entity_marker": [112, 124], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s1_BioInfer.d379.s1.p0", "text": "Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair.", "text_with_entity_marker": "Redundancy of Saccharomyces cerevisiae [E1]MSH3[/E1] and MSH6 in [E2]MSH2[/E2]-dependent mismatch repair.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH3", "entity_1_idx": [[39, 43]], "entity_1_idx_in_text_with_entity_marker": [43, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH2", "entity_2_idx": [[56, 60]], "entity_2_idx_in_text_with_entity_marker": [69, 73], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s1_BioInfer.d379.s1.p1", "text": "Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair.", "text_with_entity_marker": "Redundancy of Saccharomyces cerevisiae MSH3 and [E1]MSH6[/E1] in [E2]MSH2[/E2]-dependent mismatch repair.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH6", "entity_1_idx": [[48, 52]], "entity_1_idx_in_text_with_entity_marker": [52, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH2", "entity_2_idx": [[56, 60]], "entity_2_idx_in_text_with_entity_marker": [69, 73], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d379.s1_BioInfer.d379.s1.p2", "text": "Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair.", "text_with_entity_marker": "Redundancy of Saccharomyces cerevisiae [E1]MSH3[/E1] and [E2]MSH6[/E2] in MSH2-dependent mismatch repair.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH3", "entity_1_idx": [[39, 43]], "entity_1_idx_in_text_with_entity_marker": [43, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[48, 52]], "entity_2_idx_in_text_with_entity_marker": [61, 65], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d536.s0_BioInfer.d536.s0.p0", "text": "Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.", "text_with_entity_marker": "Several proteins, such as calmodulin, [E1]calbindin[/E1], actin, tubulin, and [E2]fimbrin[/E2], have previously been described.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "calbindin", "entity_1_idx": [[38, 47]], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fimbrin", "entity_2_idx": [[69, 76]], "entity_2_idx_in_text_with_entity_marker": [82, 89], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d536.s0_BioInfer.d536.s0.p1", "text": "Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.", "text_with_entity_marker": "Several proteins, such as [E1]calmodulin[/E1], [E2]calbindin[/E2], actin, tubulin, and fimbrin, have previously been described.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "calmodulin", "entity_1_idx": [[26, 36]], "entity_1_idx_in_text_with_entity_marker": [30, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calbindin", "entity_2_idx": [[38, 47]], "entity_2_idx_in_text_with_entity_marker": [51, 60], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d536.s0_BioInfer.d536.s0.p2", "text": "Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.", "text_with_entity_marker": "Several proteins, such as calmodulin, [E1]calbindin[/E1], [E2]actin[/E2], tubulin, and fimbrin, have previously been described.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "calbindin", "entity_1_idx": [[38, 47]], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[49, 54]], "entity_2_idx_in_text_with_entity_marker": [62, 67], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d536.s0_BioInfer.d536.s0.p3", "text": "Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.", "text_with_entity_marker": "Several proteins, such as calmodulin, [E1]calbindin[/E1], actin, [E2]tubulin[/E2], and fimbrin, have previously been described.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "calbindin", "entity_1_idx": [[38, 47]], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tubulin", "entity_2_idx": [[56, 63]], "entity_2_idx_in_text_with_entity_marker": [69, 76], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d536.s0_BioInfer.d536.s0.p4", "text": "Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.", "text_with_entity_marker": "Several proteins, such as [E1]calmodulin[/E1], calbindin, actin, tubulin, and [E2]fimbrin[/E2], have previously been described.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "calmodulin", "entity_1_idx": [[26, 36]], "entity_1_idx_in_text_with_entity_marker": [30, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fimbrin", "entity_2_idx": [[69, 76]], "entity_2_idx_in_text_with_entity_marker": [82, 89], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d536.s0_BioInfer.d536.s0.p5", "text": "Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.", "text_with_entity_marker": "Several proteins, such as calmodulin, calbindin, [E1]actin[/E1], tubulin, and [E2]fimbrin[/E2], have previously been described.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fimbrin", "entity_2_idx": [[69, 76]], "entity_2_idx_in_text_with_entity_marker": [82, 89], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d536.s0_BioInfer.d536.s0.p6", "text": "Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.", "text_with_entity_marker": "Several proteins, such as calmodulin, calbindin, actin, [E1]tubulin[/E1], and [E2]fimbrin[/E2], have previously been described.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "tubulin", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fimbrin", "entity_2_idx": [[69, 76]], "entity_2_idx_in_text_with_entity_marker": [82, 89], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d536.s0_BioInfer.d536.s0.p7", "text": "Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.", "text_with_entity_marker": "Several proteins, such as [E1]calmodulin[/E1], calbindin, [E2]actin[/E2], tubulin, and fimbrin, have previously been described.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "calmodulin", "entity_1_idx": [[26, 36]], "entity_1_idx_in_text_with_entity_marker": [30, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[49, 54]], "entity_2_idx_in_text_with_entity_marker": [62, 67], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d536.s0_BioInfer.d536.s0.p8", "text": "Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.", "text_with_entity_marker": "Several proteins, such as [E1]calmodulin[/E1], calbindin, actin, [E2]tubulin[/E2], and fimbrin, have previously been described.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "calmodulin", "entity_1_idx": [[26, 36]], "entity_1_idx_in_text_with_entity_marker": [30, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tubulin", "entity_2_idx": [[56, 63]], "entity_2_idx_in_text_with_entity_marker": [69, 76], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d536.s0_BioInfer.d536.s0.p9", "text": "Several proteins, such as calmodulin, calbindin, actin, tubulin, and fimbrin, have previously been described.", "text_with_entity_marker": "Several proteins, such as calmodulin, calbindin, [E1]actin[/E1], [E2]tubulin[/E2], and fimbrin, have previously been described.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tubulin", "entity_2_idx": [[56, 63]], "entity_2_idx_in_text_with_entity_marker": [69, 76], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p0", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in [E1]MSH2[/E1] or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of [E2]MSH3[/E2], MSH6, BAX, and TGFbeta RII.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH2", "entity_1_idx": [[148, 152]], "entity_1_idx_in_text_with_entity_marker": [152, 156], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[248, 252]], "entity_2_idx_in_text_with_entity_marker": [261, 265], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p1", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in [E1]MSH2[/E1] or [E2]MLH1[/E2] to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH2", "entity_1_idx": [[148, 152]], "entity_1_idx_in_text_with_entity_marker": [152, 156], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MLH1", "entity_2_idx": [[156, 160]], "entity_2_idx_in_text_with_entity_marker": [169, 173], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p2", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in [E1]MSH2[/E1] or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, [E2]BAX[/E2], and TGFbeta RII.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH2", "entity_1_idx": [[148, 152]], "entity_1_idx_in_text_with_entity_marker": [152, 156], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BAX", "entity_2_idx": [[260, 263]], "entity_2_idx_in_text_with_entity_marker": [273, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p3", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in [E1]MSH2[/E1] or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, [E2]MSH6[/E2], BAX, and TGFbeta RII.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH2", "entity_1_idx": [[148, 152]], "entity_1_idx_in_text_with_entity_marker": [152, 156], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[254, 258]], "entity_2_idx_in_text_with_entity_marker": [267, 271], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p4", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in [E1]MSH2[/E1] or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and [E2]TGFbeta RII[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH2", "entity_1_idx": [[148, 152]], "entity_1_idx_in_text_with_entity_marker": [152, 156], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TGFbeta RII", "entity_2_idx": [[269, 280]], "entity_2_idx_in_text_with_entity_marker": [282, 293], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p5", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or [E1]MLH1[/E1] to assess the involvement of mononucleotide repeats contained in the coding regions of [E2]MSH3[/E2], MSH6, BAX, and TGFbeta RII.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MLH1", "entity_1_idx": [[156, 160]], "entity_1_idx_in_text_with_entity_marker": [160, 164], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[248, 252]], "entity_2_idx_in_text_with_entity_marker": [261, 265], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p6", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of [E1]MSH3[/E1], MSH6, [E2]BAX[/E2], and TGFbeta RII.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH3", "entity_1_idx": [[248, 252]], "entity_1_idx_in_text_with_entity_marker": [252, 256], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BAX", "entity_2_idx": [[260, 263]], "entity_2_idx_in_text_with_entity_marker": [273, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p7", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of [E1]MSH3[/E1], [E2]MSH6[/E2], BAX, and TGFbeta RII.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH3", "entity_1_idx": [[248, 252]], "entity_1_idx_in_text_with_entity_marker": [252, 256], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[254, 258]], "entity_2_idx_in_text_with_entity_marker": [267, 271], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p8", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of [E1]MSH3[/E1], MSH6, BAX, and [E2]TGFbeta RII[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH3", "entity_1_idx": [[248, 252]], "entity_1_idx_in_text_with_entity_marker": [252, 256], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TGFbeta RII", "entity_2_idx": [[269, 280]], "entity_2_idx_in_text_with_entity_marker": [282, 293], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p9", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or [E1]MLH1[/E1] to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, [E2]BAX[/E2], and TGFbeta RII.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MLH1", "entity_1_idx": [[156, 160]], "entity_1_idx_in_text_with_entity_marker": [160, 164], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BAX", "entity_2_idx": [[260, 263]], "entity_2_idx_in_text_with_entity_marker": [273, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p10", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or [E1]MLH1[/E1] to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, [E2]MSH6[/E2], BAX, and TGFbeta RII.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MLH1", "entity_1_idx": [[156, 160]], "entity_1_idx_in_text_with_entity_marker": [160, 164], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[254, 258]], "entity_2_idx_in_text_with_entity_marker": [267, 271], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p11", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or [E1]MLH1[/E1] to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and [E2]TGFbeta RII[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MLH1", "entity_1_idx": [[156, 160]], "entity_1_idx_in_text_with_entity_marker": [160, 164], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TGFbeta RII", "entity_2_idx": [[269, 280]], "entity_2_idx_in_text_with_entity_marker": [282, 293], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p12", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, [E1]MSH6[/E1], [E2]BAX[/E2], and TGFbeta RII.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH6", "entity_1_idx": [[254, 258]], "entity_1_idx_in_text_with_entity_marker": [258, 262], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BAX", "entity_2_idx": [[260, 263]], "entity_2_idx_in_text_with_entity_marker": [273, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p13", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, [E1]BAX[/E1], and [E2]TGFbeta RII[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BAX", "entity_1_idx": [[260, 263]], "entity_1_idx_in_text_with_entity_marker": [264, 267], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TGFbeta RII", "entity_2_idx": [[269, 280]], "entity_2_idx_in_text_with_entity_marker": [282, 293], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d827.s0_BioInfer.d827.s0.p14", "text": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, MSH6, BAX, and TGFbeta RII.", "text_with_entity_marker": "We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in MSH2 or MLH1 to assess the involvement of mononucleotide repeats contained in the coding regions of MSH3, [E1]MSH6[/E1], BAX, and [E2]TGFbeta RII[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH6", "entity_1_idx": [[254, 258]], "entity_1_idx_in_text_with_entity_marker": [258, 262], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TGFbeta RII", "entity_2_idx": [[269, 280]], "entity_2_idx_in_text_with_entity_marker": [282, 293], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d503.s0_BioInfer.d503.s0.p0", "text": "Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, myosin heavy chain (MHC), and actin, but not desmin.", "text_with_entity_marker": "Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, myosin heavy chain ([E1]MHC[/E1]), and [E2]actin[/E2], but not desmin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MHC", "entity_1_idx": [[189, 192]], "entity_1_idx_in_text_with_entity_marker": [193, 196], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[199, 204]], "entity_2_idx_in_text_with_entity_marker": [212, 217], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d503.s0_BioInfer.d503.s0.p1", "text": "Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, myosin heavy chain (MHC), and actin, but not desmin.", "text_with_entity_marker": "Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, [E1]myosin heavy chain[/E1] (MHC), and [E2]actin[/E2], but not desmin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[169, 187]], "entity_1_idx_in_text_with_entity_marker": [173, 191], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[199, 204]], "entity_2_idx_in_text_with_entity_marker": [212, 217], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d503.s0_BioInfer.d503.s0.p2", "text": "Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, myosin heavy chain (MHC), and actin, but not desmin.", "text_with_entity_marker": "Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, myosin heavy chain (MHC), and [E1]actin[/E1], but not [E2]desmin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[199, 204]], "entity_1_idx_in_text_with_entity_marker": [203, 208], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[214, 220]], "entity_2_idx_in_text_with_entity_marker": [227, 233], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d503.s0_BioInfer.d503.s0.p3", "text": "Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, myosin heavy chain (MHC), and actin, but not desmin.", "text_with_entity_marker": "Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, [E1]myosin heavy chain[/E1] ([E2]MHC[/E2]), and actin, but not desmin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[169, 187]], "entity_1_idx_in_text_with_entity_marker": [173, 191], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC", "entity_2_idx": [[189, 192]], "entity_2_idx_in_text_with_entity_marker": [202, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d503.s0_BioInfer.d503.s0.p4", "text": "Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, myosin heavy chain (MHC), and actin, but not desmin.", "text_with_entity_marker": "Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, myosin heavy chain ([E1]MHC[/E1]), and actin, but not [E2]desmin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MHC", "entity_1_idx": [[189, 192]], "entity_1_idx_in_text_with_entity_marker": [193, 196], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "desmin", "entity_2_idx": [[214, 220]], "entity_2_idx_in_text_with_entity_marker": [227, 233], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d503.s0_BioInfer.d503.s0.p5", "text": "Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, myosin heavy chain (MHC), and actin, but not desmin.", "text_with_entity_marker": "Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, [E1]myosin heavy chain[/E1] (MHC), and actin, but not [E2]desmin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[169, 187]], "entity_1_idx_in_text_with_entity_marker": [173, 191], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "desmin", "entity_2_idx": [[214, 220]], "entity_2_idx_in_text_with_entity_marker": [227, 233], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p50", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and [E2]large[/E2] (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "large", "entity_2_idx": [[220, 225], [230, 237]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p51", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P), V protein, matrix protein ([E2]M[/E2]), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[118, 119]], "entity_2_idx_in_text_with_entity_marker": [131, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p52", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase ([E2]HN[/E2]) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[204, 206]], "entity_2_idx_in_text_with_entity_marker": [217, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p53", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] ([E2]NP[/E2]), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[66, 68]], "entity_2_idx_in_text_with_entity_marker": [79, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p54", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P), V protein, [E2]matrix protein[/E2] (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix protein", "entity_2_idx": [[102, 116]], "entity_2_idx_in_text_with_entity_marker": [115, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p55", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, [E2]haemagglutinin-neuraminidase[/E2] (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "haemagglutinin-neuraminidase", "entity_2_idx": [[174, 202], [208, 215]], "entity_2_idx_in_text_with_entity_marker": [187, 215], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p56", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] (NP), phosphoprotein ([E2]P[/E2]), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[87, 88]], "entity_2_idx_in_text_with_entity_marker": [100, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p57", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic ([E2]SH[/E2]) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SH", "entity_2_idx": [[161, 163]], "entity_2_idx_in_text_with_entity_marker": [174, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p58", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein ([E2]F[/E2]), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[138, 139]], "entity_2_idx_in_text_with_entity_marker": [151, 152], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p59", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large ([E2]L[/E2]) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[227, 228]], "entity_2_idx_in_text_with_entity_marker": [240, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d297.s0_BioInfer.d297.s0.p0", "text": "Immunoprecipitation of alpha-catenin was increased in response to both doses of CdCl2, while the immunoprecipitation of beta-catenin was little changed by either cadmium dose.", "text_with_entity_marker": "Immunoprecipitation of [E1]alpha-catenin[/E1] was increased in response to both doses of CdCl2, while the immunoprecipitation of [E2]beta-catenin[/E2] was little changed by either cadmium dose.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[23, 36]], "entity_1_idx_in_text_with_entity_marker": [27, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[120, 132]], "entity_2_idx_in_text_with_entity_marker": [133, 145], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s1_BioInfer.d171.s1.p0", "text": "LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.", "text_with_entity_marker": "LOH was found in the RAD51 region in 32% of tumours, in the [E1]RAD52[/E1] region in 16%, in RAD54 in 20% and in the BRCA1 and [E2]BRCA2[/E2] regions in 49% and 44% respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD52", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BRCA2", "entity_2_idx": [[118, 123]], "entity_2_idx_in_text_with_entity_marker": [131, 136], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s1_BioInfer.d171.s1.p1", "text": "LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.", "text_with_entity_marker": "LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in [E1]RAD54[/E1] in 20% and in the BRCA1 and [E2]BRCA2[/E2] regions in 49% and 44% respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD54", "entity_1_idx": [[84, 89]], "entity_1_idx_in_text_with_entity_marker": [88, 93], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BRCA2", "entity_2_idx": [[118, 123]], "entity_2_idx_in_text_with_entity_marker": [131, 136], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s1_BioInfer.d171.s1.p2", "text": "LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.", "text_with_entity_marker": "LOH was found in the [E1]RAD51[/E1] region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the BRCA1 and [E2]BRCA2[/E2] regions in 49% and 44% respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[21, 26]], "entity_1_idx_in_text_with_entity_marker": [25, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BRCA2", "entity_2_idx": [[118, 123]], "entity_2_idx_in_text_with_entity_marker": [131, 136], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s1_BioInfer.d171.s1.p3", "text": "LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.", "text_with_entity_marker": "LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the [E1]BRCA1[/E1] and [E2]BRCA2[/E2] regions in 49% and 44% respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BRCA1", "entity_1_idx": [[108, 113]], "entity_1_idx_in_text_with_entity_marker": [112, 117], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BRCA2", "entity_2_idx": [[118, 123]], "entity_2_idx_in_text_with_entity_marker": [131, 136], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s1_BioInfer.d171.s1.p4", "text": "LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.", "text_with_entity_marker": "LOH was found in the RAD51 region in 32% of tumours, in the [E1]RAD52[/E1] region in 16%, in [E2]RAD54[/E2] in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD52", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD54", "entity_2_idx": [[84, 89]], "entity_2_idx_in_text_with_entity_marker": [97, 102], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s1_BioInfer.d171.s1.p5", "text": "LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.", "text_with_entity_marker": "LOH was found in the [E1]RAD51[/E1] region in 32% of tumours, in the [E2]RAD52[/E2] region in 16%, in RAD54 in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[21, 26]], "entity_1_idx_in_text_with_entity_marker": [25, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[60, 65]], "entity_2_idx_in_text_with_entity_marker": [73, 78], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s1_BioInfer.d171.s1.p6", "text": "LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.", "text_with_entity_marker": "LOH was found in the RAD51 region in 32% of tumours, in the [E1]RAD52[/E1] region in 16%, in RAD54 in 20% and in the [E2]BRCA1[/E2] and BRCA2 regions in 49% and 44% respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD52", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BRCA1", "entity_2_idx": [[108, 113]], "entity_2_idx_in_text_with_entity_marker": [121, 126], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s1_BioInfer.d171.s1.p7", "text": "LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.", "text_with_entity_marker": "LOH was found in the [E1]RAD51[/E1] region in 32% of tumours, in the RAD52 region in 16%, in [E2]RAD54[/E2] in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[21, 26]], "entity_1_idx_in_text_with_entity_marker": [25, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD54", "entity_2_idx": [[84, 89]], "entity_2_idx_in_text_with_entity_marker": [97, 102], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s1_BioInfer.d171.s1.p8", "text": "LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.", "text_with_entity_marker": "LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in [E1]RAD54[/E1] in 20% and in the [E2]BRCA1[/E2] and BRCA2 regions in 49% and 44% respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD54", "entity_1_idx": [[84, 89]], "entity_1_idx_in_text_with_entity_marker": [88, 93], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BRCA1", "entity_2_idx": [[108, 113]], "entity_2_idx_in_text_with_entity_marker": [121, 126], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d171.s1_BioInfer.d171.s1.p9", "text": "LOH was found in the RAD51 region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the BRCA1 and BRCA2 regions in 49% and 44% respectively.", "text_with_entity_marker": "LOH was found in the [E1]RAD51[/E1] region in 32% of tumours, in the RAD52 region in 16%, in RAD54 in 20% and in the [E2]BRCA1[/E2] and BRCA2 regions in 49% and 44% respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[21, 26]], "entity_1_idx_in_text_with_entity_marker": [25, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BRCA1", "entity_2_idx": [[108, 113]], "entity_2_idx_in_text_with_entity_marker": [121, 126], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "HPRD50.d20.s0_HPRD50.d20.s0.p0", "text": "The human Imp3 and Imp4 proteins form a ternary complex with hMpp10, which only interacts with the U3 snoRNA in 60-80S ribonucleoprotein complexes", "text_with_entity_marker": "The human [E1]Imp3[/E1] and [E2]Imp4[/E2] proteins form a ternary complex with hMpp10, which only interacts with the U3 snoRNA in 60-80S ribonucleoprotein complexes", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Imp3", "entity_1_idx": [[10, 14]], "entity_1_idx_in_text_with_entity_marker": [14, 18], "entity_1_type": "pm0100548||pm0102353||pm0121765", "entity_1_type_id": 68, "entity_2": "Imp4", "entity_2_idx": [[19, 23]], "entity_2_idx_in_text_with_entity_marker": [32, 36], "entity_2_type": "pm0104160||pm0117832", "entity_2_type_id": 69}], "directed": false, "reverse": false}
{"id": "HPRD50.d20.s0_HPRD50.d20.s0.p1", "text": "The human Imp3 and Imp4 proteins form a ternary complex with hMpp10, which only interacts with the U3 snoRNA in 60-80S ribonucleoprotein complexes", "text_with_entity_marker": "The human [E1]Imp3[/E1] and Imp4 proteins form a ternary complex with hMpp10, which only interacts with the U3 [E2]snoRNA[/E2] in 60-80S ribonucleoprotein complexes", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Imp3", "entity_1_idx": [[10, 14]], "entity_1_idx_in_text_with_entity_marker": [14, 18], "entity_1_type": "pm0100548||pm0102353||pm0121765", "entity_1_type_id": 68, "entity_2": "snoRNA", "entity_2_idx": [[102, 108]], "entity_2_idx_in_text_with_entity_marker": [115, 121], "entity_2_type": "pm0114346", "entity_2_type_id": 70}], "directed": false, "reverse": false}
{"id": "HPRD50.d20.s0_HPRD50.d20.s0.p2", "text": "The human Imp3 and Imp4 proteins form a ternary complex with hMpp10, which only interacts with the U3 snoRNA in 60-80S ribonucleoprotein complexes", "text_with_entity_marker": "The human Imp3 and [E1]Imp4[/E1] proteins form a ternary complex with hMpp10, which only interacts with the U3 [E2]snoRNA[/E2] in 60-80S ribonucleoprotein complexes", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Imp4", "entity_1_idx": [[19, 23]], "entity_1_idx_in_text_with_entity_marker": [23, 27], "entity_1_type": "pm0104160||pm0117832", "entity_1_type_id": 69, "entity_2": "snoRNA", "entity_2_idx": [[102, 108]], "entity_2_idx_in_text_with_entity_marker": [115, 121], "entity_2_type": "pm0114346", "entity_2_type_id": 70}], "directed": false, "reverse": false}
{"id": "HPRD50.d20.s3_HPRD50.d20.s3.p1", "text": "The results of density gradient centrifugation experiments show that, in contrast to hU3-55K, the human Imp3 and Imp4 proteins predominantly interact with the U3 snoRNA in 60-80S ribonucleoprotein complexes", "text_with_entity_marker": "The results of density gradient centrifugation experiments show that, in contrast to hU3-55K, the human [E1]Imp3[/E1] and Imp4 proteins predominantly interact with the U3 [E2]snoRNA[/E2] in 60-80S ribonucleoprotein complexes", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Imp3", "entity_1_idx": [[104, 108]], "entity_1_idx_in_text_with_entity_marker": [108, 112], "entity_1_type": "pm0100548||pm0102353||pm0121765", "entity_1_type_id": 68, "entity_2": "snoRNA", "entity_2_idx": [[162, 168]], "entity_2_idx_in_text_with_entity_marker": [175, 181], "entity_2_type": "pm0114346", "entity_2_type_id": 70}], "directed": false, "reverse": false}
{"id": "HPRD50.d20.s3_HPRD50.d20.s3.p2", "text": "The results of density gradient centrifugation experiments show that, in contrast to hU3-55K, the human Imp3 and Imp4 proteins predominantly interact with the U3 snoRNA in 60-80S ribonucleoprotein complexes", "text_with_entity_marker": "The results of density gradient centrifugation experiments show that, in contrast to hU3-55K, the human Imp3 and [E1]Imp4[/E1] proteins predominantly interact with the U3 [E2]snoRNA[/E2] in 60-80S ribonucleoprotein complexes", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Imp4", "entity_1_idx": [[113, 117]], "entity_1_idx_in_text_with_entity_marker": [117, 121], "entity_1_type": "pm0104160||pm0117832", "entity_1_type_id": 69, "entity_2": "snoRNA", "entity_2_idx": [[162, 168]], "entity_2_idx_in_text_with_entity_marker": [175, 181], "entity_2_type": "pm0114346", "entity_2_type_id": 70}], "directed": false, "reverse": false}
{"id": "HPRD50.d14.s1_HPRD50.d14.s1.p0", "text": "Megalin and cubilin are two structurally different endocytic receptors that interact to serve such functions", "text_with_entity_marker": "[E1]Megalin[/E1] and [E2]cubilin[/E2] are two structurally different endocytic receptors that interact to serve such functions", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Megalin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "pm0100604", "entity_1_type_id": 46, "entity_2": "cubilin", "entity_2_idx": [[12, 19]], "entity_2_idx_in_text_with_entity_marker": [25, 32], "entity_2_type": "pm0100963", "entity_2_type_id": 47}], "directed": false, "reverse": false}
{"id": "HPRD50.d30.s0_HPRD50.d30.s0.p0", "text": "The tyrosine kinase Tyk-2 is physically associated with the Type I interferon (IFN) receptor complex and is rapidly activated during IFN alpha stimulation", "text_with_entity_marker": "The tyrosine kinase [E1]Tyk-2[/E1] is physically associated with the Type I interferon ([E2]IFN[/E2]) receptor complex and is rapidly activated during IFN alpha stimulation", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Tyk-2", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "pm0101504", "entity_1_type_id": 110, "entity_2": "IFN", "entity_2_idx": [[79, 82]], "entity_2_idx_in_text_with_entity_marker": [92, 95], "entity_2_type": "pm0111853", "entity_2_type_id": 111}], "directed": false, "reverse": false}
{"id": "HPRD50.d30.s0_HPRD50.d30.s0.p1", "text": "The tyrosine kinase Tyk-2 is physically associated with the Type I interferon (IFN) receptor complex and is rapidly activated during IFN alpha stimulation", "text_with_entity_marker": "The tyrosine kinase [E1]Tyk-2[/E1] is physically associated with the Type I interferon (IFN) receptor complex and is rapidly activated during [E2]IFN alpha[/E2] stimulation", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Tyk-2", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "pm0101504", "entity_1_type_id": 110, "entity_2": "IFN alpha", "entity_2_idx": [[133, 142]], "entity_2_idx_in_text_with_entity_marker": [146, 155], "entity_2_type": "pm0111853", "entity_2_type_id": 111}], "directed": false, "reverse": false}
{"id": "HPRD50.d19.s1_HPRD50.d19.s1.p0", "text": "p300/cAMP-response-element-binding-protein ('CREB')-binding protein (CBP) interacting with transcription factors is able to increase their activity on target gene promoters", "text_with_entity_marker": "[E1]p300[/E1]/[E2]cAMP-response-element-binding-protein[/E2] ('CREB')-binding protein (CBP) interacting with transcription factors is able to increase their activity on target gene promoters", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p300", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "pm0126787", "entity_1_type_id": 65, "entity_2": "cAMP-response-element-binding-protein", "entity_2_idx": [[5, 42]], "entity_2_idx_in_text_with_entity_marker": [18, 55], "entity_2_type": "pm0100874", "entity_2_type_id": 66}], "directed": false, "reverse": false}
{"id": "HPRD50.d19.s1_HPRD50.d19.s1.p1", "text": "p300/cAMP-response-element-binding-protein ('CREB')-binding protein (CBP) interacting with transcription factors is able to increase their activity on target gene promoters", "text_with_entity_marker": "[E1]p300[/E1]/cAMP-response-element-binding-protein ('[E2]CREB[/E2]')-binding protein (CBP) interacting with transcription factors is able to increase their activity on target gene promoters", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p300", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "pm0126787", "entity_1_type_id": 65, "entity_2": "CREB", "entity_2_idx": [[45, 49]], "entity_2_idx_in_text_with_entity_marker": [58, 62], "entity_2_type": "pm0100874", "entity_2_type_id": 66}], "directed": false, "reverse": false}
{"id": "HPRD50.d19.s1_HPRD50.d19.s1.p2", "text": "p300/cAMP-response-element-binding-protein ('CREB')-binding protein (CBP) interacting with transcription factors is able to increase their activity on target gene promoters", "text_with_entity_marker": "p300/[E1]cAMP-response-element-binding-protein[/E1] ('[E2]CREB[/E2]')-binding protein (CBP) interacting with transcription factors is able to increase their activity on target gene promoters", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "cAMP-response-element-binding-protein", "entity_1_idx": [[5, 42]], "entity_1_idx_in_text_with_entity_marker": [9, 46], "entity_1_type": "pm0100874", "entity_1_type_id": 66, "entity_2": "CREB", "entity_2_idx": [[45, 49]], "entity_2_idx_in_text_with_entity_marker": [58, 62], "entity_2_type": "pm0100874", "entity_2_type_id": 66}], "directed": false, "reverse": false}
{"id": "HPRD50.d39.s1_HPRD50.d39.s1.p0", "text": "SRcyp is a nuclear protein with a characteristic distribution in large irregularly shaped nuclear speckles and co-localizes perfectly with the SR domain-containing splicing factor SC35", "text_with_entity_marker": "[E1]SRcyp[/E1] is a nuclear protein with a characteristic distribution in large irregularly shaped nuclear speckles and co-localizes perfectly with the SR domain-containing [E2]splicing factor SC35[/E2]", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SRcyp", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "pm0120029", "entity_1_type_id": 144, "entity_2": "splicing factor SC35", "entity_2_idx": [[164, 184]], "entity_2_idx_in_text_with_entity_marker": [177, 197], "entity_2_type": "pm0120690", "entity_2_type_id": 147}], "directed": false, "reverse": false}
{"id": "IEPA.d126.s299_IEPA.d126.s299.p12", "text": "The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels", "text_with_entity_marker": "The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of [E1]leptin[/E1] resulted in induction of the uterine [E2]UCP2[/E2] and UCP3 levels", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[208, 214]], "entity_1_idx_in_text_with_entity_marker": [212, 218], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[252, 256]], "entity_2_idx_in_text_with_entity_marker": [265, 269], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d126.s299_IEPA.d126.s299.p13", "text": "The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of leptin resulted in induction of the uterine UCP2 and UCP3 levels", "text_with_entity_marker": "The expression of uterine UCP2 and UCP3 were up-regulated by 3.2- and 1.5-fold, respectively, during the late stage of pregnancy with an increase of WAT leptin mRNA expression and exogenous administration of [E1]leptin[/E1] resulted in induction of the uterine UCP2 and [E2]UCP3[/E2] levels", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[208, 214]], "entity_1_idx_in_text_with_entity_marker": [212, 218], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[261, 265]], "entity_2_idx_in_text_with_entity_marker": [274, 278], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d126.s300_IEPA.d126.s300.p4", "text": "These results indicate that UCP gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine UCP2 and UCP3 mRNA may be due to increased leptin levels", "text_with_entity_marker": "These results indicate that UCP gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine [E1]UCP2[/E1] and UCP3 mRNA may be due to increased [E2]leptin[/E2] levels", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "UCP2", "entity_1_idx": [[129, 133]], "entity_1_idx_in_text_with_entity_marker": [133, 137], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[172, 178]], "entity_2_idx_in_text_with_entity_marker": [185, 191], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d126.s300_IEPA.d126.s300.p5", "text": "These results indicate that UCP gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine UCP2 and UCP3 mRNA may be due to increased leptin levels", "text_with_entity_marker": "These results indicate that UCP gene expressions during pregnancy are regulated tissue-dependently, and up-regulation of uterine UCP2 and [E1]UCP3[/E1] mRNA may be due to increased [E2]leptin[/E2] levels", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "UCP3", "entity_1_idx": [[138, 142]], "entity_1_idx_in_text_with_entity_marker": [142, 146], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[172, 178]], "entity_2_idx_in_text_with_entity_marker": [185, 191], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d65.s163_IEPA.d65.s163.p0", "text": "Vasopressin-induced activation of protein kinase C in renal epithelial cells", "text_with_entity_marker": "[E1]Vasopressin[/E1]-induced activation of [E2]protein kinase C[/E2] in renal epithelial cells", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Vasopressin", "entity_1_idx": [[0, 11]], "entity_1_idx_in_text_with_entity_marker": [4, 15], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase C", "entity_2_idx": [[34, 50]], "entity_2_idx_in_text_with_entity_marker": [47, 63], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d65.s164_IEPA.d65.s164.p0", "text": "AVP induced a biphasic increase in diacylglycerol generation, characterized by an initial rapid rise and then a sustained elevation, and PKC activation, reflected by phosphorylation of a specific 80 kDa myristoylated alanine-rich PKC substrate (MARCKS)", "text_with_entity_marker": "[E1]AVP[/E1] induced a biphasic increase in diacylglycerol generation, characterized by an initial rapid rise and then a sustained elevation, and [E2]PKC[/E2] activation, reflected by phosphorylation of a specific 80 kDa myristoylated alanine-rich PKC substrate (MARCKS)", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "AVP", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[137, 140]], "entity_2_idx_in_text_with_entity_marker": [150, 153], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d65.s165_IEPA.d65.s165.p0", "text": "These results argue that Ca(2+)-dependent PKC is involved in the action of AVP, and that of other agonists, which stimulate sodium transport", "text_with_entity_marker": "These results argue that Ca(2+)-dependent [E1]PKC[/E1] is involved in the action of [E2]AVP[/E2], and that of other agonists, which stimulate sodium transport", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PKC", "entity_1_idx": [[42, 45]], "entity_1_idx_in_text_with_entity_marker": [46, 49], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[75, 78]], "entity_2_idx_in_text_with_entity_marker": [88, 91], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d60.s155_IEPA.d60.s155.p0", "text": "The activity of the MAPKs, induced by AVP or PMA was inhibited by downregulation of protein kinase C (PKC), by the tyrosine kinase inhibitor genistein and by MAPK kinase (MEK) inhibitor, PD98059", "text_with_entity_marker": "The activity of the MAPKs, induced by [E1]AVP[/E1] or PMA was inhibited by downregulation of [E2]protein kinase C[/E2] (PKC), by the tyrosine kinase inhibitor genistein and by MAPK kinase (MEK) inhibitor, PD98059", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "AVP", "entity_1_idx": [[38, 41]], "entity_1_idx_in_text_with_entity_marker": [42, 45], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase C", "entity_2_idx": [[84, 100]], "entity_2_idx_in_text_with_entity_marker": [97, 113], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d60.s156_IEPA.d60.s156.p0", "text": "We suggest that AVP activates the 42/44kDa MAPKs through a signal transduction pathway that involves stimulation of AVP-V1 receptor, tyrosine kinase, PKC and MEK", "text_with_entity_marker": "We suggest that [E1]AVP[/E1] activates the 42/44kDa MAPKs through a signal transduction pathway that involves stimulation of AVP-V1 receptor, tyrosine kinase, [E2]PKC[/E2] and MEK", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "AVP", "entity_1_idx": [[16, 19]], "entity_1_idx_in_text_with_entity_marker": [20, 23], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[150, 153]], "entity_2_idx_in_text_with_entity_marker": [163, 166], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d192.s460_IEPA.d192.s460.p0", "text": "Compared with the wild type, GA induction of alpha-amylase activity in aleurone cells of d1 was greatly reduced", "text_with_entity_marker": "Compared with the wild type, [E1]GA[/E1] induction of [E2]alpha-amylase[/E2] activity in aleurone cells of d1 was greatly reduced", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GA", "entity_1_idx": [[29, 31]], "entity_1_idx_in_text_with_entity_marker": [33, 35], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[45, 58]], "entity_2_idx_in_text_with_entity_marker": [58, 71], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d192.s461_IEPA.d192.s461.p0", "text": "Relative to the wild type, the GA(3)-treated aleurone layer of d1 had lower expression of Ramy1A, which encodes alpha-amylase, and OsGAMYB, which encodes a GA-inducible transcriptional factor, and no increase in expression of Ca(2 +)-ATPase", "text_with_entity_marker": "Relative to the wild type, the [E1]GA[/E1](3)-treated aleurone layer of d1 had lower expression of Ramy1A, which encodes [E2]alpha-amylase[/E2], and OsGAMYB, which encodes a GA-inducible transcriptional factor, and no increase in expression of Ca(2 +)-ATPase", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GA", "entity_1_idx": [[31, 33]], "entity_1_idx_in_text_with_entity_marker": [35, 37], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[112, 125]], "entity_2_idx_in_text_with_entity_marker": [125, 138], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d192.s462_IEPA.d192.s462.p0", "text": "However, in the presence of high GA concentrations, alpha-amylase induction occurred even in d1", "text_with_entity_marker": "However, in the presence of high [E1]GA[/E1] concentrations, [E2]alpha-amylase[/E2] induction occurred even in d1", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GA", "entity_1_idx": [[33, 35]], "entity_1_idx_in_text_with_entity_marker": [37, 39], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[52, 65]], "entity_2_idx_in_text_with_entity_marker": [65, 78], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d192.s463_IEPA.d192.s463.p0", "text": "All these results suggest that d1 affects a part of the GA-signaling pathway, namely the induction of alpha-amylase in the aleurone layer and internode elongation", "text_with_entity_marker": "All these results suggest that d1 affects a part of the [E1]GA[/E1]-signaling pathway, namely the induction of [E2]alpha-amylase[/E2] in the aleurone layer and internode elongation", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GA", "entity_1_idx": [[56, 58]], "entity_1_idx_in_text_with_entity_marker": [60, 62], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[102, 115]], "entity_2_idx_in_text_with_entity_marker": [115, 128], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d43.s108_IEPA.d43.s108.p0", "text": "Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation", "text_with_entity_marker": "Induction by [E1]leptin[/E1] of [E2]uncoupling protein-2[/E2] and enzymes of fatty acid oxidation", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[13, 19]], "entity_1_idx_in_text_with_entity_marker": [17, 23], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein-2", "entity_2_idx": [[23, 43]], "entity_2_idx_in_text_with_entity_marker": [36, 56], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d43.s109_IEPA.d43.s109.p0", "text": "Here we show that leptin alters in pancreatic islets the mRNA of the genes encoding enzymes of free fatty acid metabolism and uncoupling protein-2 (UCP-2)", "text_with_entity_marker": "Here we show that [E1]leptin[/E1] alters in pancreatic islets the mRNA of the genes encoding enzymes of free fatty acid metabolism and [E2]uncoupling protein-2[/E2] (UCP-2)", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[18, 24]], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein-2", "entity_2_idx": [[126, 146]], "entity_2_idx_in_text_with_entity_marker": [139, 159], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d43.s110_IEPA.d43.s110.p0", "text": "Leptin overexpression increased UCP-2 mRNA by more than 10-fold in epididymal, retroperitoneal, and subcutaneous fat tissue of normal, but not of leptin-receptor-defective obese rats", "text_with_entity_marker": "[E1]Leptin[/E1] overexpression increased [E2]UCP-2[/E2] mRNA by more than 10-fold in epididymal, retroperitoneal, and subcutaneous fat tissue of normal, but not of leptin-receptor-defective obese rats", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-2", "entity_2_idx": [[32, 37]], "entity_2_idx_in_text_with_entity_marker": [45, 50], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d43.s111_IEPA.d43.s111.p0", "text": "By directly regulating the expression of enzymes of free fatty acid metabolism and of UCP-2, leptin controls intracellular triglyceride content of certain nonadipocytes, as well as adipocytes", "text_with_entity_marker": "By directly regulating the expression of enzymes of free fatty acid metabolism and of [E1]UCP-2[/E1], [E2]leptin[/E2] controls intracellular triglyceride content of certain nonadipocytes, as well as adipocytes", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "UCP-2", "entity_1_idx": [[86, 91]], "entity_1_idx_in_text_with_entity_marker": [90, 95], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[93, 99]], "entity_2_idx_in_text_with_entity_marker": [106, 112], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d182.s436_IEPA.d182.s436.p0", "text": "The effect of leptin in adult rats appears to be exerted at hypothalamic level by regulating growth hormone releasing hormone (GHRH), somatostatin and neuropeptide Y (NPY)-producing neurones", "text_with_entity_marker": "The effect of [E1]leptin[/E1] in adult rats appears to be exerted at hypothalamic level by regulating growth hormone releasing hormone (GHRH), somatostatin and [E2]neuropeptide Y[/E2] (NPY)-producing neurones", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[14, 20]], "entity_1_idx_in_text_with_entity_marker": [18, 24], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "neuropeptide Y", "entity_2_idx": [[151, 165]], "entity_2_idx_in_text_with_entity_marker": [164, 178], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d93.s226_IEPA.d93.s226.p0", "text": "Further investigation suggested that activation of protein kinase C (PKC), which is part of the AVP-induced intracellular signalling pathway, is necessary and sufficient for the generation of the synergistic response, although it is not obligatory for AVP-induced ACTH release", "text_with_entity_marker": "Further investigation suggested that activation of [E1]protein kinase C[/E1] (PKC), which is part of the [E2]AVP[/E2]-induced intracellular signalling pathway, is necessary and sufficient for the generation of the synergistic response, although it is not obligatory for AVP-induced ACTH release", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "protein kinase C", "entity_1_idx": [[51, 67]], "entity_1_idx_in_text_with_entity_marker": [55, 71], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d85.s204_IEPA.d85.s204.p0", "text": "A barley gene encoding a novel DNA-binding protein (HRT) was identified by southwestern screening with baits containing a gibberellin phytohormone response element from an alpha-amylase promoter", "text_with_entity_marker": "A barley gene encoding a novel DNA-binding protein (HRT) was identified by southwestern screening with baits containing a [E1]gibberellin[/E1] phytohormone response element from an [E2]alpha-amylase[/E2] promoter", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "gibberellin", "entity_1_idx": [[122, 133]], "entity_1_idx_in_text_with_entity_marker": [126, 137], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[172, 185]], "entity_2_idx_in_text_with_entity_marker": [185, 198], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d17.s37_IEPA.d17.s37.p0", "text": "Only oxytocin alone increased the formation of IPs in cells from ovariectomized pigs treated with estradiol in vivo (p < 0.01)", "text_with_entity_marker": "Only [E1]oxytocin[/E1] alone increased the formation of [E2]IPs[/E2] in cells from ovariectomized pigs treated with estradiol in vivo (p < 0.01)", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[5, 13]], "entity_1_idx_in_text_with_entity_marker": [9, 17], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IPs", "entity_2_idx": [[47, 50]], "entity_2_idx_in_text_with_entity_marker": [60, 63], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d51.s133_IEPA.d51.s133.p0", "text": "Insulin stimulates the release of the glycosyl phosphatidylinositol-anchored membrane dipeptidase from 3T3-L1 adipocytes through the action of a phospholipase C", "text_with_entity_marker": "[E1]Insulin[/E1] stimulates the release of the glycosyl phosphatidylinositol-anchored membrane dipeptidase from 3T3-L1 adipocytes through the action of a [E2]phospholipase C[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Insulin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[145, 160]], "entity_2_idx_in_text_with_entity_marker": [158, 173], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d51.s134_IEPA.d51.s134.p0", "text": "The hydrophilic form of MDP released from the cells on stimulation with insulin was recognized by antibodies against the inositol 1,2-cyclic monophosphate cross-reacting determinant, indicating that it had been generated by cleavage of its GPI anchor through the action of a phospholipase C", "text_with_entity_marker": "The hydrophilic form of MDP released from the cells on stimulation with [E1]insulin[/E1] was recognized by antibodies against the inositol 1,2-cyclic monophosphate cross-reacting determinant, indicating that it had been generated by cleavage of its GPI anchor through the action of a [E2]phospholipase C[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[72, 79]], "entity_1_idx_in_text_with_entity_marker": [76, 83], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[275, 290]], "entity_2_idx_in_text_with_entity_marker": [288, 303], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d61.s157_IEPA.d61.s157.p0", "text": "Secreted form of beta-amyloid precursor protein activates protein kinase C and phospholipase Cgamma1 in cultured embryonic rat neocortical cells", "text_with_entity_marker": "Secreted form of [E1]beta-amyloid[/E1] precursor protein activates protein kinase C and [E2]phospholipase Cgamma1[/E2] in cultured embryonic rat neocortical cells", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "beta-amyloid", "entity_1_idx": [[17, 29]], "entity_1_idx_in_text_with_entity_marker": [21, 33], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase Cgamma1", "entity_2_idx": [[79, 100]], "entity_2_idx_in_text_with_entity_marker": [92, 113], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d61.s158_IEPA.d61.s158.p0", "text": "Furthermore, we demonstrate that tyrosine phosphorylation of phospholipase Cgamma1 and formation of inositol 1,4,5-trisphosphate were increased by sAPP695-stimulation", "text_with_entity_marker": "Furthermore, we demonstrate that tyrosine phosphorylation of [E1]phospholipase Cgamma1[/E1] and formation of inositol 1,4,5-trisphosphate were increased by [E2]sAPP695[/E2]-stimulation", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "phospholipase Cgamma1", "entity_1_idx": [[61, 82]], "entity_1_idx_in_text_with_entity_marker": [65, 86], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "sAPP695", "entity_2_idx": [[147, 154]], "entity_2_idx_in_text_with_entity_marker": [160, 167], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d11.s23_IEPA.d11.s23.p0", "text": "Amyloid beta protein (25-35) stimulation of phospholipases A, C and D activities of LA-N-2 cells", "text_with_entity_marker": "[E1]Amyloid[/E1] beta protein (25-35) stimulation of [E2]phospholipases[/E2] A, C and D activities of LA-N-2 cells", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Amyloid", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipases", "entity_2_idx": [[44, 58]], "entity_2_idx_in_text_with_entity_marker": [57, 71], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d11.s25_IEPA.d11.s25.p0", "text": "The effects of adrenergic, metabotropic amino acid and bombesin antagonists on the A beta P mediated stimulation of phospholipase C activity was investigated", "text_with_entity_marker": "The effects of adrenergic, metabotropic amino acid and bombesin antagonists on the [E1]A beta P[/E1] mediated stimulation of [E2]phospholipase C[/E2] activity was investigated", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "A beta P", "entity_1_idx": [[83, 91]], "entity_1_idx_in_text_with_entity_marker": [87, 95], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[116, 131]], "entity_2_idx_in_text_with_entity_marker": [129, 144], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d11.s26_IEPA.d11.s26.p0", "text": "Propranolol, a beta adrenergic antagonist, 7-chloro-kynurenic acid, a metabotropic amino acid antagonist, and [Tyr4-D-Phe12]bombesin, a bombesin antagonist, blunted the A beta P stimulation of phospholipase C activity in [3H]inositol prelabeled LA-N-2 cells", "text_with_entity_marker": "Propranolol, a beta adrenergic antagonist, 7-chloro-kynurenic acid, a metabotropic amino acid antagonist, and [Tyr4-D-Phe12]bombesin, a bombesin antagonist, blunted the [E1]A beta P[/E1] stimulation of [E2]phospholipase C[/E2] activity in [3H]inositol prelabeled LA-N-2 cells", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "A beta P", "entity_1_idx": [[169, 177]], "entity_1_idx_in_text_with_entity_marker": [173, 181], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[193, 208]], "entity_2_idx_in_text_with_entity_marker": [206, 221], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d11.s27_IEPA.d11.s27.p0", "text": "This suggests that amyloid beta protein activation of phospholipase C may be receptor mediated", "text_with_entity_marker": "This suggests that [E1]amyloid[/E1] beta protein activation of [E2]phospholipase C[/E2] may be receptor mediated", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "amyloid", "entity_1_idx": [[19, 26]], "entity_1_idx_in_text_with_entity_marker": [23, 30], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[54, 69]], "entity_2_idx_in_text_with_entity_marker": [67, 82], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d11.s28_IEPA.d11.s28.p2", "text": "The phospholipase C inhibitor U 71322 prevented the activation of phospholipase C by A beta P", "text_with_entity_marker": "The phospholipase C inhibitor U 71322 prevented the activation of [E1]phospholipase C[/E1] by [E2]A beta P[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "phospholipase C", "entity_1_idx": [[66, 81]], "entity_1_idx_in_text_with_entity_marker": [70, 85], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "A beta P", "entity_2_idx": [[85, 93]], "entity_2_idx_in_text_with_entity_marker": [98, 106], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d76.s183_IEPA.d76.s183.p0", "text": "In order to establish whether melatonin alters basal and/or stimulated oxytocin secretion, 18 normal men were treated (p.o.) with 6 or 12 mg melatonin or placebo in basal conditions (N-6 subjects) or concomitantly to the administration of insulin (O.15 IU/kg body weight in an i.v. bolus) (N-6 subjects) or angiotensin II (increasing doses of 4, 8 and 16 ng/kg/min, at intervals of 20 min)", "text_with_entity_marker": "In order to establish whether melatonin alters basal and/or stimulated [E1]oxytocin[/E1] secretion, 18 normal men were treated (p.o.) with 6 or 12 mg melatonin or placebo in basal conditions (N-6 subjects) or concomitantly to the administration of [E2]insulin[/E2] (O.15 IU/kg body weight in an i.v. bolus) (N-6 subjects) or angiotensin II (increasing doses of 4, 8 and 16 ng/kg/min, at intervals of 20 min)", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "oxytocin", "entity_1_idx": [[71, 79]], "entity_1_idx_in_text_with_entity_marker": [75, 83], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[239, 246]], "entity_2_idx_in_text_with_entity_marker": [252, 259], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d158.s377_IEPA.d158.s377.p0", "text": "NPY-leptin: opposing effects on appetitive and consummatory ingestive behavior and sexual behavior", "text_with_entity_marker": "[E1]NPY[/E1]-[E2]leptin[/E2]: opposing effects on appetitive and consummatory ingestive behavior and sexual behavior", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NPY", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[4, 10]], "entity_2_idx_in_text_with_entity_marker": [17, 23], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d158.s378_IEPA.d158.s378.p0", "text": "Many studies have indicated that neuropeptide Y (NPY) stimulates and leptin inhibits food intake", "text_with_entity_marker": "Many studies have indicated that [E1]neuropeptide Y[/E1] (NPY) stimulates and [E2]leptin[/E2] inhibits food intake", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "neuropeptide Y", "entity_1_idx": [[33, 47]], "entity_1_idx_in_text_with_entity_marker": [37, 51], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[69, 75]], "entity_2_idx_in_text_with_entity_marker": [82, 88], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d158.s379_IEPA.d158.s379.p0", "text": "In line with this, intracerebroventricular injection of NPY (10 microg) stimulated and leptin (10 microg) inhibited intake of a sucrose solution when female rats were required to obtain the solution from a bottle", "text_with_entity_marker": "In line with this, intracerebroventricular injection of [E1]NPY[/E1] (10 microg) stimulated and [E2]leptin[/E2] (10 microg) inhibited intake of a sucrose solution when female rats were required to obtain the solution from a bottle", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NPY", "entity_1_idx": [[56, 59]], "entity_1_idx_in_text_with_entity_marker": [60, 63], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[87, 93]], "entity_2_idx_in_text_with_entity_marker": [100, 106], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d158.s380_IEPA.d158.s380.p0", "text": "However, NPY inhibited and leptin stimulated intake if the solution was infused intraorally", "text_with_entity_marker": "However, [E1]NPY[/E1] inhibited and [E2]leptin[/E2] stimulated intake if the solution was infused intraorally", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NPY", "entity_1_idx": [[9, 12]], "entity_1_idx_in_text_with_entity_marker": [13, 16], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[27, 33]], "entity_2_idx_in_text_with_entity_marker": [40, 46], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d158.s381_IEPA.d158.s381.p0", "text": "Thus NPY stimulates the responses used to obtain food but inhibits those used to consume food, and leptin has the opposite effects", "text_with_entity_marker": "Thus [E1]NPY[/E1] stimulates the responses used to obtain food but inhibits those used to consume food, and [E2]leptin[/E2] has the opposite effects", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NPY", "entity_1_idx": [[5, 8]], "entity_1_idx_in_text_with_entity_marker": [9, 12], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[99, 105]], "entity_2_idx_in_text_with_entity_marker": [112, 118], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d14.s31_IEPA.d14.s31.p0", "text": "This indicates that the calcium response to OT application was principally associated with activation of the IP3-sensitive calcium stores", "text_with_entity_marker": "This indicates that the calcium response to [E1]OT[/E1] application was principally associated with activation of the [E2]IP3[/E2]-sensitive calcium stores", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "OT", "entity_1_idx": [[44, 46]], "entity_1_idx_in_text_with_entity_marker": [48, 50], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "IP3", "entity_2_idx": [[109, 112]], "entity_2_idx_in_text_with_entity_marker": [122, 125], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d45.s114_IEPA.d45.s114.p0", "text": "Cellular preincubation with 200 microg/ml antibodies against the inositolphosphoglycan (IPG) moiety of the GPI-anchor (Ab(IPG)), or depletion in GPI-anchored proteins by cellular pretreatment with 0.5 U/ml PI-PLC, 1 mM insulin and 2 HU/ml streptolysin-O, or depletion in membrane cholesterol content by filipin (5 microg/ml), digitonin (5 microg/ml) and cholesterol oxidase (0.5 U/ml) decreases the HDL3-signal, suggesting the involvement of a lipolytic cleavage of GPI-anchored proteins", "text_with_entity_marker": "Cellular preincubation with 200 microg/ml antibodies against the inositolphosphoglycan (IPG) moiety of the GPI-anchor (Ab(IPG)), or depletion in GPI-anchored proteins by cellular pretreatment with 0.5 U/ml PI-[E1]PLC[/E1], 1 mM [E2]insulin[/E2] and 2 HU/ml streptolysin-O, or depletion in membrane cholesterol content by filipin (5 microg/ml), digitonin (5 microg/ml) and cholesterol oxidase (0.5 U/ml) decreases the HDL3-signal, suggesting the involvement of a lipolytic cleavage of GPI-anchored proteins", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PLC", "entity_1_idx": [[209, 212]], "entity_1_idx_in_text_with_entity_marker": [213, 216], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[219, 226]], "entity_2_idx_in_text_with_entity_marker": [232, 239], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d25.s54_IEPA.d25.s54.p0", "text": "The responses of serum oxytocin (OT) and vasopressin (AVP) to the serotonergic HT1A agonist buspirone (15 mg p.o.) or the HTD1 agonist sumatriptan (6 mg injected subcutaneously) were evaluated in 7 normal men either in basal conditions or during an insulin (0.15 iu/kg as an i.v. bolus) tolerance test (ITT)", "text_with_entity_marker": "The responses of serum [E1]oxytocin[/E1] (OT) and vasopressin (AVP) to the serotonergic HT1A agonist buspirone (15 mg p.o.) or the HTD1 agonist sumatriptan (6 mg injected subcutaneously) were evaluated in 7 normal men either in basal conditions or during an [E2]insulin[/E2] (0.15 iu/kg as an i.v. bolus) tolerance test (ITT)", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "oxytocin", "entity_1_idx": [[23, 31]], "entity_1_idx_in_text_with_entity_marker": [27, 35], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[249, 256]], "entity_2_idx_in_text_with_entity_marker": [262, 269], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d9.s18_IEPA.d9.s18.p0", "text": "Oxytocin induced a biphasic increase in the intracellular Ca2+ concentration of porcine myometrial cells: participation of a pertussis toxin-insensitive G-protein, inositol 1,4,5-trisphosphate-sensitive Ca2+ pool, and Ca2+ channels", "text_with_entity_marker": "[E1]Oxytocin[/E1] induced a biphasic increase in the intracellular Ca2+ concentration of porcine myometrial cells: participation of a pertussis toxin-insensitive G-protein, [E2]inositol 1,4,5-trisphosphate[/E2]-sensitive Ca2+ pool, and Ca2+ channels", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Oxytocin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "inositol 1,4,5-trisphosphate", "entity_2_idx": [[164, 192]], "entity_2_idx_in_text_with_entity_marker": [177, 205], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d34.s80_IEPA.d34.s80.p0", "text": "Immunohistochemical localization of leptin and uncoupling protein in white and brown adipose tissue", "text_with_entity_marker": "Immunohistochemical localization of [E1]leptin[/E1] and [E2]uncoupling protein[/E2] in white and brown adipose tissue", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[36, 42]], "entity_1_idx_in_text_with_entity_marker": [40, 46], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein", "entity_2_idx": [[47, 65]], "entity_2_idx_in_text_with_entity_marker": [60, 78], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d34.s81_IEPA.d34.s81.p0", "text": "To establish the cell type expressing leptin, we also assessed the size and organization of lipid droplets, the ultrastructural features of mitochondria, and the presence or absence of uncoupling protein, a brown fat-specific marker", "text_with_entity_marker": "To establish the cell type expressing [E1]leptin[/E1], we also assessed the size and organization of lipid droplets, the ultrastructural features of mitochondria, and the presence or absence of [E2]uncoupling protein[/E2], a brown fat-specific marker", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[38, 44]], "entity_1_idx_in_text_with_entity_marker": [42, 48], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein", "entity_2_idx": [[185, 203]], "entity_2_idx_in_text_with_entity_marker": [198, 216], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d34.s82_IEPA.d34.s82.p0", "text": "In brown adipose tissue of lean animals, multilocular uncoupling protein (UCP)-positive brown adipocytes had typical brown mitochondria and were leptin-negative, both in fed and fasted conditions", "text_with_entity_marker": "In brown adipose tissue of lean animals, multilocular [E1]uncoupling protein[/E1] (UCP)-positive brown adipocytes had typical brown mitochondria and were [E2]leptin[/E2]-negative, both in fed and fasted conditions", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "uncoupling protein", "entity_1_idx": [[54, 72]], "entity_1_idx_in_text_with_entity_marker": [58, 76], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[145, 151]], "entity_2_idx_in_text_with_entity_marker": [158, 164], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d34.s83_IEPA.d34.s83.p0", "text": "At the periphery of the interscapular brown adipose tissue depot, unilocular, UCP-negative adipocytes (mean diameter: 41.55 microns) with white-type mitochondria were observed, and these cells were leptin-positive", "text_with_entity_marker": "At the periphery of the interscapular brown adipose tissue depot, unilocular, [E1]UCP[/E1]-negative adipocytes (mean diameter: 41.55 microns) with white-type mitochondria were observed, and these cells were [E2]leptin[/E2]-positive", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP", "entity_1_idx": [[78, 81]], "entity_1_idx_in_text_with_entity_marker": [82, 85], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[198, 204]], "entity_2_idx_in_text_with_entity_marker": [211, 217], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d34.s84_IEPA.d34.s84.p0", "text": "In obese (db/db) animals, brown fat was composed mainly of small unilocular, UCP-positive adipocytes (mean diameter: 40.08 microns), which were also leptin-positive", "text_with_entity_marker": "In obese (db/db) animals, brown fat was composed mainly of small unilocular, [E1]UCP[/E1]-positive adipocytes (mean diameter: 40.08 microns), which were also [E2]leptin[/E2]-positive", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP", "entity_1_idx": [[77, 80]], "entity_1_idx_in_text_with_entity_marker": [81, 84], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[149, 155]], "entity_2_idx_in_text_with_entity_marker": [162, 168], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d34.s85_IEPA.d34.s85.p0", "text": "In summary, classical brown adipocytes differ from white adipocytes, not only by their morphology and UCP expression, but also by their apparent lack of detectable leptin expression", "text_with_entity_marker": "In summary, classical brown adipocytes differ from white adipocytes, not only by their morphology and [E1]UCP[/E1] expression, but also by their apparent lack of detectable [E2]leptin[/E2] expression", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP", "entity_1_idx": [[102, 105]], "entity_1_idx_in_text_with_entity_marker": [106, 109], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[164, 170]], "entity_2_idx_in_text_with_entity_marker": [177, 183], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d3.s4_IEPA.d3.s4.p0", "text": "Inositol 1,4,5-trisphosphate and oxytocin binding in human myometrium", "text_with_entity_marker": "[E1]Inositol 1,4,5-trisphosphate[/E1] and [E2]oxytocin[/E2] binding in human myometrium", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Inositol 1,4,5-trisphosphate", "entity_1_idx": [[0, 28]], "entity_1_idx_in_text_with_entity_marker": [4, 32], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[33, 41]], "entity_2_idx_in_text_with_entity_marker": [46, 54], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d30.s0_LLL.d30.s0.p1", "text": "We overproduced and purified sigma(X) from Escherichia coli and demonstrate that in vitro, both sigma(A) and sigma(X) holoenzymes recognize promoter elements within the sigX-ypuN control region.", "text_with_entity_marker": "We overproduced and purified sigma(X) from Escherichia coli and demonstrate that in vitro, both [E1]sigma(A)[/E1] and sigma(X) holoenzymes recognize promoter elements within the [E2]sigX[/E2]-ypuN control region.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigma(A)", "entity_1_idx": [[96, 104]], "entity_1_idx_in_text_with_entity_marker": [100, 108], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "sigX", "entity_2_idx": [[169, 173]], "entity_2_idx_in_text_with_entity_marker": [182, 186], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d30.s0_LLL.d30.s0.p2", "text": "We overproduced and purified sigma(X) from Escherichia coli and demonstrate that in vitro, both sigma(A) and sigma(X) holoenzymes recognize promoter elements within the sigX-ypuN control region.", "text_with_entity_marker": "We overproduced and purified sigma(X) from Escherichia coli and demonstrate that in vitro, both [E1]sigma(A)[/E1] and sigma(X) holoenzymes recognize promoter elements within the sigX-[E2]ypuN[/E2] control region.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigma(A)", "entity_1_idx": [[96, 104]], "entity_1_idx_in_text_with_entity_marker": [100, 108], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "ypuN", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d30.s0_LLL.d30.s0.p3", "text": "We overproduced and purified sigma(X) from Escherichia coli and demonstrate that in vitro, both sigma(A) and sigma(X) holoenzymes recognize promoter elements within the sigX-ypuN control region.", "text_with_entity_marker": "We overproduced and purified sigma(X) from Escherichia coli and demonstrate that in vitro, both sigma(A) and [E1]sigma(X)[/E1] holoenzymes recognize promoter elements within the [E2]sigX[/E2]-ypuN control region.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigma(X)", "entity_1_idx": [[109, 117]], "entity_1_idx_in_text_with_entity_marker": [113, 121], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "sigX", "entity_2_idx": [[169, 173]], "entity_2_idx_in_text_with_entity_marker": [182, 186], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d30.s0_LLL.d30.s0.p4", "text": "We overproduced and purified sigma(X) from Escherichia coli and demonstrate that in vitro, both sigma(A) and sigma(X) holoenzymes recognize promoter elements within the sigX-ypuN control region.", "text_with_entity_marker": "We overproduced and purified sigma(X) from Escherichia coli and demonstrate that in vitro, both sigma(A) and [E1]sigma(X)[/E1] holoenzymes recognize promoter elements within the sigX-[E2]ypuN[/E2] control region.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigma(X)", "entity_1_idx": [[109, 117]], "entity_1_idx_in_text_with_entity_marker": [113, 121], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "ypuN", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d15.s0_LLL.d15.s0.p0", "text": "Dephosphorylation of SpoIIAA-P by SpoIIE is strictly dependent on the presence of the bivalent metal ions Mn2+ or Mg2+.", "text_with_entity_marker": "Dephosphorylation of [E1]SpoIIAA-P[/E1] by [E2]SpoIIE[/E2] is strictly dependent on the presence of the bivalent metal ions Mn2+ or Mg2+.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SpoIIAA-P", "entity_1_idx": [[21, 30]], "entity_1_idx_in_text_with_entity_marker": [25, 34], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "SpoIIE", "entity_2_idx": [[34, 40]], "entity_2_idx_in_text_with_entity_marker": [47, 53], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d18.s0_LLL.d18.s0.p0", "text": "Most cot genes, and the gerE gene, are transcribed by sigmaK RNA polymerase.", "text_with_entity_marker": "Most [E1]cot[/E1] genes, and the gerE gene, are transcribed by [E2]sigmaK[/E2] RNA polymerase.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cot", "entity_1_idx": [[5, 8]], "entity_1_idx_in_text_with_entity_marker": [9, 12], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigmaK", "entity_2_idx": [[54, 60]], "entity_2_idx_in_text_with_entity_marker": [67, 73], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d18.s0_LLL.d18.s0.p1", "text": "Most cot genes, and the gerE gene, are transcribed by sigmaK RNA polymerase.", "text_with_entity_marker": "Most cot genes, and the [E1]gerE[/E1] gene, are transcribed by [E2]sigmaK[/E2] RNA polymerase.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "gerE", "entity_1_idx": [[24, 28]], "entity_1_idx_in_text_with_entity_marker": [28, 32], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigmaK", "entity_2_idx": [[54, 60]], "entity_2_idx_in_text_with_entity_marker": [67, 73], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d18.s1_LLL.d18.s1.p0", "text": "Previously, it was shown that the GerE protein inhibits transcription in vitro of the sigK gene encoding sigmaK.", "text_with_entity_marker": "Previously, it was shown that the [E1]GerE[/E1] protein inhibits transcription in vitro of the [E2]sigK[/E2] gene encoding sigmaK.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GerE", "entity_1_idx": [[34, 38]], "entity_1_idx_in_text_with_entity_marker": [38, 42], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "sigK", "entity_2_idx": [[86, 90]], "entity_2_idx_in_text_with_entity_marker": [99, 103], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d18.s2_LLL.d18.s2.p1", "text": "These results demonstrate that sigmaK-dependent transcription of gerE initiates a negative feedback loop in which GerE acts as a repressor to limit production of sigmaK.", "text_with_entity_marker": "These results demonstrate that [E1]sigmaK[/E1]-dependent transcription of [E2]gerE[/E2] initiates a negative feedback loop in which GerE acts as a repressor to limit production of sigmaK.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigmaK", "entity_1_idx": [[31, 37]], "entity_1_idx_in_text_with_entity_marker": [35, 41], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "gerE", "entity_2_idx": [[65, 69]], "entity_2_idx_in_text_with_entity_marker": [78, 82], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d18.s2_LLL.d18.s2.p4", "text": "These results demonstrate that sigmaK-dependent transcription of gerE initiates a negative feedback loop in which GerE acts as a repressor to limit production of sigmaK.", "text_with_entity_marker": "These results demonstrate that sigmaK-dependent transcription of gerE initiates a negative feedback loop in which [E1]GerE[/E1] acts as a repressor to limit production of [E2]sigmaK[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GerE", "entity_1_idx": [[114, 118]], "entity_1_idx_in_text_with_entity_marker": [118, 122], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "sigmaK", "entity_2_idx": [[162, 168]], "entity_2_idx_in_text_with_entity_marker": [175, 181], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d18.s3_LLL.d18.s3.p0", "text": "A low level of GerE activated transcription of cotD by sigmaK RNA polymerase in vitro, but a higher level of GerE repressed cotD transcription.", "text_with_entity_marker": "A low level of [E1]GerE[/E1] activated transcription of cotD by [E2]sigmaK[/E2] RNA polymerase in vitro, but a higher level of GerE repressed cotD transcription.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GerE", "entity_1_idx": [[15, 19]], "entity_1_idx_in_text_with_entity_marker": [19, 23], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "sigmaK", "entity_2_idx": [[55, 61]], "entity_2_idx_in_text_with_entity_marker": [68, 74], "entity_2_type": "agent/target", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "LLL.d18.s3_LLL.d18.s3.p2", "text": "A low level of GerE activated transcription of cotD by sigmaK RNA polymerase in vitro, but a higher level of GerE repressed cotD transcription.", "text_with_entity_marker": "A low level of [E1]GerE[/E1] activated transcription of [E2]cotD[/E2] by sigmaK RNA polymerase in vitro, but a higher level of GerE repressed cotD transcription.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GerE", "entity_1_idx": [[15, 19]], "entity_1_idx_in_text_with_entity_marker": [19, 23], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "cotD", "entity_2_idx": [[47, 51]], "entity_2_idx_in_text_with_entity_marker": [60, 64], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d18.s3_LLL.d18.s3.p5", "text": "A low level of GerE activated transcription of cotD by sigmaK RNA polymerase in vitro, but a higher level of GerE repressed cotD transcription.", "text_with_entity_marker": "A low level of GerE activated transcription of [E1]cotD[/E1] by [E2]sigmaK[/E2] RNA polymerase in vitro, but a higher level of GerE repressed cotD transcription.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cotD", "entity_1_idx": [[47, 51]], "entity_1_idx_in_text_with_entity_marker": [51, 55], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigmaK", "entity_2_idx": [[55, 61]], "entity_2_idx_in_text_with_entity_marker": [68, 74], "entity_2_type": "agent/target", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "LLL.d18.s3_LLL.d18.s3.p8", "text": "A low level of GerE activated transcription of cotD by sigmaK RNA polymerase in vitro, but a higher level of GerE repressed cotD transcription.", "text_with_entity_marker": "A low level of GerE activated transcription of cotD by sigmaK RNA polymerase in vitro, but a higher level of [E1]GerE[/E1] repressed [E2]cotD[/E2] transcription.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GerE", "entity_1_idx": [[109, 113]], "entity_1_idx_in_text_with_entity_marker": [113, 117], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "cotD", "entity_2_idx": [[124, 128]], "entity_2_idx_in_text_with_entity_marker": [137, 141], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d18.s4_LLL.d18.s4.p0", "text": "Here, we show that GerE binds near the sigK transcriptional start site, to act as a repressor.", "text_with_entity_marker": "Here, we show that [E1]GerE[/E1] binds near the [E2]sigK[/E2] transcriptional start site, to act as a repressor.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GerE", "entity_1_idx": [[19, 23]], "entity_1_idx_in_text_with_entity_marker": [23, 27], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "sigK", "entity_2_idx": [[39, 43]], "entity_2_idx_in_text_with_entity_marker": [52, 56], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d18.s5_LLL.d18.s5.p0", "text": "We show that GerE binds to two sites that span the -35 region of the cotD promoter.", "text_with_entity_marker": "We show that [E1]GerE[/E1] binds to two sites that span the -35 region of the [E2]cotD[/E2] promoter.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GerE", "entity_1_idx": [[13, 17]], "entity_1_idx_in_text_with_entity_marker": [17, 21], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "cotD", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d18.s6_LLL.d18.s6.p0", "text": "These results suggest that a rising level of GerE in sporulating cells may first activate cotD transcription from the upstream site then repress transcription as the downstream site becomes occupied.", "text_with_entity_marker": "These results suggest that a rising level of [E1]GerE[/E1] in sporulating cells may first activate [E2]cotD[/E2] transcription from the upstream site then repress transcription as the downstream site becomes occupied.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GerE", "entity_1_idx": [[45, 49]], "entity_1_idx_in_text_with_entity_marker": [49, 53], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "cotD", "entity_2_idx": [[90, 94]], "entity_2_idx_in_text_with_entity_marker": [103, 107], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d36.s0_LLL.d36.s0.p1", "text": "The sigmaB-dependent promoter drives expression of yvyD under stress conditions and after glucose starvation, whereas a sigmaH-dependent promoter is responsible for yvyD transcription following amino acid limitation.", "text_with_entity_marker": "The [E1]sigmaB[/E1]-dependent promoter drives expression of [E2]yvyD[/E2] under stress conditions and after glucose starvation, whereas a sigmaH-dependent promoter is responsible for yvyD transcription following amino acid limitation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigmaB", "entity_1_idx": [[4, 10]], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "yvyD", "entity_2_idx": [[51, 55]], "entity_2_idx_in_text_with_entity_marker": [64, 68], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d36.s0_LLL.d36.s0.p4", "text": "The sigmaB-dependent promoter drives expression of yvyD under stress conditions and after glucose starvation, whereas a sigmaH-dependent promoter is responsible for yvyD transcription following amino acid limitation.", "text_with_entity_marker": "The sigmaB-dependent promoter drives expression of yvyD under stress conditions and after glucose starvation, whereas a [E1]sigmaH[/E1]-dependent promoter is responsible for [E2]yvyD[/E2] transcription following amino acid limitation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigmaH", "entity_1_idx": [[120, 126]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "yvyD", "entity_2_idx": [[165, 169]], "entity_2_idx_in_text_with_entity_marker": [178, 182], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d36.s1_LLL.d36.s1.p1", "text": "This indicates that the yvyD gene product, being a member of both the sigmaB and sigmaH regulons, might negatively regulate the activity of the sigmaL regulon.", "text_with_entity_marker": "This indicates that the [E1]yvyD[/E1] gene product, being a member of both the [E2]sigmaB[/E2] and sigmaH regulons, might negatively regulate the activity of the sigmaL regulon.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "yvyD", "entity_1_idx": [[24, 28]], "entity_1_idx_in_text_with_entity_marker": [28, 32], "entity_1_type": "agent/target", "entity_1_type_id": 2, "entity_2": "sigmaB", "entity_2_idx": [[70, 76]], "entity_2_idx_in_text_with_entity_marker": [83, 89], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d36.s1_LLL.d36.s1.p3", "text": "This indicates that the yvyD gene product, being a member of both the sigmaB and sigmaH regulons, might negatively regulate the activity of the sigmaL regulon.", "text_with_entity_marker": "This indicates that the [E1]yvyD[/E1] gene product, being a member of both the sigmaB and [E2]sigmaH[/E2] regulons, might negatively regulate the activity of the sigmaL regulon.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "yvyD", "entity_1_idx": [[24, 28]], "entity_1_idx_in_text_with_entity_marker": [28, 32], "entity_1_type": "agent/target", "entity_1_type_id": 2, "entity_2": "sigmaH", "entity_2_idx": [[81, 87]], "entity_2_idx_in_text_with_entity_marker": [94, 100], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d36.s1_LLL.d36.s1.p5", "text": "This indicates that the yvyD gene product, being a member of both the sigmaB and sigmaH regulons, might negatively regulate the activity of the sigmaL regulon.", "text_with_entity_marker": "This indicates that the [E1]yvyD[/E1] gene product, being a member of both the sigmaB and sigmaH regulons, might negatively regulate the activity of the [E2]sigmaL[/E2] regulon.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "yvyD", "entity_1_idx": [[24, 28]], "entity_1_idx_in_text_with_entity_marker": [28, 32], "entity_1_type": "agent/target", "entity_1_type_id": 2, "entity_2": "sigmaL", "entity_2_idx": [[144, 150]], "entity_2_idx_in_text_with_entity_marker": [157, 163], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d36.s2_LLL.d36.s2.p0", "text": "In addition to the typical sigmaB-dependent, stress- and starvation-inducible pattern, yvyD is also induced in response to amino acid depletion.", "text_with_entity_marker": "In addition to the typical [E1]sigmaB[/E1]-dependent, stress- and starvation-inducible pattern, [E2]yvyD[/E2] is also induced in response to amino acid depletion.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigmaB", "entity_1_idx": [[27, 33]], "entity_1_idx_in_text_with_entity_marker": [31, 37], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "yvyD", "entity_2_idx": [[87, 91]], "entity_2_idx_in_text_with_entity_marker": [100, 104], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
